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Summary 
 
Obesity is an increasing cause of poor health in Scotland and contributes to many 
premature deaths. There are a range of preventable conditions for which causal 
links with obesity have been suggested including; type 2 diabetes, hypertension,  
hyperlipideamia (which is a major risk factor for ischemic heart disease), 
cardiovascular diseases (CVD) and certain cancers. CVD relates strongly to lifestyles, 
and risk factor modifications have been shown to reduce mortality and morbidity. It 
has become clear that the major contributors to poor cardiovascular health are 
related to adverse health behaviours namely excess body weight, diet, physical 
activity and smoking, and that risk assessment and primary prevention of CVD 
should remain a priority for the Public Health Agenda. 
Participants of the TASCFORCE study screening healthy adults over 40yrs for CVD risk 
were invited to participate in the HF2 randomised comparison study. All participants 
received the brief intervention at screening, baseline measurements of body mass 
index (BMI) and lipids. Participants with BMI ≥25kg/m² were eligible for HF2. 
Questionnaires were mailed after screening to assess general health, diet and 
activity. On return of the questionnaires participants were randomised to multiple-
contact intervention or follow-up only. For 16-weeks the multiple-contact group 
received monthly information packs and telephone consultations with lifestyle 
counsellors to help achieve weight-loss goals. Participants were then re-assessed for 
changes in weight, cardiovascular risk, diet, activity and general health.  
 
13 
The novel components in the HF2 investigation were; a cohort consisting of a middle 
aged population having undergone CVD risk screening, a fully powered randomised 
controlled trial of 16 weeks duration with the primary outcome of change in body 
weight and secondary outcomes to evaluate change in CVD risk factors, using the 
telephone as the primary mode of delivery. 
Per Protocol data indicated the multiple-contact group lost significantly more weight 
than the brief single contact group (between group difference 1.1kg, CI 0.1563 – 
2.0585, p=0.023), however, when adjusted using imputed data, the ITT data showed 
weight loss was no longer significant (between group difference 0.9kg, CI-0.1420 – 
1.9180, p=0.090).  
Although the HF2 intervention was not successful in achieving statistically significant 
weight loss, there were many positive outcomes. There were significant 
improvements in anthropometric modifiable risk factors shown in the intervention 
group notably a reduction in waist circumference, total cholesterol and low density 
lipoproteins. Both groups were successful in achieving weight loss and significantly 
improving a number of CVD risk factors, indicating that the HF2 intervention and the 
brief (usual care) advice were effective at initiating behaviour change.  
The study was shown to be acceptable with good participation satisfaction feedback 
for both intervention and control groups, with 94.5% in the intervention group 
rating the program as “worthwhile or excellent”. This study demonstrates it is 
feasible to use the screening setting as an opportunity to recruit participants for a 
lifestyle intervention.  
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1 INTRODUCTION 
 
1.1 Overview of the problem  
Cardiovascular Disease (CVD) is the number one cause of death globally. More 
people are dying annually from CVD than from any other cause (1) and mortality 
rates are expected to increase to almost 23.6 million by 2030, mainly from heart 
disease and strokes, which are projected to remain the single leading causes of 
death (1, 2). CVD is the main cause of premature death before the age of 65 in 
Europe, accounting for over 680,000 deaths each year (3). Thirty one percent of 
deaths in men and 26% of deaths in women are from CVD (3). CVD can exist with 
minimal or no symptoms and can progress rapidly. The first clinical manifestation is 
often catastrophic; acute myocardial infarction (MI), stroke, or sudden cardiac death 
(4).   
CVD relates strongly to lifestyles, and risk factor modifications have been shown to 
reduce mortality and morbidity (5). It has become clear that the major contributors 
to poor cardiovascular health are related to adverse health behaviours namely 
excess body weight, diet, physical activity and smoking, and that risk assessment and 
primary prevention of CVD should remain a priority for the Public Health Agenda (3). 
 
1.2 The Scottish perspective  
1.2.1 Excess Weight 
Scotland has one of the highest levels of obesity in the developed countries, third 
only to the USA and Mexico (6). The most recent findings from the Scottish Health 
Survey showed that just under two-thirds (64.3%) of adults (aged 16 and over) had 
excess weight while over a quarter (27.7%) were obese. In 2014 an increase from 
18 
 
52.4% to 62.2% was shown in the prevalence of adults aged 16-64 that were 
overweight or obese and the prevalence of obesity showed an increase from 17.2% 
to 26.5%. The greatest increases occurred between 1995 and 2008 and figures 
remain broadly stable since then (7), however, extrapolating from trend data in the 
USA, the Scottish Government has predicted that by 2030 adult obesity in Scotland 
could reach over 40% which would show an increase of more than 50% from 2008 
levels (8).  
Obesity is an increasing cause of poor health in Scotland and contributes to many 
premature deaths. There are a range of preventable conditions for which causal 
links with obesity have been suggested including type 2 diabetes, hypertension, 
hyperlipideamia (which is a major risk factor for ischemic heart disease), 
cardiovascular diseases and certain cancers. Other conditions such as respiratory 
insufficiency, infertility, sleep apnea, depression and anxiety have also been 
attributed to obesity, highlighting the necessity for successful interventions to 
reduce body weight and modify risk factors for these non-communicable diseases. 
1.2.2 Diet  
Poor diet and nutrition continues to be a major cause of ill-health and premature 
death in Scotland. Unhealthy eating habits are the second major cause of poor 
health and chronic disease after smoking (9). An increase in fruit and vegetable 
intake has been shown to significantly reduce the risk of many chronic diseases  (10), 
whereas, high consumption of red and processed meats and alcohol appears to be 
linked to colorectal cancer which is now the third most common cancer in both men 
and women in Scotland (11).  
Recent  studies have looked at the links between consumption of fruit and 
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vegetables over a broad range of conditions and concluded  that vegetable 
consumption is more important than fruit consumption in explaining reduced risks 
of certain types of breast cancer (12), stroke (13) and diabetes (14), while reduced 
risk of coronary heart disease in women (13), and esophageal and stomach cancers 
(15) are better explained by levels of fruit consumption, highlighting the need to 
encourage a balance of fruit and vegetable portions when considering behavior 
change interventions. 
1.2.3 Physical Activity 
Regular moderate intensity physical activity, such as walking, cycling, or participating 
in sports has significant benefits for health and weight control. It can reduce the risk 
of a range of conditions such as cardiovascular diseases, diabetes, colon and breast 
cancer, and depression (16). In 2014 The Scottish Health Survey reported that 63% 
of adults were active at the recommended level (150 minutes of moderate or 75 
minutes of vigorous activity per week), similar to the proportions in 2012 (62%) and 
2013 (64%) (17).  
One in five (22%) adults did fewer than 30 minutes of moderate or 15 minutes of 
vigorous activity per week and a significantly smaller proportion of women than men 
met the physical activity guidelines (59% and 68% respectively)(17). The main 
barriers cited by both men and women to preventing physical activity uptake in 
2012/2014 were: poor health (35%), a lack of time (32%), and lack of interest 
(17%)(17), therefore, weight reduction and behavior interventions need to include a 
range of behaviour techniques to address motivation, goal setting and individual 
barriers to changing behaviour.  
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1.2.4 Alcohol  
In Scotland alcohol consumption has long been regarded as socially acceptable. The 
misuse of alcohol not only brings negative social effects but also the potential for 
harmful physical effects such as hypertension, liver cirrhosis, some cancers, 
accidents/trauma, and can result in mental ill-health (18). It is also thought that 
alcohol is involved in 70% of assaults requiring treatment at A&E (18).  
 
Family and friends are often affected by others alcohol misuse with the potential for 
violence, neglect and/or abuse (19). In 2014 Alcohol Focus Scotland reported an 
estimated 1 in 2 people were harmed as a result of someone else’s drinking in 
Scotland (20). Changing individuals’ views on excessive alcohol intake can not only 
lead to a reduction in the negative social effects but also reduce risk for the 
conditions referred to earlier and contribute to weight reduction.  
 
1.2.5 Smoking 
Smoking remains the greatest preventable cause of ill-health and premature death 
in Scotland. In 2014, 20% of adults (22% of men and 19% of women) aged 16 years 
and over were cigarette smokers (21). Each year in Scotland there are over 10,000 
smoking-related deaths and 128,000 smoking-related admissions to hospitals. 
Smoking prevalence among adults has declined across the UK in the past 40 years, 
but continues to remain higher in Scotland than in England and Wales  (21). Smoking 
patterns need to be assessed and targeted for cessation within behaviour change 
interventions targeting weight loss and CVD risk reduction. This can often present a 
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challenge as many people are resistant to stop smoking due to the fear of gaining 
weight, which can be a major psychological hurdle to pass  (22). 
1.2.6 Conclusions 
In 2014 life expectancy in Scotland was reported to be 77.1 years for males and 81.1 
years for females, but with considerable variation between areas. Scottish males and 
females have the lowest life expectancy at birth in the United Kingdom. Males and 
females can expect to live shorter lives (by 2.3 years and 2.0 years respectively) than 
in England, where male and female life expectancy is the highest in the UK (23).  
Continued efforts through controlling weight, improving diet, increasing physical 
activity and reducing harmful levels of smoking and alcohol intake are necessary to 
increase healthy life expectancy and prevent ill health from non-communicable 
diseases. Despite significant Scottish Government investment in tackling health 
inequalities since devolution, the gap between rich and poor in Scotland remains 
persistently wide (24). A report into Health Inequalities in Scotland in 2015 pointed 
out that Government investment in public health campaigns  for example to tackle 
poor diet, lack of exercise, smoking and alcohol often led to disproportionate uptake 
that could widen health inequalities rather than narrow them (24). The causes of 
inequality in health in Scotland are considerable and complex, and out with the 
scope of this thesis to discuss, however, obesity, diet, physical activity, alcohol and 
smoking are highlighted in every Scottish Government report concerned reducing 
the incidence of non-communicable diseases and health inequality, and the reason 
why it is important to continue to look at behaviour change interventions directed at 
reducing levels of obesity and improving modifiable lifestyle behaviour outcomes.  
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1.3 Modifiable Risk Factors- an overview 
1.3.1 Excess Weight 
In the vast majority of cases, excess weight can be treated by caloric reduction and 
increasing caloric expenditure.  Psychologically, carrying excess weight affects many 
aspects of a person’s life, lack of self-esteem, feelings of isolation, difficulty and 
embarrassment in some social situations creating a cycle of eating food for comfort 
and consequent weight gain (25). Physically, increasing weight stresses the body 
particularly the heart as it becomes more difficult to pump blood around the body 
with the additional pressure resulting in hypertension (26).  
High consumption of dietary saturated fats leads to arteriosclerosis which obstructs 
blood flow contributing to hypertension, coronary heart disease, strokes and 
myocardial infarction. Intra-abdominal fat increases waist measurement an 
important indicator of increasing cardiovascular disease risk which consequently 
affects blood pressure, blood lipid levels and potentially insulin resistance.  Insulin is 
required to process glucose derived from food, the body's primary fuel. When that 
process is impaired hyperinsulinaemia will result in diabetes, an important risk factor 
of cardiovascular disease (27). 
Studies have shown that moderate intentional weight loss of around 5% body 
weight or more in overweight and obese adults with a history of diabetes is 
associated with lowered all-cause mortality. Intentional weight loss of between 5 kg 
to 10 kg in obese women with some obesity-related illness is associated with 
lowered cancer-related mortality and lowered diabetes-related mortality (28).  
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1.3.2 Diet 
Much of Scotland’s poor health can be attributed to an unhealthy diet. D iet plays a 
significant role in either protecting or pre-disposing a person to CVD.  Diet is one of 
the most important factors that can alter cardiovascular risk. A diet high in saturated 
and trans fats can lead to high levels of serum cholesterol which has a strong 
correlation with a risk of coronary artery disease, heart attack and death. Eating oil 
rich fish (high in omega-3 fatty acids), once or twice a week has been associated 
with a decrease in triglycerides, lower blood pressure, reduced blood clotting, a 
boost in immunity and improved arthritis symptoms and appears to reduce both the 
primary and secondary risk of heart disease (29).  
Dietary fats are important for several aspects of health and optimal bodily function. 
They are not only a source of energy and are indispensable for a number of 
important biological functions including growth and neural development but are 
involved in vital physiological processes such as carrying fat-soluble vitamins A, D, E 
and K, supporting their absorption in the intestine (30).  
A high sodium intake has been linked to hypertension, a major risk factor of CVD. It 
has been estimated that a universal reduction in dietary intake of sodium by about 
1g a day (3g of salt) would lead to a 50% reduction in the number of people needing 
treatment for hypertension.  The same decrease would lead to a 22% drop in the 
number of deaths resulting from strokes and a 16% fall in the number of deaths 
from coronary heart disease (31).  
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Diets high in fruit and vegetables have a number of bioactive components including 
polyphenols and glucosinolates which protect against heart disease and stroke.  
Unrefined grains contain folic acid, B vitamins and fibre, all of which are important 
protectors against heart disease (32). The protective effects of soluble fibre on 
cardiometabolic diseases is achieved through multiple mechanisms, reducing blood 
lipids, improving glucose metabolism, reducing chronic inflammation, controlling 
blood pressure and regulating body weight (32). 
 
1.3.3 Physical Activity  
Adults are more likely to maintain a healthy weight if they have an active lifestyle 
and are less sedentary. Regular physical activity can reduce the risk of developing 
CVD, type 2 diabetes, and certain cancers. It also strengthens bone and muscle and 
improves mental health and the ability to retain necessary function in old age such 
as climbing stairs, shopping and daily activities such as household chores  (33).  
Physical activity helps to regulate weight and improve the body’s use of insulin (34). 
Being active is beneficial in regulating blood pressure, blood lipid levels, blood 
glucose levels, blood clotting factors, the health of blood vessels and preventing 
blood vessel inflammation, all of which are potential indicators of CVD (35). 
Therefore, regular physical activity is one of the most important components of a 
healthy lifestyle. Current recommendations from the Scottish Intercollegiate 
Guidelines Network (SIGN) are for an individual to have at least 150 minutes (2.5 
hours) a week of moderate intensity physical activity in bouts of 10 minutes or more 
(36). In addition, for general health, the Department of Health recommend that the 
UK physical activity guidelines for adults should include a recommendation to 
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undertake muscle strengthening activities involving the major muscle groups of the 
body on two or more days per week (36).  
1.3.4 Smoking 
Smoking has long been recognised as the biggest single cause of preventable ill -
health and premature death in Scotland. There has been considerable success in 
reducing the smoking rate in recent years but smoking continues to be a major 
contributor to Scotland’s poor health. The Scottish Health Survey 2014 reported 
since 2003 generally, a continued downward trend in the proportion of adults who 
smoke has been observed. The survey showed a smoking level of 28% in 2003 with a 
statistically significant decline between 2012 and 2013 (from 25% to 21%). The level 
in 2014 sits at 22%, a 6% reduction on 2003 (19).  
Smoking is the most preventable cause of cardiovascular morbidity and mortality. It 
has been associated with a two to fourfold increased risk of coronary heart disease, 
a higher than 70% excess rate of death from coronary heart disease, and an elevated 
risk of sudden death (37). These risks are increased when combined with 
hypertension, elevated lipids, glucose intolerance, and diabetes. The risk of smoking 
and peripheral arterial disease has also been well documented.   
 
1.3.5 Metabolic Syndrome  
There has been an increase over the past two decades in the number of people with 
metabolic syndrome also known as “Syndrome X” (the insulin resistance syndrome). 
This increase is associated with the global epidemic of obesity and diabetes with a 
quarter of the world’s adult population reported to have the condition (38). People 
with metabolic syndrome are twice as likely to die, and three times as likely to suffer 
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a heart attack or stroke. They also have a five-fold greater risk of developing type 2 
diabetes compared with people without the syndrome. Up to 80% of the 200 million 
people with diabetes globally will die of CVD, which puts metabolic syndrome and 
diabetes way ahead of HIV/AIDS in morbidity and mortality terms yet is not as well 
recognized (39). 
Metabolic syndrome usually indicates high risk of CVD and developing diabetes. 
Lifestyle has a strong influence on all the components of metabolic syndrome, 
therefore, the main emphasis in the management of  metabolic syndrome should be 
in professionally supervised lifestyle changes, particularly efforts to reduce body 
weight and increase physical activity (40).  
The contributing components of metabolic syndrome include a combination of a 
waist circumference of 102 cm (40 inches) or more (in men) and 88 cm (35 inches) or 
more (in women), high levels of triglycerides and low levels of high density lipids, 
hypertension and glucose intolerance (type 2 diabetes, impaired glucose tolerance, 
or impaired fasting glycaemia) (39). 
Lower rates of these conditions are seen in subjects who undertake 120 to 150 
minutes a week of at least moderate-intensity aerobic activity, and the more 
physical activity one undertakes, the lower one’s risk (33). Current evidence 
reviewing modifiable risk factors has shown that rates of cardiovascular and other 
non-communicable disease mortality and morbidity can be reduced by adhering to 
recommended guidelines for diet, physical activity, weight and smoking cessation 
(41).  
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1.3.6 Socioeconomic Class  
There is a strong association between all of the risk factors discussed in the previous 
sections and socioeconomic classification. Marmot’s suggestion that elevated long -
term stress levels leading to elevated levels of adrenaline and cortisol in the blood in 
turn causes an increase in cholesterol levels and other physiological risk factors for 
diseases such as CVD and some cancers is entirely plausible (42). Long-term 
activation of the body’s stress-response increases susceptibility to these potential 
diseases and significantly increase morbidity and mortality levels in the lower 
socioeconomic group (42). 
 
1.4 Individual level Change and Opportunities for Change  
Individuals’ health behaviours are influenced by intrapersonal, socio-cultural, policy 
and physical-environmental factors. These variables are likely to interact, and 
multiple levels of environmental variables, such as living and working conditions, 
and community characteristics are relevant for understanding and changing these 
health behaviours (43). It is clear that in order for individuals to engage in behaviour 
change to improve diet and physical activity all the variables discussed previously 
which exert an influence on the individual’s opportunity to engage in healthy eating 
and physical activity have to be considered, along with the opportunities in everyday 
life which can promote these. The recently described COM-B model, a new method 
for characterising and designing behaviour change interventions considers the 
important factors required to predict behavior intention and facilitate behaviour 
change across many societal domains (44). 
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1.4.1 NICE Guidance for Individual Cardiovascular Disease Prevention. 
Guidance from The National Institute for Health and Care Excellence (NICE) Charter 
2013 (45), has highlighted primary care as an important setting for the promotion of 
individual physical activity and dietary change for the individual, and as so has made 
several recommendations in regards to physical activity shown in Table 1.1. These 
recommendations will be considered in the in the context of the delivery of diet and 
physical activity advice given at screening and follow up to HF2 study participants in 
this investigation, and adopt the principals that all health professionals utilise 
teachable moments to deliver lifestyle advice. 
Table 1.1 Summary of Guidance from The National Institute for Health and Care 
Excellence (NICE) Charter 2013 (45) 
 The recognition of the importance of GPs contribution in the promotion of physical 
activity and dietary change needs to be combined with the expertise of exercise and 
behaviour change specialists to offer in-depth and continued support to individuals.  
 A systematic approach is needed to integrate the promotion of physical activity into 
general practice rather than it being seen as an ‘add on’.  
 The need to encourage primary care staff to work on ‘lifestyle’ issues such as 
physical activity as currently other priorities compete for attention.  
 A requirement for training of GPs and other professionals to promote physical 
activity and counseling for other lifestyle risk factors  
 The design and content of interventions should be based on behavioural theories.  
 Interventions should tailor their options for activity on the needs of their 
participants and offer a range of moderate physical activities, in particular walking.  
 Interventions should contain tailored and targeted programmes to reach inactive 
individuals and contain regular contact and support with primary care staff.  
 Promotion of home-based walking and other moderate-intensity physical activities 
with a choice of local opportunities to be active (46). 
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1.5 The Challenge of Change, The Environment/Population level 
Challenges 
1.5.1  Population Dietary Changes 
The Foresight Report “Tackling Obesities: Future Choices” reported future 
implications for the increase in obesity, its causes and the evidence for i ts 
determinants and their associated uncertainties (47). Evidence from the report 
supports the concept of “passive obesity” where wider environmental conditions 
determine obesity irrespective of the desire to prevent increasing weight (47). 
Recent decades has seen a change in the way the environment and society 
influences daily living in the UK. Many people are employed in sedentary 
occupations and continue to be sedentary at home, car ownership has increased, 
eating habits have changed, in many cases eating patterns are less structured and 
“fast foods” low cost, energy dense high fat, salt and sugar foods are widely 
available and consumed on a regular basis.  
1.5.2 Environmental Changes 
There are several ways of theorising about the influence of the environment for the 
purposes of focusing research relating to diet. Black and Macinko summarised the 
literature on neighbourhood determinants of obesity and described the differences 
between the micro and the macro environment. The micro level environment 
includes genetic disposition, social class, cultural traditions, and individual 
demographics such as income, age, education, gender and ethnicity (48). These 
often fixed determinants go on to influence the macro environment which 
encompasses social, historical and political factors, such as public policies, food 
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availability, marketing influences, group-level social factors and the overarching 
economic, cultural and legislative influences that have shaped the local environment 
over time.  
Each of these levels potentially exerts a direct and indirect influence on behavioural 
choices (dietary and physical activity behaviours) and can ultimately impact on 
weight and weight-related morbidity (48). These environments are inextricably 
linked making the challenge of designing behaviour change interventions complex in 
the need to address a multitude of factors on an individual and population level.  
The number and complexity of determinates which contribute to the challenge of 
changing unhealthy dietary behaviour described in this theory is reflected in the 
complexity of the map produced in the Foresight report and shows the variety of 
systems at play which contribute to the challenge of changing the culture of 
overeating and its contribution to the increasing levels of obes ity (Figure1.1). 
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Figure 1.1 Obesity System Influence Diagram:  Foresight Tackling Obesity Future 
Choices Project Report 2nd Edition Government Office for Science. Reproduced with 
permission. 
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1.5.3 Physical Activity Changes 
Individual behaviour change interventions incorporating educational and 
motivational techniques to target CVD have been a focus in the past decade with 
some success. Considering what influences a person’s behaviour out with the 
individual, has triggered considerable thought about the built environment and how 
it allows opportunities to engage in physical activity.  Certain characteristics of the 
built environment in towns and cities have been related to the prevalence of chronic 
diseases and mental health (49).   
The changes in the way the environment around us have been developed by society 
and policy over past decades have reduced the need for us to engage in physical 
activity as part of the daily routine. The demise of an industrial nation, increase in 
mechanisation and computerisation has reduced the physical side of employment 
and labour saving devices at home have reduced our household chores. Cars are 
frequently favoured as a means of transport over walking and cycling all of which 
has resulted in a decrease in physical activity. The evidence is growing in support for 
major changes in population levels of physical activity which are required to improve 
cardiovascular health will require major modifications in environments and social 
policies. 
 
1.6 TASCFORCE/ Healthforce2  
The recently completed TASCFORCE (Tayside Screening for the Prevention of Cardiac 
events) (TF) investigation was a screening programme designed to identify risk of 
CVD in apparently healthy adults over the age of 40. Healthforce2 (HF2) is a nested 
cohort of volunteers within the Tascforce sample.  
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The HF2 study builds on the previous Healthforce (HF) feasibility study, (also a 
nested cohort) (50) which demonstrated that it was feasible to recruit 78 (64%) of 
121 eligible participants over an eight-month period and successfully deliver an 
acceptable, three month lifestyle intervention to participants of the TF study (50).  
The HF intervention was delivered via three face to face counselling sessions where 
the goals were to avoid weight gain, increase current levels of physical activity and 
increase fruit and vegetable intake towards achieving “5 a day”. In the intervention 
group the physical activity goal (to increase moderate physical activity by at least 
30 minutes per week) was achieved by 63%, the weight goal (weight 
maintenance/loss) was achieved by 82%, mean BMI and waist circumference both 
fell and those reporting regularly eating five portions of fruit and vegetables per day 
increased (56% at baseline vs. 85% at follow up) (50).  
Potential efficacy for the intervention was indicated, but remained to be assessed in 
a fully powered trial. A review of the literature supported a weight loss specific 
outcome such as that in the HF intervention had not been tested in a randomised 
controlled trial of CVD risk screening participants before, however, the relatively 
high costs inherent in delivering monthly face to face counselling sessions indicated 
a need for a more cost-effective approach. Healthforce2 (HF2) now aims to assess 
the outcome of delivering  brief (usual care) lifestyle advice versus a more intensive, 
minimal contact intervention in reducing body weight and modifiable CVD risk 
factors in healthy volunteers following cardiovascular risk screening. 
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2. Aim and Objectives 
 
2.1 Aim  
The primary aim of the HF2 study was to assess the outcome of a brief lifestyle 
intervention versus a multiple contact, minimal cost intervention on reducing body 
weight and modifiable CVD risk factors in healthy volunteers following cardio-
vascular risk screening, using the telephone as the mode of delivery.  
Primary Outcome Body weight change at 16 weeks 
 
2.2 Objectives  
 
1. To evaluate differences between groups with regard to changes in modifiable risk 
factors (changes in diet/physical activity, CVD risk and physiological measures). 
2. To evaluate change in modifiable risk factors; diet, physical activity, physiological 
markers of cardio metabolic disease and CVD risk in healthy volunteers following 
cardiovascular risk screening. 
3. To identify the subgroups (eg SIMD, gender) in which this intervention might be 
more effective. 
4. To examine risk perceptions and health beliefs relating to participants CVD risk, 
and self-reported Quality of Life measures. 
5.  To assess participant acceptability of a single versus multiple contact intervention 
approach. 
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3.  Literature Review 
3.1  Introduction  
The increasing prevalence and acceptance of overweight and obesity in society 
today has given cause for concern not only for individual health but also on our 
overburdened healthcare system.  CVD, type 2 diabetes and cancers have a direct 
impact in cost to the NHS in the UK in terms of treatment and long term disability. 
The importance of implementing effective interventions to address the increasing 
public health problem has been recognized, but the challenge of changing unhealthy 
behaviour and implementing successful policy and individual level interventions is 
yet to be fully realised.  
Designing effective behaviour change interventions to reduce the burden of non-
communicable diseases and changing modifiable risk factors requires an 
understanding of behaviour change theory and innovative strategies to enhance 
participant engagement and adherence. The results of the literature search that was 
carried out to provide an overview of previous research carried out on behaviour 
change interventions influencing weight loss are carried out in this chapter. 
Some specific areas the search considered related to theoretical behaviour change 
models and the methodology used to guide weight loss and modifiable risk factors 
interventions, the behaviour change techniques adopted and how they contributed 
to positive or negative outcomes, the duration, content and setting of brief 
interventions, the effectiveness of multiple contacts versus minimal contact face to 
face interventions and the use of the telephone in behaviour interventions. The 
search also looked at  behaviour change interventions carried out in a screening 
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setting and primary care as these can be seen as  similar settings in the a way that 
opportunistic lifestyle counselling can be readily applied.   
To inform the direction of the HF2 investigation, a breadth of literature was reviewed 
including empirical research, original quantitative and qualitative studies, systematic 
reviews and meta-analysis, surveys and government policy and reviews.  
 
3.2  Primary Search 
An electronic search was conducted using Cross Search, The University of Dundee 
federated search service which enables a simultaneous search of up to ten 
information sources. The Cross Search service allows access to a range of databases; 
Scopus, Medline, CINAHL plus EBSCO, PsycArticles, Pub Med, and Wiley InterScience 
Journals (which includes Cochrane) covering disciplines such as Medicine, Dentistry, 
Nursing, Social Sciences and Psychology.  
The “Cinahl Subject Headings List” in EBSCO and MeSH (Medical Subject Headings) 
equivalent subject heading list in MEDLINE were used to carry out advanced searches 
and provided an efficient searching tool to choose the most effective terms or subject 
for the search. In order to identify relevant literature for inclusion in the review the 
following key words and their combinations were used to carry out the search:  
Behaviour change, techniques, theory, theoretical models, brief intervention, 
screening, screening setting, weight reduction, weight loss, telephone, telephone 
interventions, behaviour change interventions, cardiovascular, CV screening, CVD risk 
prevention, methodology used in interventions.  
The initial literature search was conducted between September 2010 and November 
2010 to include literature published between 1990 and 2010. A follow up search was 
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conducted in August 2011 to October 2011, for literature published between 2010 
and 2011. The next search was conducted between September 2012 and December 
2012 to include literature published between 2011 and 2012. June 2013 – 
September 2013 completed the search for the review. A final search was carried out 
in 2016 for articles published to date. 
Boolean operators were used to combine, restrict, widen and exclude specified key 
words or terms from the results. Reference lists from the selected publications were 
reviewed and a search for these papers and books was carried out electronically 
through the internet and e-library to ensure as complete coverage of the literature as 
possible. Search alerts were set in order to ensure notification of new literature as it 
was published (Appendix A).  Each publication was considered by reviewing the title 
and abstract and included or excluded from the search as determined by a set 
criterion (Appendix B). 
3.3  Extraction of Data 
In order to safeguard validity and rigour in the papers reviewed it was important to 
seek  evidence of  the methods used in the collection and analyses of the data, for 
example aims and objectives of the study, the study population including 
demographic characteristics, sample size, methods of obtaining the sample, methods 
of measurement, response and non-response rates, respondent validation, 
triangulation, evidence of reflexivity on the part of the researcher, acknowledgment 
of limitations, potential and actual bias in the study, generalisability of the study, 
main findings and conclusions. In order to minimise bias during the process of 
extracting data from the papers a check list was used to assess the methodological 
quality of the studies. The assessment of methodological quality of the studies 
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included in the review is based on a check list for critical appraisal of studies (51) 
(Appendix C). 
3.4 Secondary Search 
 In addition to the traditional evidence base a search was conducted manually and 
electronically via local, national government and public health organisation related 
websites to reveal “grey literature”.  Appropriate governmental, Scottish 
Government, charitable organizations and other authoritative group website 
documents on strategies to inform public health interventions, manage weight and 
reduce CVD levels both domestic and international including NICE, WHO and British 
Heart Foundation were sourced/searched.   
These publications are considered worthy of inclusion and bring weight to the 
evidence presented in this thesis as these policies are informed by research carried 
out by health practitioners considered expert within their field, and have been used 
to inform the development of strategies to tackle the prevalence of non-
communicable diseases.  Using the search terms described in section 3.2 a wide 
range of empirical literature and systematic reviews were identified and used to 
influence the direction of this investigation. The next few sections will further 
discuss the evidence from the literature search into themes integral to the design of 
the HF2 investigation.  
 
3.5 Findings from Literature Review 
The scope for the design of behaviour change interventions is vast, and 
encompasses a broad range of activities and approaches, which focus on the 
individual, community, and environmental influences on behaviour.  Behaviour 
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change is more likely to be maintained when a strong motivation has been 
established or there has been a significant life crisis, when the person making the 
change experiences a significant benefit reinforcing the ongoing behaviour and 
when changes are ‘sustainable’ in that they require little or no ongoing effort or 
motivation to continue (34).  
 
3.5.1 Interventions for Change – Directions for Best Practice  
 3.5.1.1 Complex Interventions  
Complex interventions can be defined as interventions with several interacting 
components which can present with an array of distinct problems for evaluators, as 
well as the practical and methodological challenges which any successful evaluation 
must overcome (52). Complex interventions are used extensively within the health 
service in developing social policy and in public health practice. Developing and 
evaluating complex studies requires a good theoretical understanding of plausible 
mechanism for intervention to promote change, so that important links in the causal 
chain can be identified and incorporated into intervention designs. 
Three important questions to ask when evaluating complex interventions are what 
are the active ingredients and how are they exerting their effect, and are these 
interventions likely to be effective in everyday practice (53). The answers to these 
questions are necessary to contribute to the growing evidence base for the design 
and application of effective interventions across groups and settings, and specific to 
evaluating the key components in previous work carried out in lifestyle behaviour 
change interventions which can be replicated in the HF2 study design.   
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3.5.1.2 MRC Framework 
In 2000, the MRC published a Framework for the development and evaluation of 
randomised controlled trails (RCTs) for complex interventions to improve health 
(54). In 2006 it concluded that, while the initial Framework had been useful, 
expertise in evaluating complex interventions and a growing interest in the 
methodology had accumulated since its inception necessitating a review of the 2000 
framework (55).  
Limitations had been identified in the 2000 framework, and recommendations made 
to afford greater attention to early phase piloting and development work (56), 
consideration of a less linear model of evaluation process (57), an
 integration of 
process and outcome evaluation (58), and recognition that complex interventions 
may work best if they are tailored to local contexts rather than completely 
standardized (59), The key is to be clear about the degree of change or adaptation 
which is permissible and ensure that variations are recorded in the implementation 
of the intervention so that fidelity can be assessed in relation to the degree of 
standardization required by the protocol (52).  
In summary the 2006 model advocates that the best available evidence is sourced 
and most appropriate theory used. Interventions are tested for feasibility to assess 
whether the study can be done, and piloted, to explore and evaluate the various 
aspects of the intervention ensuring all the components of the intervention can 
work together. Surveillance and monitoring of the implementation process should 
be ongoing, and results disseminated as widely as possible. Evaluation should then 
be undertaken in order to understand the change process and evaluate 
effectiveness and cost effectiveness. 
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3.5.1.3 Context for Change  
The way in which a behaviour intervention is delivered can significantly impact on its 
effectiveness. The context in which it is delivered is important in regard to the 
setting, the content of the delivery, the personal attributes of the interventionist 
and the particular personal and social circumstances of the recipient. Significant 
events or transition points in people's lives may present an important opportunity 
for intervening in behaviour change interventions (so called “teachable moments”) 
as it is often at these points that people will review their own behaviour.  
Typical transition points include being diagnosed or having a family member 
diagnosed with a serious medical condition, retirement, or bereavement. Behaviour 
change interventions can be successfully carried out in a range of healthcare 
settings. Primary care has been identified as a suitable setting in which to deliver 
behaviour change interventions, principally due to the large number of people using 
the vast array of primary care services and the frequency with which the services are 
used (60).  
3.5.1.4  Concept of a Teachable Moment  
Screening a healthy population of volunteers in a research setting for risk of CVD can 
provide a platform and opportunity to relate individual risk to lifestyle choice and is 
consistent with the concept of a “teachable moment“. The effectiveness of this 
method of introducing a lifestyle intervention has been shown with the successful 
weight outcomes from the Healthforce Study where the study sample was recruited 
from volunteers in a CVD risk screening cohort (50). 
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Targeting an age group over 40 with this type of intervention may provide the 
opportunity to target individuals at a time in the life course when they may be more 
likely to weigh up the benefits of future good health against the burden of ill health 
and when chronic disease diagnosis is often made amongst friends and family 
members.  
3.5.1.5 CVD Risk perceptions and beliefs  
Controlling modifiable risk factors is key to primary prevention of CVD and has been 
the mainstay of prevention policy in primary care. Individual assessment and 
discussion of modifiable cardiovascular risk factors is central to prevention strategies 
as previous work has shown that people are probably less likely to change behaviour 
on the basis of CVD risk factors  they perceive they cannot change (61).  Providing 
feedback and entering discussion with individuals on their biomarker and 
physiological status may be effective in motivating those individuals to change 
unhealthy behaviours. A few studies have reviewed risk perception and attitudes on 
lifestyle change using a variety of formats of risk communication in feedback 
communications. A prospective, randomised controlled trial by Benner et al, 
demonstrated patients with hypertension and 10-year absolute risk for CVD of  
≥10% receiving education of their risk of MI or death, along with a variety of 
graphical representation of risk, educating patients about modifiable risk factors and 
three follow-up telephone calls by a doctor or nurse resulted in behaviour 
modification and a reduction in CVD risk at 6 months compared to usual care 
(61),(62).  
The study highlights it is possible to combine feedback from individuals biomarker 
status with other educational material i.e., BMI charts, educational booklets to 
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convey risk and initiate discussion to make behaviour change. To my knowledge, 
using risk communication as part of a weight loss intervention has not been tested in 
a screening setting, although it is recognised that this approach has the potential to 
change not only weight loss but reduce CVD risk, type 2 diabetes and certain cancers 
(62). 
3.5.1.6  Brief Interventions  
Research has shown brief advice given in general practice can significantly increas e 
the chances of smoking cessation compared with receiving no advice (63). There is 
also good evidence indicating the effectiveness of brief interventions in changing 
eating and physical activity behaviour and reducing body weight, within the primary 
care setting (64,65). Brief interventions involve opportunistic advice, discussion, 
negotiation or encouragement and are commonly used in many areas of health 
promotion by a range of health professionals (66). 
A brief intervention is a technique which aims to enable people to think differently 
or make changes towards positive health behaviour by providing them with the 
knowledge and skills to change their behaviour. It can be used effectively at any 
point along the continuum of health promotion, disease prevention, early 
intervention and treatment, depending on the person's readiness to change, and 
preferably as early as possible to prevent a problem from developing (67).   
They can lead to at least short-term changes in weight loss if they focus on both diet 
and physical activity, are delivered by practitioners who are trained in motivational 
interviewing, incorporate behavioural techniques, are tailored to individual 
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circumstances and encourage the individual or patient to seek support from other 
people (67).  
The content depends on the person, the setting, whether the person is ready to 
change, and whether it builds on previous interactions.  
3.5.1.7  Brief Interventions in Primary Care 
The evidence reviewed in this section focuses largely on the primary care setting as 
it most closely resembles the setting and in which the HF2 CVD risk screening will 
take place and the type of situation where lifestyle modification advice may be 
given. 
Much of the evidence available on this topic has come from studies carried out in 
the primary care setting, although not exclusively. Interaction with GP’s and practice 
nurses is often instigated by a particular health condition with which the patient has 
presented such as a chronic medical condition (68). Lifestyle advice given in this 
context has been shown to be effective showing that patients often retain 
information if it is directly related to the condition, making it salient and proving 
more likely to instigate action. The accident and emergency setting has also been 
shown to be an effective place for brief Interventions to be given particularly in 
relation to alcohol or drug abuse (69). 
Evidence has shown that particularly in a primary care setting GP’s are more likely to 
provide advice to patients at risk of greater health problems especially in chronic 
conditions or obesity (60).  While instigating a brief intervention in this setting is 
evidently of benefit, it can often be a proven to be a reactive approach rather than 
pro preventative.  
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A cross-sectional observational study conducted in eight family medicine practices 
showed that patient’s initiation of a health behaviour topic was four times less likely 
to result in advice being provided than when a physician initiated the discussion. 
Advice was more likely to be given if the GP instigated the discussion about the 
problem rather than the patient (60). These findings suggest variability both in the 
way patients initiate health behavior discussions and in physician attentiveness or 
openness to patient initiation of these topics.  
This view is correlated by a survey study looking at the characteristics of those 
patients who were more likely to receive advice; it concluded that patients with a 
strong patient provider relationship, middle aged adults and patients with chronic 
conditions were more likely to receive a brief intervention from their GP (70). 
Patients initiating a discussion may be more interested and prepared to change, 
therefore a lack of advice and assistance on the part of the GP could represent a 
missed opportunity for facilitating health behavior change (71). A cross- sectional 
survey carried out in the UK supports this view concluding that advice from 
healthcare professionals increases motivation to lose weight and weight loss 
behaviour, but only a small number of overweight and obese adults had received 
such advice. It also highlighted the need for better training for health professionals 
in delivering brief weight counselling interventions (72).  
3.5.1.8   Barriers to Delivery of Brief Interventions 
A recent study highlighted a variety of barriers which can exist in preventing lifestyle 
change advice being given, such as perceived time constraints, knowledge, training 
and confidence (72). Perhaps more importantly healthcare professionals can find 
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treating overweight or obese patients daunting or even futile, (73) and 
professionally unrewarding (74, 75, 76, 77, 78). 
A questionnaire study with a representative population of primary care providers 
from four health regions in Scotland investigated primary care providers’ views and 
experiences on providing physical activity advice. The results revealed the same 
reasons cited in the previous paragraph for staff not providing advice as lack of time, 
lack of confidence in knowledge of the current recommended levels of physical 
activity and a feeling of lack of the skills and efficacy needed to motivate patients to 
change. These factors were highlighted as effecting whether staff would intervene 
with advice (or not) and the nature of the advice that is given (79). Primary care 
offers a valuable opportunity for health professionals to discuss lifes tyle related 
issues, however, often GP’s and practice nurses are not comfortable discussing these 
concerns (80).   
3.5.1.9  Future Strategies for Implementing Brief interventions 
In 2016 The Scottish Government released its Local Delivery Plan (LDP) a strategy 
which proposes more emphasis on person-centred care to support people to 
develop the knowledge, skills and confidence they need to more effectively manage 
and make informed decisions about their own health and health care (81). The plan 
cites primary care as integral to integrated health and social care where the 
overwhelming majority of healthcare interactions start, and finish both in-hours and 
out-of-hours. The plan also sets a NHS LDP standard to “Sustain and embed alcohol 
brief interventions in three priority settings (primary care, A&E, antenatal) and to 
broaden delivery in the wider setting (81). By supporting the introduction of brief 
interventions in settings where healthcare professionals can assess individual’s 
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readiness to make health behaviour changes demonstrates a commitment by the 
Scottish government to challenge healthcare professionals from all disciplines to 
recognise and engage in utilising teachable moments to encourage the practice to 
be seen as part of the healthcare professionals role. Through time these skills would 
then become transferrable to all unhealthy behaviours such as obesity, smoking, 
diet and exercise. 
 3.5.1.10 Conclusion 
It is clear from the evidence that with adequate resources and time afforded to 
training staff in behaviour techniques such as motivational interviewing, primary 
care can provide a suitably effective place for initiating behaviour change 
interventions. This study intended to show the same principles and techniques can 
be applied to a screening setting to initiate weight loss and show changes in 
modifiable CVD risk factors using trained nurses and lifestyle counsellors in a cohort 
of healthy volunteers following cardiovascular risk screening.  
 
3.5.2  Delivery of Weight and Lifestyle Change Interventions  
Introduction 
This section will outline the merits of individual versus group interventions for 
delivery of weight and lifestyle change interventions and then explore the different 
methods of delivery available of communicating and supporting individuals in 
behaviour change interventions 
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3.5.2.1 Individual Interventions 
  
It has been recommended that individual sessions should be used for assessment of 
an individual’s readiness to change behaviour (82). They should include behavioural 
techniques that motivate and support to understand the short, medium and longer-
term consequences of their health-related behaviours for themselves and others 
develop belief in their ability to succeed in a particular situation (self-efficacy) and 
help make a personal commitment to adopt health-enhancing behaviours by setting 
and recording goals over a specified time (82).  
Advice on how to cope with ‘lapses’ and ‘high-risk’ situations and providing ongoing 
support is also recognised as best practice. For individual or group delivered 
interventions to be effective in weight loss management interventions requires 
support in making lifestyle change which can be sustained long term. Both require 
incorporating behaviour change techniques such as goal setting and self-monitoring 
and be acceptable to the individuals’ personal circumstances with an emphasis on 
using a well-balanced, healthy eating regular exercise approach. 
 
3.5.2.2 Group Interventions 
Group sessions using cognitive-behavioural strategies can be useful to teach skills  to 
modify diet and develop a physical activity programme. They can also provide role 
modelling and the opportunity for patients to learn from the success of others 
maximising the benefits of peer support and group problem solving (83). 
A one year randomised controlled trial comparing a range of eight management 
programmes with primary outcome of weight loss at 12 weeks provided evidence 
that commercial weight management services were more effective and cheaper 
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than primary care services led by specially trained staff. All of the weight 
management programs discussed adopted a range of behaviour change techniques 
with the primary care service using a theoretical component in addition to the 
behaviour techniques. The behaviour model used was the Stages of Change (section 
3.6.3) which, given the different stages an individual can be within the model at any 
given time may produce bias as to the achievable weight loss within the study 
timeframe (84). 
NICE recommends that primary care organisations and local authorities should only 
recommend to patients, or consider endorsing, self-help, commercial and 
community weight management programmes if they follow best practice (85) as 
shown in Table 2.1. 
 
Table 2:1 National Institute for Health and Clinical Excellence. Obes ity: Guidance on 
the prevention, identification, assessment and management of overweight and 
obesity in adults. London: NICE; 2006. (85)*Also recommend in SIGN Guidelines (86) 
 helping people assess their weight and decide on a realistic target (people 
should usually aim to lose 5–10% of their original weight)* 
 aiming for a maximum weekly weight loss of 0.5–1kg  
 
 focusing on long-term lifestyle changes rather than a short-term, quick-fix  
approach  
 being multi-component, addressing both diet and activity, and offering a 
variety  
of approaches  
 
 using a balanced, healthy-eating approach  
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3.5.2.3 Face to Face 
Behaviour change interventions have been traditionally delivered face to face. The 
major drawback of this mode of delivery is that it is resource intensive and 
expensive and thus limits the scope for population based cost effective 
interventions. Lack of time, lack of confidence in current knowledge of guidelines 
and lack of skills to motivate patients (79), were identified by GP’s (section 3.5.1.8) 
as barriers to engage with patients to change unhealthy behaviour.  
 
3.5.2.4 Text 
Studies using mobile technology text messaging as reinforcement in the delivery of 
interventions are having some success as a means of delivering health interventions. 
These studies have demonstrated increased adherence to antiretroviral medication 
in a low-income setting and increase smoking cessation in a high-income setting 
(87). The “txt2 stop” study, a smoking intervention using text messaging more than 
doubled biochemically verified smoking cessation (88).  
There are now more than 250 smartphone applications that claim to aid smoking 
cessation, but these have not yet been evaluated adequately (89). Other trials 
indicated that using text messages to encourage physical activity improved diabetes 
control but had no effect on body weight (87). Combined diet and physical activity 
text messaging interventions also have no effect on weight, whereas interventions 
for asthma control showed suggestive benefits in some but not all  cases (87).   
Whilst there is evidence to support the use of SMS as reminders focused on 
improving medication adherence and appointment attendance, further evidence of 
the effectiveness of use over time is required as patients adapt and the effectiveness 
of the messages diminish as seen in a study by Strandbygaard et al  (90). 
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3.5.2.5 Telephone Interventions 
Current literature shows there is solid evidence which supports the efficacy of 
physical activity and dietary behaviour change interventions in which the telephone 
is the primary intervention method (91). The evidence for support of this method of 
delivery was favourable in a combination of telephone and print or face to face 
sessions being more successful than telephone interventions alone which are rare 
(92).  
Eakin and colleagues reviewed the evidence in a systematic review and highlighted 
the need for more research using the telephone as the primary method of 
intervention in studies targeting outcomes in both physical activity and dietary 
interventions. Only four (93, 94, 95, 96) of the 26 studies under review had targeted 
both behaviours and only one of those studies recruited healthy adults rather than 
those with chronic conditions. In this one study the participation rate was not 
described and there was no theoretical component.  
Telephone interventions can offer the capacity to not only provide participants with 
an opportunity to obtain health related advice from a health professional it can also 
provide emotional support (97).  A meta-analysis reviewing telehealth interventions 
in secondary prevention of coronary heart disease has also shown that telephone 
based interventions also were more effective than internet and videoconferencing 
communication in reducing patients systolic blood pressure and improving lipid 
profiles (98). This finding is consistent with a study carried out in patients with heart 
failure where phone interventions improve adherence to medical therapy and 
reduced hospital admissions (99). Recent evidence from the BeWEL study has shown 
52 
 
intervention participants continued to lose weight over a month period through 
telephone call interventions only (100).   
3.5.2.6  Conclusions 
In summary there is good evidence to demonstrate that the telephone can still be a 
valuable means of communicating and supporting individuals in behaviour change 
interventions as it is readily accessible, and can offer immediate means of personal 
support, however, there remains a  need to have back up with written or face to 
face consultation. There may also be limitations; for example the inability to 
measure weight objectively and the potential to miss report self-reported 
behaviour. There also remains a lack of fully powered randomised controlled trials 
investigating weight loss interventions where the telephone is the primary method 
of delivery.  
 
 
3.5.3   Single or multiple contact Interventions  
When designing behaviour change interventions one needs to consider whether to 
have single or multiple contact, how many sessions are offered, the duration of 
these sessions and the frequency of follow-up sessions after the initial brief 
intervention. As well as the format of delivery, consideration also needs to be given 
to the optimal frequency of contact and duration of each session.  
Although there is review level evidence that motivational interviewing (section 
3.7.1), can be effective even in brief encounters of only 15 minutes it is clear that 
more than one encounter with a patient and increased exposure time increases the 
likelihood of a positive effect (101). In most studies, more frequent and/or longer 
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contact sessions are associated with greater reductions in body mass and 
improvements in physical activity and diet (101,102,103).  
Reviews have found the median duration of an individual counselling encounter in 
healthcare settings to be 60 minutes (range = 10–120 minutes) with 64% of the brief 
interventions (less than 20 minutes duration) showing an effect (104). The 
interventions with significant benefit beyond 12 months were all high-intensity 
counselling interventions with group, phone, or mail contact throughout. Most 
“high-intensity interventions” (promote weight loss through decreased caloric intake 
and increased physical activity) that had follow-up beyond 12 months showed 
persistent beneficial changes in adiposity and lipids, as well as improvements in self-
reported behavioural outcomes 103). 
It is, therefore, recommended that interventions allow sufficient time for 
consultations, plan to provide repeat consultations and arrange frequent follow-up 
appointments (104). NICE recommends that for behaviour change to be sustained at 
one year, several follow-up sessions over a period of three to six months are 
required after the initial consultation episode (85). Overall, the level of support 
offered should be determined by the person’s needs, and be responsive to changes 
over time (105). 
 
3.5.4 Current Guidelines: Weight Loss Education/Physical Activity  
Two of the key risk factors contributing to non-communicable diseases are diet and 
physical activity. Diet and physical activity influence health both together and 
separately. Although the effects of diet and physical activity on health often interact, 
particularly in relation to obesity, there are additional health benefits to be gained 
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from physical activity that are independent of nutrition and diet, and there are 
significant nutritional risks that are unrelated to obesity (106). The national 
guidelines set out in Tables 3.1 and 3.2 highlight the recommendations on dietary 
advice and level of physical activity to be used when imparting lifestyle advice. These 
guidelines have been followed when giving such advice to participants in the HF2 
study.  
3.5.4.1  Dietary Advice Recommendations 
Specific recommendations have been made by NICE for individuals seeking advice on 
making dietary changes. The specific weight loss advice to be given is set out in 
Table 3.1. The long term advice to be given should encourage moves toward eating a 
balanced diet, consistent with other healthy eating advice (107). The recently 
updated Nice guideline CG 181 provided recommendations to help healthcare 
professionals identify people who are at risk of CVD including people with type1, 
type2 diabetes and chronic kidney disease, it offers recommendations for giving 
advice on recommended levels of physical activity and the components of a cardio 
protective diet (108). 
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Table 3:1 NICE Pathways Dietary Interventions and Advice for Adults (2013) (107) 
 
 Dietary changes should be individualised, tailored to food preferences and allow for 
flexible approaches to reducing calorie intake.  
 Unduly restrictive and nutritionally unbalanced diets should not be used, because 
they are ineffective in the long term and can be harmful. 
 People should be encouraged to improve their diet even if they do not lose weight, 
because there can be other health benefits. 
 The main requirement of a dietary approach to weight loss is that total energy intake 
should be less than energy expenditure. 
 Diets that have a 600 kcal/day deficit (that is, they contain 600 kcal less than the 
person needs to stay the same weight) or that reduce calories by lowering the fat 
content (low-fat diets), in combination with expert support and intensive follow-up, 
are recommended for sustainable weight loss 
 Low-calorie diets (1000–1600 kcal/day) may also be considered, but are less likely to 
be nutritionally complete. 
 Very-low-calorie diets (less than 1000 kcal/day) may be used for a maximum of 12 
weeks continuously, or intermittently with a low calorie diet (for example for 2–4 
days a week), by people who are obese and have reached a plateau in weight loss.  
 Any diet of less than 600 kcal/day should be used only under clinical supervision. 
 
3.5.4.2 Physical Activity Recommendations 
Physical activity includes everyday activities such as walking and cycling to get from 
A to B, work related activity, housework, DIY and gardening. It also includes 
recreational activities such as working out in a gym, dancing or playing active games, 
as well as organized and competitive sport (109). The National physical activity 
recommendations given by the Chief Medical Officers (CMO) shown in Table 3.2 
state that: 
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Table 3.2 Start Active Stay Active: a report on physical activities from the four home 
countries’ Chief Medical Officers (2011). (109) 
 
 All adults aged 19 years and over should aim to be active daily. 
 Over a week, this should add up to at least 150 minutes (2.5 hours) of 
moderate intensity1 physical activity in bouts of 10 minutes or more.  
 Alternatively, comparable benefits can be achieved through 75 minutes of 
vigorous intensity activity spread across the week or combinations of 
moderate and vigorous intensity2 activity.  
 All adults should also undertake physical activity to improve muscle strength 
on at least 2 days a week.  
 They should minimise the amount of time spent being sedentary (sitting) for 
extended periods.  
 Older adults (65 years and over) who are at risk of falls should incorporate 
physical activity to improve balance and coordination on at least 2 days a 
week.  
 Individual physical and mental capabilities should be considered when 
interpreting the guidelines, but the key issue is that some activity is better 
than no activity (109) 
 
 
 
 
 
                                                                 
1
 Moderate-intensity physical activity leads to faster breathing, increased heart rate and feeling warmer. 
Moderate-intensity physical activity could include walking at 3-4 mph, and household tasks such as vacuum 
cleaning or mowing the lawn. 
 
2
Vigorous-intensity physical activity leads to very hard breathing, shortness of breath, rapid heartbeat and 
should leave a  person unable to maintain a  conversation comfortably. Vigorous-intensity activity could include 
running at 6-8 mph, cycl ing at 12-14 mph or swimming slow crawl (50 yards per minute). 
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3.6  Behaviour Change Theory  
Theories are used to describe psychological determinates or predictors of health 
behaviour, and models have been developed to include wider social determinates 
such as personal beliefs, environment, and the wider community.  Constructing 
theories about these determinates enables us to test these theories by evaluating 
interventions targeting these core predictors. In this way theory based interventions 
can allow us to understand what works and what doesn’t and provide the base to 
build better interventions. 
Theoretical frameworks are important in guiding the development of interventions 
to increase confidence and motivation to achieve successful behaviour change. By 
omitting to describe any theoretical component in the development of an 
intervention means the impact of the intervention cannot be tested against any 
theoretical paradigm.  
 
3.6.1 Reporting Theory in Behaviour Change Interventions 
The evidence regarding reporting of the application of Theoretical frameworks in 
behaviour change intervention studies is mixed (110). A review conducted between 
2000 - 2005 concluded that approximately one third of the papers reviewed stated a 
theoretical basis to their intervention but only a small proportion rigorously applied 
it. Surprisingly, a more recent review in 2010 of systematic reviews on the 
effectiveness of interventions to change six health behaviours (111) didn’t report 
any meaningful theoretical input into the design of any of the 103 study 
interventions reviewed.  
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One limitation of this type of review is that the data included was not primary data 
and some or all of the theoretical component may not have been reported, 
however, if making a case for supporting successful interventions and making 
recommendations for future policy it is surprising that a comprehensive review of 
the theories used was not reported given the significance of behaviour change 
theory. 
A  recent review of communication-related behaviour change techniques used in 
lifestyle interventions in primary care  highlighted a little over half of the 26 studies 
looked at in the review describes theory as a basis for the intervention and 16 
described their theoretical foundation. The report concluded that these 
interventions were theory inspired rather than theory based and there were very 
little aspects of the theory linked to the intervention (112), which can be as a result 
of the difficulty of applying theory in the design of an intervention.  
Some of the common models cited in studies identify what predictors of behaviour 
should be targeted, but not how to go about actually applying the theory to the 
intervention. Ajzen writes on his Theory of Planned Behaviour “Once it has been 
decided which beliefs the intervention will attempt to change, an effective 
intervention method must be developed. This is where the investigator's experience 
and creativity comes into play” (113). This quote highlights the complexity of 
behaviour change intervention design, and the need for innovative thinking in the 
design and implementation of interventions.  More recent models have tried to 
address the issue of the complexity of applying theory in real life in the design of 
interventions and will be discussed in section 3.6.7. 
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3.6.2 Models in Use 
There are several behaviour change models and frameworks currently in use to 
guide behaviour change interventions, some of which are described in this section. 
Most behaviour change interventions, use constructs from established health 
behaviour change models such as the Trans-theoretical Model of Change (114) the 
Health Belief Model (115) or Social Cognitive Theory (116). Following review of the 
literature this investigation plans to use two theoretical models to guide the 
intervention. 
3.6.3 Transtheoretical Model of Behaviour Change  
The first The Transtheoretical Model of Behaviour Change (TTM) was originally 
developed by Prochaska and Di Clemente (1982) and is commonly known as The 
Stages of Change Model (SOC) (117). The model emphasises the dynamic nature of 
beliefs, time, and costs and benefits and how they interact over five stages of 
change (Table 3.3). 
Table3:3 Prochaska JO, Di Clemente CC. (1982). Transtheoretical therapy: toward a 
more integrative model of change. Psychotherapy. 19: p: 276-88. (102)  
5 Stages of Change 
• Precontemplation: not intending to make any changes 
 
• Contemplation: considering a change 
 
• Preparation: making small changes 
 
• Action: actively engaging in a new behaviour 
 
• Maintenance: sustaining change over time 
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These stages, however, do not always occur in a linear fashion a person may move 
to the preparation stage and then back to the contemplation stage several times 
before progressing to the action stage. Furthermore, even when the individual has 
reached the maintenance stage they may slip back to the contemplation stage over 
time. The model examines how the individual weighs up the costs and benefits of a 
particular behaviour. In particular its authors argue that individuals at different 
stages of change will differently focus on either the costs of behaviour e.g. stopping 
smoking will make me anxious in company, or the benefits, stopping smoking will 
improve my health.  A smoker at the action and the maintenance stages tend to 
focus on the favourable and positive features of their behaviour whereas the 
smokers in the pre contemplative stage tend to focus on the negative features of the 
behaviour. 
The stage of change model is used both in research and as a basis to develop 
interventions that are tailored to the particular stage of the individual concerned. 
The model has been criticized for being too simplistic particularly in its application to 
complex behaviours such as physical activity and dietary intake (118). Staging 
models are based on self-assessment, and a person’s view on their particular stage 
in the algorithm is entirely subjective. A person can believe they are taking the 
recommended amount of physical activity and eating the recommended amount of 
fruit and vegetables when they are not, they are in fact pre-contemplators where 
they believe they are in maintenance and in being so are not motivated to change 
(118). 
Most studies based on the stages of change model use cross-sectional designs to 
examine differences between different people at different stages of change. These 
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designs do not allow conclusions to be drawn about the role of different causal 
factors at the different stages ie (people at the preparation stage are driven forward 
by different factors than those at the contemplation stage). More experimental and 
longitudinal studies are needed for any conclusions about causality to be valid. The 
key finding of a Cochrane Review highlighted that the TTM showed limited impact 
on weight loss and that the weight loss that occurred was not shown to be 
sustainable. However, the TTM did show that with a combination of physical activity, 
diet and other interventions (such as feedback and counselling) produced significant 
effects on other outcome measures, such as change in physical activity, dietary 
intake and progression through the stages of change process  (119). This 
investigation will use the TTM to inform the HF2 intervention in a randomized 
comparison study, which has rarely been tested.  
 
3.6.4 The Theory of Reasoned Action 
The second model to be used in the HF2 investigation The Theory of Reasoned 
Action (TRA) (120,121,122) was developed by Ajzen & Fishbein to examine 
predictors of behaviours and was central to the debate within social psychology 
regarding the relationship between attitudes and behaviour. The Theory of Planned 
Behaviour (TPB) model (123,124,125) was a progression from the TRA model and 
emphasised the belief that the behavioural intention was the outcome of a 
combination of several beliefs (Figure 3.1). The theory proposes that the behavioural 
intention should be viewed as “Plans of Action” in pursuit of behavioural goals  (126).  
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Figure 3.1. Source: Ajzen, I. (1991). The theory of planned behaviour. Organizational 
Behavior and Human Decision Processes, 50, p. 179-211.  
 
Within the TRA model behaviour change is seen as a function of;  
 Beliefs about the consequences or outcomes of the behaviour 
 Evaluations of the importance of the outcomes of the behaviour 
 The expectations of significant others 
 A motivation to conform 
 
The TRA model suggests that people’s perceptions of the attitudes of others towards 
their behaviour could be a powerful influence on them to change. The motivation to 
comply with perceived social pressure from significant others could cause an 
individual to behave in a way that these groups/others would think is right. Peer 
group pressure can be very powerful if the individual values membership of the 
group or wants to belong to it. 
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According to this theory behaviour is dependent on the two variables of Attitudes 
and Subjective Norms. 
Attitudes – resulting from beliefs about the consequences of the behaviour and an 
appraisal of the positive and negative aspects of making a change. 
Subjective Norms – What significant others think, do and expect and the extent to 
which the person wants to conform and be liked by others. Combing the two 
influences will predict Behaviour Intention. 
Ajzen (127) developed the Theory of Reasoned Action in 1991 to include a third 
variable of control, suggesting people’s behaviour is also a consequence of their 
perceived control, described as Internal Locus of Control, which represents the 
extent to which a person believes they are responsible for their own health. External 
Locus of Control represents the belief that an individual’s actions are limited by 
powerful others, chance fate or luck. The inclusion of this element of control was 
developed by Ajzen into the Theory of Planned Behaviour Model (127).  
Locus of control is also described as being linked to socioeconomic status. Self-
efficacy is important for individuals in making behaviour choices. Self-efficacy is 
determined to a large extent by self-esteem which is affected by social economic 
factors such as education and cultural-social environment. 
 
3.6.5 Self-Regulatory Theory (Common Sense Model)  
Risk perceptions are formed through the appraisal of experiences in a person’s life. 
Perceptions can be important motivators to actions such as risk-reduction 
behaviours. The Common Sense Model (CSM) is a self-regulation model of health 
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threat, cognition and behaviour which was developed by Howard Leventhal and 
colleagues and suggests a number of important cognitive and affective aspects of 
risk perceptions (128,129,130).  
 
The CSM explains that individuals appraise their beliefs and knowledge about an 
illness to form their view of that illness. People’s perception of health risk is based 
on perceptions of a particular illness or disability, and creates the development of a 
representation of illness risk. Understanding risk perception, therefore, must include 
a theoretical understanding of illness representations. The risk perception is then 
realized when the discussion around the 10 year CVD risk and other measures; BMI 
and blood pressure are discussed. This in turn will allow us to see if the 
communication of CVD risk has predicted behaviour change in the brief intervention 
and the HF2 intervention groups. 
People may show consistent beliefs about illness that can be used to make sense of 
their illness and help their understanding of any developing symptoms. These illness 
cognitions have been incorporated into a model of illness behaviour to examine the 
relationship between a person’s cognitive representation of perceived illness and 
their subsequent coping behaviour. This model is known as the “Self-Regulatory 
Model of illness behaviour” (131).  
One issue to consider is whether measures of risk judgments and worry are 
sufficient indicants of the illness representation attributes influencing behaviour, or 
whether we need more detailed assessments of the illness representations in order 
to predict responses. It may be that influences of representational beliefs on 
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behavior are completely accounted for by simple measures of risk judgment and 
worry (132). 
3.6.6 What are Il lness Cognitions? 
Leventhal, Meyer and his colleagues (131) defined illness cognitions as “a patient’s 
own implicit common sense beliefs about their illness”. They propose that these 
cognitions provide patients with a framework or schema for coping with and 
understanding their illness, and telling them what to look out for if they are 
becoming ill. Using interviews with patients suffering from a variety of different 
illnesses, Leventhal identified five cognitive dimensions of these beliefs shown in 
Table 3.4. 
Table 3:4 Leventhal’s five cognitive dimensions of beliefs  
 Identity, (the label or diagnosis)  
 
 Perceived cause of the illness (biological or psychological),  
 
 Time line, (how long the illness will last)  
 
 The consequences (possible effects illness will have on their lives)  
 
 Curability and controllability (believe that the illness can be treated and 
cured and the extent to which the outcome for the illness is controllable 
either by themselves or by others). 
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This model is based on approaches to problem solving and assumes that given a 
problem or a change in the status quo the individual will be motivated to solve the 
problem and re-establish their state of normality. 
Once the individual has received information about the possibility of illness 
according to problem solving theory the individual is then motivated to return to a 
state of “problem-free” normality. This involves assigning meaning to the problem, 
the first stage in a process. According to Leventhal the problem can be given 
meaning by accessing the individual’s illness cognitions. Therefore, the symptoms 
and social messages will contribute to towards the development of illness cognition, 
which will be constructed according to the following dimensions; identity, cause, 
consequences, timeline cure/control. These cognitive representations of the 
“problem” will give the problem meaning and will enable the individual to develop 
and consider suitable coping strategies (131). 
However, a cognitive representation is not the only consequence of symptom 
perception and social messages. The identification of the problem of illness will also 
result in changes in emotional state. For example, perceiving the symptom of pain 
and receiving the social message that this pain may be related to coronary heart 
disease may result in anxiety. Therefore any coping strategies have to relate to both 
the illness cognitions and the emotional state of the individual (131).  
The next stage in the SRM is the development and identification of suitable coping 
strategies, Coping can take many forms, however two broad categories of coping 
have been defined that incorporate the multitude of other coping strategies; 
approach coping (for example, taking pills, going to the doctor, resting, talking to 
friends about emotions) and avoidance coping (eg denial wishful thinking) When 
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faced with the problem of illness the individual will therefore develop coping 
strategies in an attempt to return to a state of health normality (131) 
The third stage of the SRM is appraisal. This involves individual’s evaluating the 
effectiveness of the coping strategy and determining whether to continue with this 
strategy or whether to opt for an alternative one (131). 
3.6.7 The COM-B Model  
Complex interventions can present challenges in their ability to identify the active, 
effective components within them. A well-specified intervention is essential before 
evaluation of effectiveness is worth undertaking as an under-specified intervention 
cannot be delivered with confidence of rigor and, if evaluated, could not be 
replicated (133). The COM-B Model is a more recent framework in which capability, 
opportunity and motivation are considered a focus in designing behaviour change 
interventions (134) Table3.5. The use of frameworks such as the Behaviour Change 
Wheel to guide intervention development is relatively new in behaviour change 
research and wasn’t standard practice when the HF2 intervention was being 
developed, 
 
Table 3:5 Three essential components in the hub of the Wheel of Behaviour Change 
 Capability: the psychological or physical ability to enact the behavior 
 
 Opportunity: the physical and social environment that enables the behaviour 
 
 Motivation: the reflective and automatic mechanisms that activate or inhibit 
behavior 
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These three essential components are contained in the hub of the Wheel of 
Behaviour Change which in turn has nine intervention functions aimed at addressing 
deficits, education, persuasion, incentivisation, coercion, training, enablement, 
modeling, restrictions and environmental restructuring in one or more of these three 
conditions, around these are placed seven categories of policy that could enable 
those interventions to occur; Environment/social planning, 
communication/marketing, legislation, service provision, regulation, fiscal measures 
and guidelines (134). 
 
The COM-B system seeks to characterise behaviour change interventions and link 
them to an analysis of the targeted behaviour thus improving the design, 
implementation and evaluation of future behaviour change intervention practice 
(134).  This model draws from many models the important factors required to 
predict behaviour intention and facilitate behaviour change across many societal 
domains. It has been shown that the framework can be implemented in a variety of 
behaviour interventions such as improving hand hygiene in hospitals to improving 
the environment by reducing litter (135) Figure 3.2. 
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Figure 3:2 Michie S, et al. (2011). The behaviour change wheel 
 
 
3.7 Behaviour Change Techniques  
Behaviour Change Techniques are theory based methods used in interventions to 
change one or more determinants of behaviour such as attitudes toward certain 
behaviours. They were developed in response of necessity to clarify the difference 
between behaviour change methods and the practical applications of these 
methods. 
Evaluation of the findings from behaviour interventions are required in order for 
behavioural science to move forward. The methods used in the course of the 
interventions are required to be described in order to identify which interventions 
work.  Previously there had been no common terminology in place to describe the 
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methods used to identify effective behaviour change methods, which made it 
difficult   to evaluate and accurately replicate the intervention content. Intervention 
mapping was developed in response to the lack of theoretical frameworks by which 
to design health promotion programs (136).  It provided a taxonomy of six behaviour 
change methods which could be used to interpret intervention content (137). 
More recently the Com-B model has provided a framework and “The taxonomy of 
behaviour change techniques” by Abraham and Michie (134) provided a 
standardised terminology which enabled intervention designers to review 
interventions, and identify which components were effective and which were not 
(136). 
3.7.1 Motivational Interviewing 
Motivational Interviewing (MI) is “grounded in a respectful stance with a focus on 
building rapport in the initial stages of the counseling relationship” (138). A central 
concept of MI is the identification, examination, and resolution of ambivalence 
about changing behaviour. It was first developed by William R. Miller in 1983 in 
response to his experience with problem drinkers. Motivational Interviewing is a 
collaborative, goal oriented means of communication with a focus on change. It is 
designed to strengthen an individual’s motivation for and movement toward a 
specific goal by eliciting and exploring the person’s own arguments for change. MI is 
guided by five basic principles;  
 express empathy 
 avoid argument 
 support self-efficacy 
 roll with resistance 
 develop discrepancy (138) 
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3.7.2 Techniques Used in Motivational Interviewing  
-
 
Giving advice and educational materials with regard to specific behaviours requiring 
change and discussion around removing barriers, providing choice clarifying that if 
an individual chooses not to make change then it is their right to make that choice, 
facilitating change should be encouraging  and not insisted upon (146). 
 
3.7.3 Goal setting 
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-
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3.7.4 Self-Monitoring 
-
-
-
 
 
-
-
- - -
 
 
3.7.5 Feedback and reinforcement   
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An overview of behaviour techniques in 210 studies showed an inconsistency in 
results for three health behaviour outcomes diet, physical activity and smoking. The 
results varied as with some studies very few techniques were performed. However, 
positive results for techniques directed towards reinforcement in studies on diet and 
exercise were shown to be successful 46% over all the health behaviours. This report 
again highlighted the continued insufficient reporting of the content of interventions 
the limitation of this review is that it was heavily biased toward smoking cessation 
(150).  
An overview carried out of the effectiveness of behaviour change techniques 
concluded that self-monitoring of behaviour, prompting specific goal setting, 
providing feedback on performance, and review of behavioural goals in 
interventions designed to promote healthy eating and physical activity to be 
effective (156). This mega regression was found to be the most robustly carried out 
analysis of behaviour techniques found in the literature to date.  
3.7.6  Conclusions 
The evidence from the search of the literature undertaken to inform this 
investigation concludes that in order to design, implement and evaluate the 
effectiveness of a weight loss intervention and to instigate a change in health risk 
behavior, many variables need to be addressed, these are outlined in Table 3.8. This 
equates to a large body of literature to be considered and evaluated and it is not 
within the scope of this thesis to cover all aspects of health risk behaviour.  
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Table 3:8 Considerations when planning weight loss interventions  
 
 who to target: individuals/populations 
 what to target: single or multiple behaviours 
 which theories/models to use 
 which behaviour techniques to use 
 length of intervention and follow up 
 cost effectiveness 
 settings 
 
Lifestyle risk communication can be a powerful motivator and equally can 
discourage people from making essential changes in health behaviour if change is 
viewed as an impossible task. The literature shows there are health professionals 
still not taking advantage of opportunistic situations to convey health risk from poor 
diet and inactivity, sometimes as a result of lack of knowledge, lack of time and 
resources but sometimes also through lack of confidence in ability to bring  about 
the necessary change in an individual (157,158). 
The HF2 study design is underpinned by two theoretical frameworks; The 
Transtheoretical Model of Behaviour Change, (The Stages of Change Model: SOC) 
and The Theory of Reasoned Action (TRA) described previously in sections 3.6.3 and 
3.6.4. Behaviour techniques to be used include goal setting, self-monitoring, 
feedback and reinforcement, development of self-efficacy, relapse prevention, 
enlisting social support, overcoming barriers, decision balance discussion, pros and 
cons of change. 
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4. Methodology 
4.1  Study/trial design 
 
The study was a two-arm randomised comparison study which compared the HF2 
intervention with usual care i.e. the standard brief intervention provided at the 
TASCFORCE screening. HF2 was a nested cohort within the TASCFORCE study. 
4.2 Inclusion/Exclusion Criteria 
 
4.2.1 Inclusion 
Participants who had taken part in the TF CVD risk screening study, 40 years old and 
over, with a BMI ≥ 25kg/m2, had no known cardiovascular disease or ill health and 
had given informed consent to take part in HF2. 
4.2.2 Exclusion  
Participants who had failed screening criteria for TF, e.g. found to have 
hypertension, CHD risk score ≥20 (based on Framingham Risk Score) (159) or 
previous serious illness requiring ongoing follow-up. 
 
4.3 Study Population 
4.3.1 Geographical Distribution 
 
Tayside region is situated in the north east of Scotland. It covers an area of 7508 sq 
km, comprises of three local authority areas, Angus, Dundee City and Perth & 
Kinross and had an estimated total population of 411,750 mid 2012 (160).  
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4.3.2 Angus 
Angus is largely remote, with rural glens, small market towns and busy coastal 
towns, which contain around half of the 116,210 population. Most of the Angus 
population are found in the middle decile SIMD classification; however, the most 
deprived area in Angus is the coastal town of Arbroath which is amongst the 10% 
most deprived areas in Scotland (161). 
4.3.3  Dundee 
The Dundee City area covers 62 square kilometers, and is geographically the 
smallest local authority area in Scotland but has the largest population estimated to 
be 147,800. It is bordered by Perth and Kinross to the west and by Angus to the 
north and east (160). The proportion of Dundee’s population whose lives are 
affected by poverty and who are classed as socially excluded is almost the highest in 
Scotland, exceeded by only Glasgow and Inverclyde.  
4.3.4 Perth and Kinross 
Perth and Kinross is the fifth largest geographical area in Scotland it has an 
estimated population of 147,740 with almost one third of the population living in 
Perth. It also has the third highest level of migrant workers in Scotland, after 
Edinburgh and Glasgow. It is a diverse area comprising of a number of small 
communities, each with its own distinct challenges and opportunities, remote 
communities like Kinloch Rannoch pose many challenges in terms of access to, and 
delivery of, essential services including basic infrastructures such as water supplies  
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(160). Figure 4.1 shows a map of the Tayside area signified by the pale and dark 
green shaded areas of Perthshire, Dundee, Angus and East Fife.  
 
 
Figure 4:1Map of Tayside Area 
4.4 Recruitment Strategies 
Tayside has a diverse population in both rural and urban areas from which to recruit 
participants into the HEALTHFORCE2 study (HF2). The primary methodology was a 
randomised comparison trial from a nested cohort sample of the TASCFORCE (TF) 
study, participants were recruited into a two arm randomised comparison trial. 
Recruitment took place between April 2011 and March 2012 (first period - 12 
months), then September 2012 and November 2012 (second period – 3months).  
Recruitment initially began with local newspaper advertising and a request for 
healthy volunteers to take part in the cardiovascular risk screening program 
North Fife 
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TASCFORCE. This approach provided an initial list of volunteers which started the 
TASCFORCE Project and from which HF 2 participants would subsequently be 
recruited. The list increased through word of mouth as more volunteers presented.  
A second strategy was deployed which aimed to recruit employees from local 
businesses, local authority departments and educational institutions (Table 4.1).  
The decision to travel into workplaces proved productive and visits over a period of 
several months to some workplaces were organised to facilitate recruitment.  
Volunteers recruited from workplaces in some instances travelled large distances 
across Tayside which increase the sample’s geographical diversity. 
The final recruitment strategy involved approaching several GP practices within the 
Tayside area. Administrative support and resources from the Health Informatics 
Centre (HIC) within the University of Dundee provided assistance, liaising with GP 
practices to select healthy volunteers from their patient lists and mailing study 
invitation letters. 
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Table 4:1 Workplace Recruitment Sites  
Workplace Area Recruited in Tayside 
Stagecoach Group  North Fife, Perth & Kinross, Angus and 
Dundee 
St Columba's High RC School Perth 
Menzieshill   High School Dundee 
Dundee College Dundee 
Angus College Arbroath 
University of Dundee Dundee 
University of Abertay Dundee 
The James Hutton Institute Dundee 
Scottish and Southern Energy Perth and Dundee 
Scottish and Southern Water Dundee 
AVIVA Insurance Perth 
Perth Local Council Perth 
Dundee Fire and Rescue Services Dundee 
GP Practices Dundee Angus  and Perth 
Tesco Stores and Call Centres Dundee 
NCR Dundee 
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4.5   Screening Visit 
4.5.1 Screening and CVD Risk Perception Questionnaire Completion 
Prior to cardiovascular screening, all study participants received the standardised TF 
participant information leaflet (PIL) (Appendix D) with a separate PIL describing the 
HF2 study (Appendix E), and invited to provide informed consent to both. All 
participants were then invited to complete the pre-cardiovascular risk perception 
questionnaire (Appendix F). The questionnaire was designed purposely for the HF2 
study as the investigator was unable to source an appropriate validated 
questionnaire specific to the question asked. The question was designed to illicit a 
response with regard to participants own risk perception, “Compared with a person 
of your own age and sex, how would you rate your risk of having a heart attack or 
stroke in the next 10 years?” 
Participants were asked to make a choice from the following answers: 
 Much lower than average 
 
 Lower than average 
 
 Average 
 
 Higher than average 
 
 Much higher than average 
 
Post-screening all participants received the brief lifestyle intervention (usual care) 
and then invited to complete the post-cardiovascular risk perception questionnaire 
asking the same question as at pre-screening (Appendix G).   
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4.5.2 Eligible HF2 Participants 
Participants with a BMI ≥ 25kg/m2 who wished to take part in the HF2 study were 
then informed that questionnaires would be mailed out to them within two weeks. 
These would assess baseline dietary intake, physical activity, general health and 
demographic information. The questionnaires were in three parts and selected for 
ease of use, they were designed not to be too arduous for participants to complete:  
 Part 1 assessed Quality of Life (QOL) and was based on the Short Form Health 
Survey (SF-12) (Appendix H) the short version of the SF-360 (162). It was used 
in the HF2 study to measure of participants self-perceived health state and 
quality of life and pre and post intervention or usual care, see section 4.6 for 
further details of all questionnaires used. 
 Part 2 assessed dietary intake (Appendix I and J) using the Dietary Instrument 
for Nutritional Education (DINE)(163), and the Five a day Community 
Evaluation Tool for assessing fruit and vegetable intake FACET appendix I)  
(164). This questionnaire was used to evaluate differences between groups 
with regard to changes in modifiable risk factors and physiological measures 
such as weight, BP, blood lipids and CVD risk score. 
 Part 3 recorded physical activity levels and was evaluated using the 
International Physical Activity Questionnaire (IPAQ) (Appendix K) short 
questionnaire (165). It was used to assess between group changes in physical 
activity levels and views on initiating and maintaining changes in physical 
activity. 
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4.5.3 Support for participants in exclusion criteria for HF2 
Participants who were not eligible for HF2 at screening but were receptive to 
additional advice and support were directed to other sources of health information 
in the community, for example; written educational material provided as booklets 
from British Heart Foundation and their own GP services. In the case of participants 
wishing to discuss their health concerns with their own GP the study team alerted 
the GP in advance via letter that the participant may present for consultation. 
Individuals were given the opportunity to decline to consent from taking part in the 
HF2 study and this would not have prevented them from taking part in the TF 
screening. Ethical approval for the study had been received from NHS Tayside 
Committee for Medical Research Ethics.   
 
 
4.6 Details of Questionnaires Administered to HF2 Participants  
 
4.6.1 Quality of Life Questionnaire (SF12v2) 
The SF-12v2 questionnaire is designed to assess the quality of an individual’s life 
across a broad range of specific areas.  This questionnaire has been validated to be 
used in evaluating the effectiveness of health related interventions in clinical 
practice and research and can indicate areas of an individual’s life that may benefit 
from modification (166). The SF-12v2 is a generic measure and does not target a 
specific age or disease group. It provides a shorter, yet valid alternative to the SF-36, 
which has been seen by many health researchers as too long to administer. It is 
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weighted and summed to provide easily interpretable scales for physical and mental 
health.  
Physical and Mental Health Composite Scores are computed using the scores of 
twelve questions and range from 0 to 100, where a zero score indicates the lowest 
level of health (162). Data derived from the questionnaire is entered into the Quality 
Metric Health Outcomes Scoring Licensed Software 4.5 where the reports are 
generated. 
4.6.2 Physical Activity Questionnaire 
 
Physical Activity levels were determined using The International Physical Activity 
Questionnaire (IPAQ). The IPAQ was developed to measure health-related physical 
activity in populations. The short version of the IPAQ used in the HF2 study has been 
tested extensively and is now used in many international studies. It was developed 
in 1996 to provide a valid and reliable questionnaire measuring health-related 
physical activity suitable for both research and surveillance (165). The first part of 
the questionnaire gathers information with regard to number of days, hours and 
minutes per week spent undertaking levels of vigorous, moderate, walking and 
sedentary activity. The second part of the questionnaire uses questions both 
dichotomous and within a possible range to gather data on participants confidence 
and readiness to initiate and maintain physical activity change. The data is then 
presented into participants levels of confidence and stage of readiness to initiate 
change (Appendix K). 
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4.6.3 Dietary Questionnaires 
4.6.3.1 FACET 
Finally dietary intake was assessed using the Five A-Day Community Evaluation Tool 
(FACET). The FACET questionnaire (Appendix I) was designed and piloted in 2001 by 
the MRC Dunn Nutrition Unit, Cambridge and the University of Dundee for the 
purposes of assessing the effectiveness of five-a-day activities nationally. The 
questionnaire was intended for use by non-nutritionists working in the field of 
primary health care. During the pilot study it was found that there was a positive 
correlation between the intakes assessed by FACET and those assessed by a more 
detailed food diary method (164).  The survey continues to be recommended by the 
Department of Health as an evaluation tool.  The questionnaire asks participants to 
indicate by ticking a box on a five point scale (0 – 4+) the number of portions of fruit 
and vegetables eaten within the last 24 hours. Analysis involved calculating the total 
number of portions consumed each day. 
4.6.3.2 Dietary Instrument for Nutrition Education (Dine) 
The Dietary Instrument for Nutrition Education (DINE) Appendix J (163) was 
designed and validated by the Department of Primary Care at Oxford University. It is 
a brief, structured dietary questionnaire which attempts to make a brief assessment 
of an individual’s fat and fibre consumption. Validation of this questionnaire was 
carried out in 1994 against a four day detailed diet record; and the groups of foods 
included in the questionnaire were based on the 1989 Annual Report of the National 
Food Survey Committee (167). The DINE questionnaire is still frequently used by 
health professionals and a section within it has been adapted for use in the Health 
Survey for England and the Scottish Health Survey (Appendix J). Groups of foods 
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with a similar nutrient content and dietary use are combined; each group of foods is 
assigned a score proportional to the fat or fibre content of a standard portion size. 
The scores are weighted by the frequency of consumption using four categories 
which range from "less than once a week" to "six times a week or more"; more 
frequently eaten foods are categorized on a daily basis. The classification of fat and 
fibre are low, medium, or high (168). 
4.6.4 Demographic Questionnaire 
Participants were also sent a questionnaire to capture demographic characteristics 
including ethnicity, educational attainment, employment and marital status 
(Appendix L). The questionnaires were sent by post approximately 2 weeks from 
consenting to participate in the study and participants were provided with freepost 
envelopes to return the questionnaires.  
4.7 Randomisation 
On receipt of completed questionnaires participants were randomised to 
intervention (Group 1) (Appendix M) or usual care (control) (Group 2) (Appendix N). 
Participants were randomly allocated 50% to intervention and 50% control in blocks 
of 4 using SPSS (Version 18). The investigator was blinded to the participant’s group 
allocation and a second investigator conducted the randomisation and contacted 
the participants by letter to inform them of their group allocation.  
4.8  Outcome Measures and follow up  
 
Measures at all outcome points were completed face-to-face excluding the 
questionnaire data which was self-reported and mailed back via freepost envelope 
87 
 
by participants. Details of the outcomes collected at the different time points are 
detailed in Table 4.1.  
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Table 4:1 Outcome Measures: (B = Baseline F = 4 months follow-up) 
 
4.8.1    Anthropometric Measurement 
4.8.1.1  Weight, BMI and Measures 
All anthropometric measures were carried out on annually calibrated equipment 
within the Clinical Research Centre. Weight and height were recorded and BMI 
 Measure Point 
Primary Outcome  
Body Weight (Kg) 
BMI (Weight and Height) (kg/m2) 
Calibrated combined Seca Scales 
and Stadiometer 
B, F 
Secondary Outcome   
Waist Circumference (cm) Tape Measure B, F 
Lipid Profile (mmol/L) Venous sample whole blood B, F 
Blood Glucose (mmol/L) Venous sample whole blood  B, F 
Cardio-Vascular Risk Assessment Venous sample whole blood  B, F 
Blood Pressure (mm Hg) eSecureAneroid 
Sphygmomanometer 
B, F 
Diet DINE / FACET Questionnaires B, F 
Physical Activity IPAQ Short Questionnaire B, F 
Cardio-Vascular Risk Perception Cardio-Vascular Risk Perception 
Questionnaire 
B 
Quality of Life SF12 Questionnaire B, F 
Program Acceptability Exit Questionnaire F 
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calculated using a “Seca 703 Wireless 360 High Capacity Digital Medical Scale” 
(Appendix O), values were recorded to one decimal place.  Body Mass Index (BMI) is 
an index of weight-for-height that is commonly used to classify underweight, 
overweight and obesity in adults. It is defined as the weight in kilograms divided by 
the square of the height in meters (kg/m2) (169). 
4.8.1.2  Height  
Height was measured to two decimal places using a portable “Seca Leicester 
Stadiometer” (Appendix O). Participants were asked to remove their footwear and 
stand with a straight back against the metered device.  
4.8.1.3  Waist Measures  
Waist measurement was measured in centimeters to one decimal place at the 
midpoint between the lower margin of the last lower rib and the top of the iliac 
crest, using a stretch‐resistant tape. The recommended gender specific cut‐off 
points of 94 cm for men and 80 cm for women for increased risk, and 102 cm for 
men and 88 cm for women for substantially increased risk were used (194). 
 
4.8.1.4  Blood pressure measurements 
Baseline blood pressure measurement was carried out using an “eSecure - Aneroid 
Sphygmomanometer Monitor Meter” (Appendix O). Participants were seated for 10 
minutes post introduction to study and informed consent, and prior to blood 
pressure measurement. The arm was extended to a 45 degree angle and two 
readings were taken, the mean of the two was recorded.  All measurements were 
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carried out in accordance with localized Standard Operating Procedures within the 
Clinical Research Centre 
4.8.1.5  Blood Sampling 
During the initial TF screening visit participants consented to provide non-fasting 
samples of venous blood where possible drawn from the antecubital fossa. From 
these samples a full cholesterol profile was calculated and blood glucose 
measurement obtained. All blood samples were processed using the * Alere 
Cholestech LDX Analyser (Appendix O) which calculated CVD risk based on the 
Framingham risk score calculation (170). Results were available in five minutes.  
4.8.1.6  Cholestech LDX 
Each member of the research team involved in screening participants were given full 
training in operating and interpreting the results by the training department of 
“Inverness Medical”  supplier of the analyser. Prior to screening, daily checks were 
performed on the **Cholestech LDX to determine if the analyzers “optics” were 
functioning and a print out of each optics check was logged. Monthly calibration 
checks were also carried out using live assays to ensure accurate results using a 
“Multianalyser Kit” (Appendix O) supplied by Alere.  
For the duration of the Tascforce study, at six monthly intervals participant samples  
were sent to Ninewells Hospital biochemistry laboratory (once TF results were 
obtained) for further verification of calibration accuracy.  Results measured 
cholesterol within the same bias and accuracy as commercial laboratories. 
A 10 year CVD risk was calculated by the “Cholestec LDX Analyser” prior to 
randomisation based on the individuals lipid profile, age, systolic blood pressure, 
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current smoking or non-smoking and gender. The device has been validated for 
people between the ages of 30 – 74 with no known CVD (171). The Medicines and 
Healthcare Products Regulatory Agency (MHRA) concluded in their evaluation of the 
Cholestec LDX Aanalyser that sensitivity and specificity for detecting high risk 
individuals on total cholesterol alone were 73% and 100% respectively.  
If the ratio of total cholesterol to HDL cholesterol was used, then sensitivity 
improved to 80% and specificity slightly reduced to 98% it was also stated that the 
device was “simple to use and gave results comparable with those obtained by using 
a laboratory instrument" (171). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Alere Cholestech LDX® 
The TC HDL GLU Cassette measures total cholesterol (TC), a measure of the  total amount of cholesterol in the blood, and high 
density lipoprotein (HDL) cholesterol (referred to as the "good cholesterol") as well as glucose (GLU), a measure of blood su gar. 
TC HDL GLU also calculates the TC/HDL ratio and non-HDL cholesterol.  
* *The Optics Check Cassette performs a test on the Cholestech LDX to determine if the Analyzers optics are functioning 
properly. 
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4.9 HF2 Intervention Group 
Each month following randomisation the intervention group participants received a 
telephone call and lifestyle information pack. Appendix P shows the introduction 
letters provided to participants outlining the structure for the subsequent month’s 
telephone call with their counsellor. (Full details of the intervention are described in 
section 4.11.2). Telephone calls were scheduled for 1 week following the arrival of 
the information pack. Further details of the structure of the telephone consultations 
and call schedule are outlined in Appendix Q.  
 
4.10 Follow-Up  
Prior to the four month follow-up appointment both groups received repeat 
questionnaires to enable a comparison with baseline questionnaire data. These 
were returned using the freepost envelope. A courtesy call was given the day prior 
to appointment to help minimise loss to follow up. The 30 to 40 minutes follow-up 
appointment took place in the Clinical Research Centre at Ninewells Hospital (Figure 
4.2) 
 
Figure 4:2 Clinical Research Centre, Dundee 
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A sample of venous blood was obtained to calculate cholesterol and blood glucose 
levels, blood pressure was measured and weight, height and waist measurements 
obtained to calculate (BMI) using the same methods previously outlined in section 
4.8. These repeat measures were replicated to enable an accurate comparison from 
baseline data.  Participants were given the opportunity to discuss the results with 
the study nurse.  
4.11 The Two Study Arms 
4.11.1 Control arm: Brief intervention (usual care) 
The usual care brief intervention given to all 314 participants took between 10 and 
20 minutes. Discussion was led by the results from the lipid evaluation and the 
number of lifestyle factors requiring discussion with the individual participant.ie 
smoking, waist measurement, BMI, diet and levels of physical activity. British Heart 
Foundation booklets (172), explaining types and acceptable levels for lipids, blood 
sugar, how diet and physical activity affects weight, CVD risk and cholesterol, were 
given to both the control and experimental arm as added information to enhance 
participants understanding and motivation to consider improving aspects of their 
health.  
Following this brief intervention participants were randomised to either follow- up 
only (control group - usual care), or the multiple contact intervention. Participants 
randomised to the (control group - usual care) had no contact until follow-up visit at 
4 months. 
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4.11.2 Experimental arm: Brief intervention (usual care) plus Multiple 
contact intervention (HF2) 
- -
 
 
 
 -  
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-
 
-
– -
external prompt such as follow up from counselors with a monthly 30 minute 
telephone call encouraged continued self-monitoring as each telephone contact 
provided discussion from the previous months behavior change focus which also 
established a routine to the intervention. 
 
  
small changes opportunities and 
activities for consideration in their local area. Planning what they will do (where and 
when) and setting a goal for week one, going through current physical activity 
guidelines and discussing discrepancies between guidelines and what they are 
actually doing and  discussing ways of overcoming barriers to becoming more active. 
providing feedback on current level of 
achievement enables the individual to continue to set realistic goals for future 
improvement (147).  
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 -  
-
discussing and identifying barriers to 
change and ways of overcoming these were considered at each contact.
 
 
  
The HF2 counsellors facilitated participants to reach a decision balance by 
encouraging them to consider the pros and cons of making behaviour changes, 
including the risks of being overweight/obese and benefits of a healthy weight. 
Educational printed material was provided to support the decision making i.e. 
images describing the impact of weight loss/gain on CVD risk, fruit and vegetable 
literature which included recipes, healthy weight literature e.g. portion control, 
snacking, 10 top tips for a healthy weight leaflet, local group/community activities 
were also described and contact information provided for activities such as walking 
groups, healthy eating groups, weight reduction groups.  
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Figure 4.3 Structure of telephone calls 
 
4.12  Randomisation  
 
The target recruitment figure was 314 participants, 157 in both control and 
intervention groups. This figure was based on the data from HF to show a 7% change 
in body weight at 80% power (173). The sample size calculation is described in 
section 5.1.1. Participants were randomly allocated 1:1 to either HF2 intervention or 
control on receipt of completed questionnaires. A researcher independent of the 
analysis of study outcomes randomly allocated participants in blocks of 4 using “The 
Statistical Package for the Social Sciences “(SPSS v18). Analysis was carried out blind 
until all study outcomes were complete. It was necessary to add a second 
recruitment phase as a number of participants were unable to commit to follow up 
visits for a variety of reasons, mainly other family commitments making it difficult to 
arrange appointments. A short second recruitment and follow up period was 
introduced which successfully preserved statistical power.   
 
 
Week One 
Week Four 
Week Eight 
Week Twelve 
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4.13 Statistical Analysis 
4.13.1 Primary Outcome 
The study was powered to a detect weight loss of 7% and intention to treat analysis 
(ITT) was carried out on the primary outcome only.  Baseline and follow up data was 
described using means, percentages and standard deviations.  Independent T tests 
were used for comparing differences between groups for quantitative data and 
general linear model univariate analysis applied to control for baseline weight and 
randomised group. Paired T tests were used for within group differences. Regression 
modelling was used to explore which factors may have independently or in 
combination have had an influence on weight loss. General linear modelling was 
used to test each variable independently, as it can additionally test for categorical 
predictors. Where variables were found to be significant predictors of weight loss 
(p=<0.05) these significant predictors were in turn entered into a two-variable 
model with non-significant variables being removed from the analysis. The process 
continued resulting in a three variable model where all variables and interactions in 
the model were significant (p=<0.005), SPSS v21 and v22 were used for the 
calculations. 
4.13.2 Secondary Outcomes 
Secondary outcome data was analysed using data from only those subjects who 
completed the study (Per Protocol). The main analysis involved standard two sample 
comparisons (parametric or non-parametric as dictated by the distribution of the 
data). Descriptive summaries of baseline and follow up data were tabulated. Results 
were reported as mean/standard deviations, medians/inter-quartile ranges, p values 
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and confidence intervals.  
Paired t-tests were used within groups to check for differences from baseline to 
follow-up and independent t tests for changes between groups at baseline and 
follow up. Categorical variables were analysed with Pearson chi-squared tests where 
appropriate. Demographic, physiological and anthropometric data was compared to 
assess change in modifiable risk factors, and questionnaire data to assess change in 
diet, physical activity, self-reported health status and perceived CVD risk were 
analysed using Pearson chi-squared tests. 
4.14  Blinding  
 
Research staff involved in participant recruitment and follow-up visits were not 
involved in delivery of the intervention. Questionnaires were anonymised using ID 
numbers and sequential study participant numbers. Entry of baseline and follow-up 
data and analysis of data was carried out by the investigator who did not have 
contact with the participants until the four month follow-up visits. The investigator 
remained blind to group allocation by asking participants not to disclose which 
group they were allocated to at the follow up visit and until statistical analysis was 
complete. A second study investigator was responsible for randomisation and had 
no input into data entry.  
4.15 Dealing with missing data 
It is important to account for the effect of missing data from the proportion of 
participants who did not complete the study. Missing data can lead to bias and 
exclusion of a significant proportion of the original sample, which in turn can cause a 
substantial loss of precision and power. In order to preserve power and eliminate 
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bias a Multiple Imputation method of dealing with missing data was adopted for the 
ITT analysis. This method gave a best estimate of what the actual missing values  
were likely to have been, and reassurance that bias from missing data had been 
accounted for (Appendix R).  
4.15  Data handling and Record Keeping 
 
All data was handled according to good clinical practice (GCP) requirements and 
entered on to a computerised database at the University of Dundee. All data was 
identified via a unique participant ID and data tables were linked using this number. 
The names and addresses of subjects matched to their trial number were stored in a 
separate secure database. All databases were password protected and stored 
according to the requirements of the Data Protection Act 1998.  
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5.  Results  
5.1  Results (1) Recruitment and Retention 
5.1.1 Recruitment   
The TASCFORCE Project and the Healthforce 2 study aimed to recruit healthy 
volunteers aged between 40 and 75 years, with an equal distribution of SIMD 
classification. A decision to travel into workplaces to recruit proved productive and 
volunteers recruited from workplaces were drawn from a wide cross section of 
Tayside which increased the sample’s geographical diversity. Recruitment strategies 
proved successful in attracting the target of 5000 participants over five years into 
the TASCFORCE Project and provided the cohort from which HF2 participants were 
recruited. 
A consort diagram (figure 5.1) shows progression of the HF2 study through 
recruitment, enrolment and follow up. Volunteers were enrolled from 13th April 
2011 to 29th March 2012 (first period), and 3rd September 2012 to 13TH November 
2012 (second period).  This second period was necessary due to a higher than 
expected attrition rate of participants from the initial recruitment period, reducing 
the numbers completing to below the minimum required for statistical power.  
To demonstrate a 7% weight loss with 80% power, n=230 participants 115 from each 
group, would be required to complete the study.  An extra 15% (n=264) were initially 
randomised to allow for potential drop-outs, but when this was found to be 
insufficient, this was later increased to 37%, such that n=314 were ultimately 
randomised (157 in each group). 
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A total of 1134 TASCFORCE volunteers were screened in the HF2 recruitment 
periods: 770 (67.9%) fulfilled the eligibility criteria to take part in HF2, 364 (32.1%) 
did not (BMI ≤25kg/m2). Of those eligible, 438 (56.9%) accepted and 332 (43.1%) 
declined to take part. One hundred and twenty four people were excluded from 
randomisation for the following reasons: seven questionnaires were not sent back 
within the allotted time frame of less than three weeks, 23 questionnaires were 
returned after randomisation was completed, and 94 failed to return questionnaires.  
A total of 314 people were randomised to take part in HF2, 157 were randomised to 
intervention and 157 to control. Despite efforts to arrange suitable appointments, of 
the 314 participants randomised, 24 (7.6%) from the intervention group and 11 
(3.5%) from the control group informed the study team of their wish to withdraw 
from further participation in the study. A further 16 (5.1%) from intervention and 17 
(5.4%) from control were considered lost to follow up as they did not notify the 
team of an intention to withdraw. Two attempts were made via telephone to each 
of the participants considered lost to follow up. Messages were left on answer 
machines asking participants to contact the study team to arrange a follow up 
appointment or to indicate if there wish was to withdraw from the study.  
 
Introducing the short second recruitment and follow up period ensured statistical 
power was preserved. There was no difference in mean body weight, BMI, waist 
circumference or gender between subjects who completed the HF2 study and 
subjects who were lost to follow up but there was a significant difference in age and 
SIMD category (Table 5.1). 
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Figure 5:1: Consort Flow Diagram for Progression through Healthforce2 
 
 
 
 
 
 
   
 
  
  
 
  
 
 
  
 
 
 
 
 
 
 
Eligible (BMI ≥ 25kg/m
2
)
 
for period 1 
(n=623) + period 2 (n=147) Total=770 
(67.9%) 
 
Assessed for eligibility (n=  ) 
Analysed (n=117) 
 Excluded from analysis (n=0) 
 
 Received HF2 intervention (n=157) 
 Did not receive allocated intervention (n=40) 
 n=17 (5.4%) LTF 
 n=11 (3.5%) withdrew 
 
 
 Received Usual Care only  (n=157) 
 Did not receive allocated intervention (n=0) 
Analysed (n=129) 
 Excluded from analysis (n=0) 
Declined invitation to take part 
period 1(n=256) +period 2 (n=76): 
Total=332 (43.1%) 
Allocation 
Follow-Up 
Excluded period 1 (n=103) + period 2 
(n=21) Total=124 (28.3%) 
 
 Failed to return questionnaire 
period 1 (n=78) + period 2 (n=16) 
 Returned Questionnaire too late 
o Out with l imit for returning  of 
<3 weeks: period 1 (n=4) 
+period 2 (n=3) 
o After randomisation complete 
period 1 (n=21) + period2 (n=2) 
 
 
 
 n=16 (5.1%) LTF 
 n=24 (7.6%) withdrew  
 
Agreed to take part and 
questionnaires sent out period 1 
(n=367) + period 2 (n=71) 
Total=438 (56.9%) 
Enrolment 
Analysis 
Randomised (period 1 
(n=264) + Period 2 (n=50 
Total=314 (71.7%) 
 
 
 
 
Not eligible BMI ≤25kg/m
2 
Period 
1 (n=327) + period 2 (n=37) Total= 
364 (32.1%) 
 
Screened for TASCFORCE during HEALTHFORCE 2 
recruitment and invited to consent to take part i n 
HF2 (excluding total TF screen fails  n=122) Period 
1(n=936) + period 2 (n=198) Total = 1134 
 
Brief Intervention delivered to 
all  TASCFORCE participants at 
screening visit 
104 
 
 
Table 5:1:  Per protocol and LTFU participants, baseline body weight, BMI, Waist circumference, age, 
gender and SIMD. Values are Mean, SD and Range 
 Per Protocol 
(n=246) 
Mean (SD) 
Range 
LTFU (n=68) 
Mean (SD) 
Range 
Difference 
Mean, p-value 
95% (CI) 
Body weight (kg) 85.3  (13.3) 
57 - 141 
85.8  (13.5) 
61 – 120 
0.48 *p=0.795 
(-4.07 - 3.12) 
Body mass index (Kg/m2) 30.5  (4.3) 
25.0 – 62.9 
31.0  (3.6) 
25.3– 41.6 
0.47 *p=0.408 
(-1.59 – 0.65) 
Waist  circumference (cm) 96.8  (9.9) 
76 – 134.5 
96.1  (9.9) 
76.4 – 121.0 
0.74 *p=0.593 
(-1.99 – 3.47) 
Age 53.7 (8.3) 
40-75 
49.8    (6.6) 
40-64 
3.95 *p=<0.01 
(1.78 - 6.11) 
 Per Protocol 
(n=246) 
Mean (SD) 
N       (%) 
LTFU (n=68) 
Mean (SD) 
N      (%) 
Difference 
p-value 
 
Gender:  
Male                                                                           
Female        
 
99     (40.2) 
147   (59.8) 
 
23   (33.8) 
45   (66.2) 
 
 
*p= 0.399  
Scottish Index of Multiple 
Deprivation:  
1 (High 1-3)         
2 (Medium 4 - 7)     
3 (Low 8 – 10) 
 
 
60     (24.4) 
90     (36.6) 
96     (39.0) 
 
 
27     (39.7) 
23     (33.8) 
18    (26.5) 
 
 
*p=0.032 
 
Between group difference – Mean, 95% confidence intervals and *p values  
 
 
 
5.1.2 Representativeness of the TASCFORCE and HF2 Samples to the 
Scottish Health Survey Population  
The TASCFORCE screening sample age range of 40 to 75 years, and mean BMI of 27.1 
kg/m2 was found to be similar to that found in the 35 to 74 year old age group of the 
SHS (28.3 kg/m2) (7).  A one sample t-test showed no significant difference between 
the SHS and the total TASFORCE mean BMI (p=0.500 (CI -8.22 – 7.02)). The 
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TASCFORCE study sample from which HF2 participants were recruited were 
considered representative of the Scottish population as a whole for overweight and 
obese participants (Table 5.2).   
The HF2 study sample was selected to include only subjects who were overweight 
and obese. An Independent t test showed a significant difference between the HF2 
sample and total TASCFORCE sample from which it was drawn, (mean= -3.5kg/m2  (SE 
0.25), CI (-4.15 – 2.84) p=<0.001), therefore, the mean BMI of the HF2 study 
participants was as expected higher than the sample from the Scottish Health Survey 
and the TASCFORCE sample. 
Table 5:2 Scottish BMI comparisons to TASCFORCE and Healthforce2 sample 
 
 
 
 
 
Mean BMI (kg/m2) 
Scottish Health 
Survey sample 
(2012) 
Age 35-74  
 
 
Mean            (SD)           
Total TASCFORCE  
sample  (n=4424) 
Age 40 – 75 
 
 
 
Mean            (SD) 
Total TASCFORCE 
sample eligible 
for HF2  (BMI 
≥25kg/m2) 
(n=2893) 
Age 40 – 75 
Mean     (SD) 
Total 
Healthforce2 
sample (BMI ≥ 
25 kg/m2) 
n=314 
Age 40 – 75 
Mean     (SD) 
28.3         (0.45) 27.1         (0.78)    29.5    (4.25) 30.6     (4.17) 
Sample Mean and SD. 
 
5.1.3 Baseline socio-demographic characteristics  
The HF2 (ITT) sample at randomisation comprised 314 participants of which the 
majority were female (61.1% vs 38.9% males). Of these, 246 (78.3%) completed 
follow up visits (Per Protocol). The per protocol group included 99 (40.2%) males 
with a mean age of 51 years (SD 7.5) and 147 (59.8%) females with a mean age of 56 
years (SD 8.3). Baseline characteristics for the ITT and Per Protocol sample are 
described in Tables 5.3 and 5.4.  
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Table 5:3: Intention to treat sample characteristics at randomisation. Values are numbers (%) unless 
stated.  
*Mean age and range **No response to question ***p=<0.05 
(1) SIMD and Seasonal group are grouped deciles   
Baseline Characteristics ITT 
(n=314) 
Intervention 
(n=157) 
Control  
(n=157) 
Group  
difference  
p value 
Age (years) mean (SD)  
range 
*53.0  (8.2) 
40 - 75 
52.9  (8.5) 
40 – 75 
53.0  (7.9)  
40 – 74 
P=0.929 
Gender: n (%) 
 Male:                                                                            
 Female                                                                        
 
122   (38.9)
192   (61.1) 
 
54         (34.2)                                                                      
104       (65.8)                                                                        
 
68  (43.6)
88  (56.4)
 
P=0.105
Marital Status: n (%) 
 Single:                                                              
 Married/Co Habiting:       
 Widowed/Separated/Divorced:       
 **Missing:           
 
22   (7.0) 
232   (73.9)  
47      (15.0) 
13        (4.1) 
 
10           (6.3)                                                                     
108       (68.4)                                                                  
32         (20.3)                                                                   
8              (5.1)                                                                    
 
12 (7.7)                   
124 (79.5)              
15    (9.6)               
5 (3.2)                                                
 
***P=0.023
Ethnicity:  n (%) 
 White:                   
 Mixed                    
 Asian/Asian British       
 Other                       
 **Missing                    
 
294   (93.6) 
1          (0.3) 
5          (1.6) 
1          (0.3) 
13        (4.1) 
 
149       (94.3)                                                                  
0                 (0)                                                                        
1              (0.6)                                                                         
0                 (0)                                                                     
8              (5.1)                                                                     
 
145 (92.9)             
1 (0.6)                                                         
4 (2.6)                                
1 (0.6)                                                            
5 (3.2)                                                
 
 
P=0.213
Highest Educational Qualification: n (%) 
 Secondary School:      
 Other Professional/Technical 
Qualification 
 University Degree:               
 Post Graduate Degree 
Masters/PhD:      
 **Missing:  
 
98      (31.2) 
 
149   (47.5) 
32      (10.2) 
 
16        (5.1) 
19        (6.1) 
 
54         (34.2)       
 
70         (44.3)      
15           (9.5) 
 
8              (5.1)   
11           (7.0)   
 
44   (28.2)                                                         
 
79   (50.6)                                                          
17   (10.9) 
 
8       (5.1)                                                            
8       (5.1) 
 
 
P=0.688
Employment Status:  n (%) 
 Retired:                       
 Employed Full time:                   
 Unemployed:                    
 Employed Part time:        
 Student Part-time          
 Other:                                 
 **Missing:                               
 
61      (19.4) 
168   (53.5) 
10        (3.2) 
51      (16.2) 
1          (0.3) 
10        (3.2) 
13        (4.1) 
 
33         (20.9)   
78         (49.4)   
 5             (3.2)                                                                     
27         (17.1)       
0                 (0)                                                                              
7              (4.4)        
8              (5.1)           
 
28   (17.9)                                                         
90   (57.7)                                                        
5 (3.2) 
24   (15.4)                                                            
1 (0.6)                                                                                                 
3       (1.9)                                                              
5    (3.2)                                                             
 
 
P=0.555
(1) Scottish Index of Multiple 
Deprivation: n (%) 
 1 (High 1-3):         
 2 (Medium 4 - 7):     
 3 (Low 8 – 10):  
 
 
83      (26.4) 
115   (36.6) 
116   (36.9) 
 
 
50         (31.6)      
52         (32.9)                                                                           
56         (35.4) 
 
 
33   (21.2)         
63  (40.4)
60   (38.5)                                                         
 
 
P=0.099
(1) Seasonal Group:  n= (%) 
 Dec/Jan/Feb 
 Mar/April/May 
 Jun/July/Aug 
 Sep/Oct/Nov 
 
50      (15.9) 
37      (11.8) 
78      (24.8) 
149   (47.5) 
 
24         (15.3) 
20         (12.7) 
38         (24.2) 
76         (48.4) 
 
26   (16.6) 
17   (10.9) 
40   (25.5) 
73   (46.8) 
 
 
P=0.973 
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Table 5:4 Per Protocol sample characteristics at randomisation. n= numbers (%)   
*Mean age and range **No response to question ***p=<0.05 
(1) SIMD and Seasonal group are grouped deciles  
  
Baseline Characteristics Per Protocol 
(n=246) 
Intervention 
(n=117) 
Control 
(n=129) 
Group 
difference  
p value 
Age (years) mean (SD)  
range 
*53.7     (8.3)  
40 -75 
53.9          (8.7)  
40-75 
53.5   (8.1)   
40- 74 
P=0.708 
Gender: n (%) 
 Male:                                                                            
 Female                                                                        
 
99        (40.2) 
147      (59.8) 
 
42           (35.6)                                                                    
76           (64.4)                                                                    
 
57  (44.5)                      
71  (55.5)                     
 
P=0.153 
Marital Status: n (%) 
 Single:                                                              
 Married/Co Habiting:       
 Widowed/Separated/Divorced:       
 **Missing:           
 
15           (6.1) 
190      (77.2) 
36         (14.6) 
5             (2.0) 
 
6                (5.1)                                                                     
85           (72.0)                                                                  
24           (20.3)                                                                   
3                (2.5)                                                                    
 
9 (7.0)                           
105 (82.0)                                                     
12    (9.4)                
2 (1.6)                      
 
***P=0.045
Ethnicity:  n (%) 
 White:                   
 Mixed                    
 Asian/Asian British       
 Other                       
 **Missing                
 
237      (96.3)                                                                                                                                                              
1             (0.4) 
2             (0.8) 
1             (0.4) 
5             (2.0) 
 
115     (97.5)               
0                   (0)                                                                        
0                   (0)                                                                         
1                (0.8)                                                                     
3                (2.5)                                                                     
 
122  (95.3)  
1    (0.8)                                  
2    (1.6)                                                       
0 (0)                   
2 (1.6)               
 
P=0.499
Highest Educational Qualification: n (%) 
 Secondary School:      
 Other Professional/Technical 
Qualification 
 University Degree:               
 Post Graduate Degree Masters/PhD:      
 **Missing:  
 
76         (30.9) 
120      (48.8) 
 
28         (11.4) 
15           (6.1) 
7             (2.8) 
 
40           (33.9)       
54           (45.8)      
 
14           (11.9) 
7                (5.9)   
3                (2.5)   
 
36    (28.1)                                                         
66    (51.6)                                                          
 
14    (10.9) 
8         (6.3)                                                            
4         (3.1) 
 
P=0.767 
Employment Status:  n (%) 
 Retired:                       
 Employed Full time:       
 Student Full time:              
 Unemployed:                    
 Employed Part time:        
 Other:                                 
 **Missing:                                
 
55         (22.4) 
132      (53.7) 
0                 (0) 
8             (3.3) 
38         (15.4) 
8             (3.3) 
5             (2.0) 
 
29           (24.6)   
61           (51.7)   
0                   (0)                                                                             
3                (2.5)       
17           (14.4)   
5                (4.2)                                         
3                (2.5)                      
 
26    (20.3)                                                         
71    (55.5)                                                        
0 (0) 
5         (3.9)                                                            
21    (16.4)                                                           
 3 (2.3)                                                                                                     
2 (1.6)                                                             
 
P=0.779
(1) Scottish Index of Multiple Deprivation: n 
(%) 
 1 (High 1-3):         
 2 (Medium 4 - 7):     
 3 (Low 8 – 10):  
 
60         (24.3) 
90         (36.6) 
96         (39.0) 
 
35           (29.7)      
40           (33.9)                                                                           
43           (36.4) 
 
25    (19.5)         
50  (39.1)
53    (41.4)                                                         
 
 
P=0.181 
(1) Seasonal Group:   n= (%) 
 Dec/Jan/Feb 
 Mar/April/May 
 Jun/July/Aug 
 Sep/Oct/Nov 
 
42         (16.6) 
31         (10.9) 
54         (25.5) 
119      (46.8) 
 
20           (17.1) 
17           (14.5) 
23           (19.7) 
57           (48.7) 
 
22    (17.1)  
14    (10.9) 
31    (24.0) 
 62   (48.1) 
 
P=0.757 
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The randomised groups completing were well matched for age, gender, educational 
qualification, employment and deprivation. The majority of participants were white 
(96.3%), employed full time (53.7%) and had a professional or technical qualification 
(48.8%). Participant representation across the range of SIMD deciles was good with 
39% in the three least deprived SIMD deciles (8 – 10). The only significant between 
group difference seen in baseline socio-demographic characteristics  was in marital 
status, with a significantly lower proportion in the intervention group  married or co-
habiting and twice as many participants  widowed, separated or divorced (20.3% vs. 
9.4%, respectively) than the control group. 
 
 
5.2 Results (2) Weight loss 
 
The study was powered to a detect weight loss of 7%; therefore, an intention to treat 
analysis was carried out on the primary outcome only.  Secondary outcomes were 
analysed using data from only those subjects who completed the study. To preserve 
sample size and prevent bias from a non-representative sample a multiple imputation 
method was used to account for missing data.  The methods used to apply a multiple 
imputation process are reported in Appendix S.  
5.2.1 Weight loss  
When the data was adjusted following multiple imputation, weight loss was shown not 
to be statistically significant (between group difference 0.9kg, p=0.09, CI -0.14 – 1.92) 
(Table 5.5), however, analysis of the Per protocol data indicated that the intervention 
group lost significantly more weight than the control group (between group difference 
1.1kg, p= 0.02, CI 0.16 – 2.06).  
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Table 5:5 Weight loss (kg) Per Protocol  sample and Intention to treat dataset 
 
Intention to Treat Intervention  (n=157) Control   (n=157) 
Between group 
difference baseline 
to follow-up 
Mean (CI), p value 
Mean (SD) Mean kg 
weight 
loss  
(SE) 
Mean (SD) Mean kg 
weight 
loss 
(SE) 
 
 
Body weight (kg) 
 
 
Baseline 
Follow up 
 
 
85.6 (12.8)  
83.5 (12.6) 
 
 
-2.1 
(1.82) 
P=0.238 
 
 
 
 
86.7  (14.3) 
83.8  (13.2) 
 
 
-2.9 
(0.36) 
P=0.097 
-0.88,(-1.91 to 0.14) 
P=0.090 
Per Protocol Intervention  (n=117) Control   (n=129) Between group 
difference baseline 
to follow-up 
Mean (CI), p value 
 
 
Mean (SD) 
Mean kg 
weight 
loss (SD) 
 
 
Mean (SD) 
Mean kg 
weight 
loss 
(SD) 
 
 
Body weight (kg) 
 
 
Baseline 
Follow up 
 
 
83.8 (12.4) 
81.6 (12.4) 
 
-2.2 
(3.31) 
P=<0.005 
 
 
86.7 (13.9) 
85.6 (13.0) 
 
-1.1 
(4.16) 
P=<0.005 
 
-1.10 (-2.05 to -
0.156)   
*P= 0.023 
Mean (kg) weight loss with 95% confidence intervals: difference between randomised groups *P=<0.05  
 
5.2.2 Controlling for baseline weight  
General linear model univariate analysis applied to the primary outcome weight loss, 
showed, when controlling for randomised group and baseline weight the treatment 
effect decreased: mean weight loss for intervention group, 1.4kg, p=<0.01, (95% CI 
0.44-2.36) compared to 1.1kg for control group, p=0.02 (95% CI 0.16-2.06), a 
difference of 0.3kg, p=<0.01, (95% CI 0.40 – 2.25,) for per protocol data. Using the 
intention to treat data, the intervention group lost 1.0 kg, p=0.05, (95% CI, -0.00 -1.82) 
compared to 0.9kg for the control group, p=0.09, (95% CI, -014 -1.92), a difference of 
0.1kg, p=0.05, (95% CI, -0.31 – 1.71). 
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5.3 Results (3) Change in Cardiovascular Risk Factors  
 
5.3.1 BMI and Waist Measures 
Results from BMI and waist measurements are seen in Table 5.6. A significant between 
group difference is shown at follow up for waist measurement (-1.21cm p=0.002) but 
not for calculated BMI, however, the difference from baseline to follow up BMI in both 
groups was significant, -0.8kg/m2 p=<0.001 in the intervention group versus -0.7 kg/m2  
p=<0.001 in the control group.  A significant difference was also seen in waist 
measurement from baseline to follow up with a 4cm loss (p=<0.001) in the 
intervention group versus 2.8cm loss (p=<0.001) in the control group.  
Table 5.6 Anthropometric measures per randomised group 
 Intervention  (n=118) Control   (n=128) Change between 
groups from 
baseline to follow -
up 
Mean (CI),  
p value 
Mean (SD) Difference 
to baseline 
Mean (SD) 
P-value 
Mean (SD) Difference 
to baseline 
Mean (SD) 
P-value 
BMI (kg/m2) Baseline 
Follow up 
30.2 (4.63) 
29.4 (4.54) 
-0.8 (1.14) 
P=<0.001 
30.4 (4.11) 
29.7 (4.05) 
-0.7 (1.47) 
P=<0.001) 
-0.28 (-1.521 to - 
0.948,) 
p= 0.648 
Waist 
circumference 
(cm) 
Baseline 
Follow up 
95.4 (8.74) 
91.4 (8.41) 
-4.0 (5.10) 
P=<0.001 
98.0 (11.24) 
95.2 (9.86) 
-2.8 (19.98) 
P=<0.001 
-1.21 (-6.021 to 
0.904) 
*p=0.002 
BMI (kg/m
2
) and Waist circumference (cm) difference between groups at follow up Mean with 95% 
confidence intervals *p=<0.05 
 
5.3.2  Summary of main findings from follow up CVD risk factors 
Baseline and follow up measures for cardiovascular risk factors, including sys tolic and 
diastolic blood pressure, lipid profile, non-fasting blood glucose and cardiovascular risk 
score (based on the Framingham risk assessment algorithm (159) are reported in Table 
5.7. 
111 
 
5.3.2.1  Blood Pressure  
Reductions in both systolic and diastolic blood pressures (mmHg) were seen in both 
groups, with a larger but not significant reduction in systolic BP in the intervention 
group. Mean diastolic reduction in the intervention group was statistically greater than 
in the control group: - 3.25 mmHg (SD=7.8) versus. -2.68 mmHg (SD=7.8), respectively 
(95% CI -4.57, -0.68 p=0.008). 
5.3.2.2  Total Cholesterol 
Participants from both groups significantly reduced their total cholesterol levels; 
however, the reduction in the intervention group was significantly greater than in the 
control group: -0.37 mmol/L (SD=0.7) versuss.-0.29 mmol/L (SD=0.7) respectively (95% 
CI -0.45 – 0.09, p=0.003). 
5.3.2.3 Blood Lipids 
There was no significant difference between groups when absolute mmol/L non-
fasting triglyceride levels were measured. The intervention group slightly reduced 
levels -0.04 mmol/L) and the control group slightly increased levels (0.01 mmol-L). 
Both groups increased absolute mmol/L HDL cholesterol levels, but not significantly, 
however, both groups reduced their LDL cholesterol levels with a significant between 
group mean difference of -0.22 (p=0.034).  
5.3.2.4  Blood Glucose 
The between group difference was non-significant for non-fasting blood glucose 
(p=0.426), however, the intervention group showed a small but significant reduction 
(p=0.046). 
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5.3.2.5  CVD risk score 
 
Both groups significantly reduced calculated 10 year CVD Framingham risk scores at 
follow up (p=<0.001). The control group achieved the greater reduction 4.9% to 4.0% 
versus 4.1% to 3.3% in the intervention group although there was no between group 
significance. 
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Table 5:7 Cardiovascular risk values Per protocol sample. Independent T-tests show mean differences with 95% confidence intervals p=<0.05  *significant values  
 Baseline Follow-up Within group change Between group differences 
from baseline to follow-up   
Measures N= Mean (SD)  Range N= Mean (SD)  Range Mean (SD), P-value  Mean (95% CI), P value 
Systolic blood pressure (mm Hg):   
Intervention       
Control            
 
117 
129 
 
126.1 (11.8) 94-145 
126.3 (11.9) 100-145 
 
117 
129 
 
122.0 (10.7) 98 -144 
122.7 (11.8) 98 -158 
 
-4.02 (8.2) P=<0.001 
-3.57 (9.1) P=<0.001 
 
1.20 (-0.98-3.39), P=0.281 
Diastolic blood pressure (mm Hg): 
Intervention 
Control 
 
117 
129 
 
73.8   (10.0) 50 - 95 
75.2   (10.0) 50 - 90 
 
117 
129 
 
70.5   (9.4)    50 - 90 
72.5   (9.9)    50 - 90 
 
-3.25 (7.8) P=<0.001 
-2.68 (7.8) P=<0.001 
 
2.63  (0.68 – 4.57), *P=0.008 
Total Cholesterol (mmol/L): 
Intervention 
Control 
 
117 
129 
 
5.5  (0.98)  2.7-8.1 
5.6  (0.90)  3.6-8.8 
 
117 
129 
 
5.2  (0.88)   2.5-7.0 
5.3  (0.87)   3.1-7.7 
 
-0.37 (0.7) P=<0.001 
-0.29 (0.7) P=<0.001 
 
-0.27 (-0.45 - 0.09), *P=0.003 
HDL Cholesterol (mmol/L): 
Intervention 
Control 
 
117 
129 
 
1.2  (0.45) 0.4- 2.4 
1.2  (0.47) 0.4- 2.5 
 
117 
127 
 
1.3  (0.41)  0.3-2.5 
1.3  (0.47)  0.3-3.9 
 
0.11 (0.3) P= 0.003 
0.09 (0.3) P=<0.001 
 
-0.01 (-0.10 - 0.06), P=0.706 
LDL Cholesterol (mmol/L: 
Intervention 
Control 
 
111 
124 
 
3.51 (0.85) 0.9- 5.6 
3.50 (0.84) 1.7- 6.0 
 
113 
119 
 
3.02 (0.80)  0.9-4.8 
3.09 (0.79)  1.1-5.3 
 
-0.49 (0.7) P=<0.001 
-0.38 (0.7) P=<0.001 
 
-0.22 (-0.41 to -0.01),*P=0.034 
Triglycerides (mmol/L): 
Intervention 
Control 
 
117 
129 
 
1.79 (1.15) 0.5-7.2 
1.90 (1.12) 0.5-7.3 
 
118 
127 
 
1.75 (0.95) 0.5- 4.8 
1.91 (1.13) 0.5- 6.1 
 
-0.04 (0.9) P=0.646 
  0.01 (1.0) P=0.850 
 
0.9 (-0.73 - 2.53), P=0.280 
Non Fasting Blood Glucose (mmol/L): 
Intervention 
Control 
 
117 
129 
 
5.35 (0.76) 3.5-8.3 
5.36 (0.80) 4.0-9.9 
 
117 
127 
 
5.17 (0.77) 3.5- 7.6 
5.32 (0.83) 3.4- 9.1 
 
-0.17 (0.9) *P=0.046 
-0.03 (0.9) P=0.680 
 
0.69 (1.00 - 2.38), P=0.426 
Framingham Cardiovascular Risk Score 
Intervention 
Control 
 
117 
129 
 
4.1 (3.92) 0 - 16  
4.9 (4.53) 0 - 18 
 
117 
126 
 
3.3 (3.91)  0 - 20 
4.0 (4.12)  0 - 20 
 
-0.79 (1.9) P=<0.001 
-0.86 (2.5) p=<0.001 
 
0.07 (-0.18 –0.33), P=0.185 
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5.4 Results (4) Factors which influenced weight loss  
5.4.1  Predictors for Weight Loss  
Regression modelling was used to explore which factors may have been predictors in 
order to test whether a significant amount of variation in weight loss could be 
explained by differences in individual anthropometric or demographic 
characteristics. As the number of factors available to test is limited by the sample 
size, 10 were chosen using a p-value of 0.05 as a cut off. The variables chosen to 
investigate were hypothesis generated: 
 Randomised Group 
 Gender 
 Baseline Total Cholesterol 
 Baseline Body Mass Index (kg/m2) 
 Waist to hip ratio (cm) 
 SIMD category (1-3 high deprivation, 4-7 medium, 8-10 low) 
 Educational attainment  
 Employment status 
 Marital status 
 Seasonal groups 
 
As the data regarding these variable was available it was considered prudent to 
analyse each individually so as not to dismiss any which may have had an influence 
on weight loss. General linear modelling was used to test each variable 
independently, as it can additionally test for categorical predictors. Where variables 
were found to be significant predictors of weight loss (p=<0.05) these significant 
predictors were in turn entered into a two-variable model with non-significant 
variables being removed from the analysis. The process continued resulting in a 
three variable model where all variables and interactions in the model were 
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significant (p=<0.005). (See Appendix S for models used in the process) Table 5.8 
show the variables used and significance of predictive values. 
Table 5:8 Univariate independent variable models used to predict kg weight loss  
Predictor Variables P -values Significant predictor Adjusted R2 
Randomised Group <0.001* Yes 0.068 
Seasonal Group <0.005* Yes 0.044 
Gender 0.241 No 0.002 
Baseline BMI Index (kg/m2) 0.064 No 0.011 
Waist to Hip ratio 0.399 No 0.013 
Employment  <0.001* Yes 0.016 
Marital status <0.001* Yes 0.064 
Educational attainment 0.732 No 0.009 
Baseline Total cholesterol 0.719 No 0.028 
SIMD category  
 1-3 high deprivation  
 4-7 medium  
 8-10 low 
0.404 No 0.001 
General Linear Modelling: *significant predictors for weight loss p=<0.05 
The one variable model showed that randomised group, marital status, employment 
and seasonal grouping were all significant predictors for weight loss, (p<0.001, 
p<0.001, p<0.001 and p<0.005 respectively). 
 
5.4.2  Marital status effects on weight loss 
Marital status was a significant predictor for weight loss, p= <0.001 and an R 2 value 
of 0.064 indicating that it explained approximately 6.4% of the variation in weight 
loss. Analyses of marital status showed greatest weight loss in the widowed, 
separated or divorced group for both intervention and control groups (2.9kg (SD1.9 
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v’s 2.2kg (SD 2.4)) respectively (Figure5.2). The intervention group showed greatest 
overall weight loss per marital status, 2.1kg (SD 0.7) versus 1.1kg (SD 0.9).  
Figure 5:2 Weight loss (kg) by marital status. Error bars represent standard error of the mean. 
Regression analysis, shows marital status predictor for weight loss ANOVA p=<0.001  
 
5.4.5  Seasonal weight loss difference 
Analysis of weight loss by seasonal grouping was a significant predictor for weight 
loss independent of marital status p=<0.005 and an R2 value of 0.044 indicating that 
it explained approximately 4.4% of the variation in weight loss. Analyses of weight 
loss by seasonal grouping showed greatest weight loss in the December through to 
February cohort with the greatest weight reduction in the intervention group (2.9kg 
(SD1.55)), and March through to May in the control group (1.6kg (SD 2.4)). Figure 5.3 
illustrates weight loss  (kg)  over seasonal groups with the intervention group 
achieving a greater mean kg weight loss (kg) across all seasonal groupings, 
intervention group 2.1kg (SD 0.9) versus control group 0.9kg (SD 1.0). 
 
 
0 0.5 1 1.5 2 2.5 3 3.5 4
Single
Married/co-habiting
Widowed/seperated/divorced
weightloss (Kg) 
Weightloss (kg) per marital status 
Control n=128
Intervention n=118
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Figure 5:3 Weight loss (kg) by season. Error bars represent standard error of the mean. Regression 
analysis shows seasonal grouping a predictor for weight loss ANOVA p=<0.005  
 
5.4.3  Effect of employment on Weight loss 
Employment status was a predictor for weight loss p=<0.001 with an R2 value of 
0.016 indicating that it explained approximately 1.6% of the variation in weight loss. 
In the intervention group the greatest proportion of participants were employed full 
time (n=56) or in the retired group (n=26). This was also the case in the control 
group with participants employed full time (n=69) and retired (n=25) respectively. 
The greatest weight reduction in the intervention group was seen in the retired; 
(3.4kg,SD 2.2)  and greatest weight reduction in the control group was seen in the 
employed part time group (2.0kg SD 2.0) (Figure 5.4) The intervention group 
achieved a greater mean kg weight loss across all employment groupings , 
intervention 2.2kg (SD 0.8) versus control 1.3kg (SD 0.7).  
-0.5 0.5 1.5 2.5 3.5 4.5
Mar Apr May
Jun Jul Aug
Sep Oct Nov
Dec Jan Feb
Mean weightloss (Kg) 
weight loss (Kg) per season 
Control
Intervention
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Figure 5:4 Weight loss (kg) by employment status: Error bars represent standard error of the mean. 
Regression analysis, ANOVA p=<0.001 
* Other” full  time and part time students/ self-employed 
 
5.5 Results (5) Changes in diet and lifestyle behaviours 
5.5.1 Views on Initiating Dietary Change 
Questionnaires were completed to assess participant’s views with regard to 
readiness and confidence to initiate a change in diet (Appendix I and J) and chi 
square tests were used to determine differences between groups. There was no 
significant difference between groups at baseline (p=0.131) or follow up (p=0.324) 
and significance was not reached in the change in their response from baseline to 
follow up (p=0.106). 
The intervention group showed 88.7% of participants reporting they were “currently 
thinking about eating a healthy diet in the future” compared with 81.7% in the 
control group at baseline. When asked if feeling confident about “sticking to a plan 
to eat healthier” there was no between group difference at baseline (p=0.226) and 
follow up (p=0.062) and no difference in the change in their response from baseline 
to follow up (p=0.648).  
-1 0 1 2 3 4 5
Retired
Employed full time
Unemployed
Employed part time
*Other
Mean Kg weight loss 
Weight loss (kg) per employment  
Control
Intervention
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Figure 5.5 shows the changes in levels of confidence per group from baseline to 
follow up. Of  those who went on to make changes, as reported in the question “are 
you still eating a healthy diet”, more participants in the control group (76%) than the 
intervention group (74.6%) reported continuing to eat a healthy diet, this did not 
demonstrate a significant change (Table 5.9). 
Figure 5:5 Between group difference in Participant confidence levels in sticking to plan to eat a 
healthier diet baseline to follow up. Values shown as % from data in table 22; p=0.648  
 
0 10 20 30 40
Not at all confident
Mildly confident
Somewhat confident
very confident
Answered no to question
% of Participant Response 
Confidence in sticking to a plan to eat a healthier diet 
Intervention Baseline
Intervention Follow up
Control Baseline
Control Follow up
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Table 5:9 Views on initiating dietary change 
 Baseline Follow up Between 
Group 
Difference 
 Intervention 
n=115      (%) 
Control 
n=126      (%) 
Intervention    
n=114    (%) 
Control 
n=121     (%) 
Currently thinking about 
eating a healthier diet in 
the future 
     
Yes 
No 
Total 
102      (88.7) 
  13      (11.3) 
115 
103      (81.7) 
23         (18.3) 
126 
88         (77.2) 
26         (22.8) 
114 
94         (77.7) 
27         (22.3) 
121 
P=0.324 
If yes when do you plan 
to begin eating a 
healthier diet 
     
Within next month 
Within next 6 months 
Yet to decide 
Answered no to question 
Total 
88         (76.5) 
  3           (2.6) 
11           (9.6) 
13         (11.3) 
115 
85         (67.5) 
  2          (1.6) 
16         (12.7) 
23         (18.3) 
126 
76         (66.7) 
  3           (2.6) 
  9           (7.9) 
26         (22.8) 
114 
81         (67.0) 
  3           (2.5) 
10           (8.3) 
27         (22.3) 
121 
P=0.615 
How confident are you 
that you will stick to this 
plan 
     
Very confident 
Somewhat confident 
Mildly confident 
Not at all confident 
Answered no to question 
Total 
12         (10.4) 
42         (36.5) 
36         (31.3) 
12         (10.4) 
13         (11.3) 
115 
19         (15.1) 
41         (32.5) 
35         (27.8) 
  8           (6.3) 
23         (18.3) 
126 
21         (18.4) 
35         (30.7) 
29         (25.4) 
  3           (2.6) 
26         (22.8) 
114 
26         (21.5) 
39         (32.2) 
19         (15.7) 
10           (8.3) 
27         (22.3) 
121 
P=0.648 
Have you ever made 
deliberate effort to 
improve your diet 
     
Yes 
No 
Total 
95         (82.6)  
20         (17.4)   
115 
103      (81.7) 
24         (19.0) 
126 
102      (89.5) 
12         (10.5)  
114 
105      (86.8) 
15         (12.4) 
121 
p=0.918 
If yes are you still eating a 
healthy diet 
     
Yes 
No 
Answered no to question 
Total 
64         (55.7)    
31         (27.0)  
20         (17.4)  
115  
81         (64.3)    
22         (17.5) 
24         (19.0)  
126 
85         (74.6)  
17         (14.9) 
12         (10.5) 
114 
92         (76.0) 
14         (11.6) 
15         (12.4) 
121 
P=0.307 
If yes have you been able 
to maintain eating a 
healthy diet  
     
Yes 
No 
Answered no to question 
Did not answer the 
question 
Total 
40         (34.8) 
24         (20.9) 
20         (17.4) 
31         (27.0) 
 
115 
53         (42.1) 
28         (22.2) 
24         (19.0) 
21         (16.7) 
 
126 
57         (50.0) 
28         (24.6) 
12         (10.5) 
17         (14.9) 
 
114 
54         (44.6) 
38         (31.4) 
15         (12.4) 
14         (11.6) 
 
121 
P=0.470 
Questionnaire not completed at baseline Group 1 n=2 / Group 2 n=3  
Questionnaire not completed at follow up Group 1 n=3/ Group 2 n=8  
Values numbers and percentage with between group differences at follow up 
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5.5.2 Reported dietary intake 
5.5.2.1 Total Fat /unsaturated fat Scores 
Results from the DINE questionnaire administered to subjects pre and post 
intervention provided a score indicating the level of consumption of foods high in total 
and unsaturated fat. The results are shown in Table 20.  Both groups’ total fat scores 
were in the low category a score less than 30 which represent a fat intake of 83g per 
day or less corresponding to 35% of the energy RDA for an average woman (168). 
Independent t tests showed both groups significantly reduced their fat intake: 
intervention group by 5.1 (SD 9.4) and control group by 3.7 (SD 8.5), however, the 
degree of change was not significantly different between the groups. 
Unsaturated fat intake scores increased in the intervention group from 8.5 (SD 1.7) to 
8.7 (SD 2.3) however the control group decreased from 8.8 (SD 2.0) to 8.5 (SD 2.1). 
Neither groups change was significant nor was there significant difference between 
groups (mean score difference 0.24, p=0.413, 95% CI -0.34-0.82). 
5.5.2.2   Fruit, vegetable and fibre intake 
At baseline both groups fibre intake was low, less than 30 which corresponds to a fibre 
intake of 20g/day or less. Whereas the intervention group increased their fibre score 
significantly from 27.4 (SD 10.5) to 30.5 (SD 9.8), and out of the low category the 
control group reduced their intake from 28.1 (SD 9.4) to 26.6 (SD 10.3).  This change in 
intake between the groups was significantly different 4.11 p=0.003, (95% CI 1.417-
6.802).  
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Both groups significantly increased total number of fruit and vegetable portions over a 
24hr period. Table 5.10 shows between group differences in change in number of 
portions consumed at follow up not to be significant. Both groups level of fruit and 
vegetable intake was high, possible reasons for why this may be are reviewed in the 
discussions chapter (section 6.7.2.3).  
Table 5:10 Baseline and follow up changes from the DINE (163) and Facet (164) dietary questionnaire 
data 
  
N= 
Intervention 
Mean       (SD)  
 
N= 
Control 
Mean       (SD)  
Between group 
difference from 
baseline to follow-up: 
mean,  CI and P value   
Total Fat score 
 
 
 
 
 
 
 
 
 
 
 
Baseline 
Follow up 
 
Difference to baseline 
117 
112 
25.3         (10.7) 
20.1           (7.2)  
 
-5.1            (9.4)   
P=<0.001       
129 
120 
24.9          (9.9) 
21.2          (8.9) 
 
-3.7           (8.5) 
P=<0.001      
 
-1.06   ( -3.14 – 1.02) 
p=0.318   
 
Total Unsaturated Fat 
score 
 
 
 
 
 
 
 
 
 
 
 
Baseline 
Follow-up 
 
Difference to baseline 
 
117 
112 
8.5             (1.7) 
8.7             (2.3) 
 
-0.2            (2.4) 
P=0.254         
129 
120 
8.8            (2.0) 
8.5            (2.1) 
 
0.4            (2.6)  
P=0.112         
 
0.24   ( -0.33 – 0.82)  
P=0.413    
Total Fibre score 
 
     
 
Baseline 
Follow-up 
 
Difference to baseline 
 
 
117 
112 
 
27.4        (10.5) 
30.5           (9.8) 
 
2.7           (10.1) 
P=<0.001 
 
129 
120 
 
28.1          (9.4) 
26.6        (10.3) 
 
-1.3        (10.7) 
P=0.001      
 
4.11    (1.41 – 6.80)  
P=**0.003     
Number of fruit and 
vegetable portions  in 
24 hours  
 
 
 
 
 
 
 
 
 
 
 
Baseline 
Follow-up 
 
Difference to baseline 
 
115 
128 
 
*5.3           (3.1) 
6.6             (3.6) 
 
1.4             (4.0) 
P=0.004 
 
114 
124 
 
 
5.5            (3.1) 
6.8            (3.2) 
 
1.3            (3.1) 
P=0.002 
 
-0.109  ( -1.07-0.85) 
P=0.825 
Values are mean total scores, *number of daily portions of fruit and vegetables. Last column mean 
difference from baseline to follow up between groups, with confidence intervals and level of 
significance**p=<0.05 
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5.5.2.3  Sugar Intake 
Both groups reported similar numbers of sugar drinks consumed at baseline, with no 
significant difference per group from baseline to follow up. A Pearson Chi square test 
also indicated no association between group allocation and change in number of 
sugary drinks consumed at follow up (p=0.737). Change in number of teaspoons of 
sugar consumed per day also showed no significant difference between groups mean 
0.4, (95% CI-0.86 – 0.11) p=0.793, however, the intervention group did show a 
significant reduction from baseline to follow up from 1.0 to 0.5 of a spoonful, p=0.029 
(Table 5.11). 
Table 5.11 Reported sugar intake 
Average number of 
*sugar drinks 
Intervention 
N=117 
Mean     (SD) 
 
Control 
N=124 
Mean      (SD) 
Between group 
Difference  
P value 
Baseline 
Follow up 
 
Difference to baseline 
7.7               (1.8) 
7.6               (2.0) 
 
P=0.233 
7.7               (1.6) 
8.0               (1.6) 
 
P=0.450 
 
p=0.737 
Average number of 
spoonful’s of sugar 
daily 
  Between group mean 
Difference,  95% CI and  
P value 
Baseline 
Follow up 
 
Difference to baseline 
1.0             (0.26) 
0.5             (0.15) 
 
P=0.029 
0.7             (0.17) 
0.9             (0.22) 
 
P=0.528 
0.4  (-0.86 – 0.11) 
p=0.134 
Change in average 
number of sugar 
drinks 
N=111 
N                  (%) 
N=117 
N                 (%) 
 
Increased 
Decreased 
No Change 
29              (26.1) 
18              (16.2) 
64              (57.7) 
 
33              (28.2) 
19              (16.2) 
65              (55.6) 
 
p=0.935 
Change in average 
number of spoonful’s 
of sugar daily 
N=112 
                    
N                  (%) 
N=117 
 
 N                (%) 
 
Increased 
Decreased 
No Change 
13              (11.6) 
12              (10.7) 
87              (77.7) 
  12            (10.3)  
  10              (8.5) 
  95            (81.2) 
 
p=0.793 
*Sugary drinks not including diet or low-calorie drinks or fresh fruit juice 
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5.5.2.4  Alcohol Intake 
The control group had a larger number of participants never having taken alcohol than 
the intervention group at baseline 10.3% versus 6.8%, although not significantly. Chi 
Square tests were carried out on baseline and follow up measures for alcohol intake. 
Between group differences for frequency of drinking alcoholic drinks and reported 
changes in alcohol intake are shown in table 5.12 and table 5.13. At follow up the 
intervention group reduced drinking whilst the control group remained the same. Of 
those reporting drinking alcohol at follow up the control group had reduced daily 
intake while the intervention group remained the same. There were no significant 
changes shown in frequency or quantity of alcohol drunk. 
5.5.2.5  Smoking 
There was no difference in smoking status between groups at baseline, p=0.858.  Of 
the nine smokers in each group one participant per group had stopped smoking at 
follow up (Table 5.13). 
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Table 5.12 Between group changes in Alcohol intake 
 Baseline Follow-up 
How often do you have 
a drink containing 
alcohol 
 
Intervention 
(n=118) 
N      (%) 
Control 
 (n=126) 
N       (%) 
Difference  
p= 
 
Intervention 
 (n=110) 
N      (%) 
Control 
 (n=118) 
N         
(%) 
Difference  
p= 
 
 
Never 
Monthly or less 
2-4 times month 
2-3 times a week 
4 or more times a week 
 
 
8             (6.8) 
24         (20.4) 
25         (21.2) 
43         (36.4) 
18         (15.3) 
 
13     (10.3) 
25     (19.8) 
31     (24.6) 
33     (26.2) 
24     (19.0) 
 
 
 
     P=0.438 
 
9            (8.2) 
27        (24.5) 
22        (20.0) 
42        (38.2) 
10          (9.1) 
 
8       (6.8) 
29  (24.6) 
32  (27.1) 
32  (27.1) 
17  (14.4) 
 
 
 
     P=0.301 
 
 
Alcohol intake 
drinks/day when 
drinking 
Intervention 
 (n=116) 
N       (%) 
Control 
(n=124)  
N      (%) 
Difference 
 p= 
Intervention 
 (n=108) 
N      (%) 
Control 
 (n=117) 
N      (%) 
Difference  
p= 
 
N/A 
1 or 2 
3 or 4 
5 or 6 
7 to 9 
10 or more 
 
 
8             (6.9) 
58         (50.0) 
29         (25.0) 
13         (11.2) 
6             (5.2) 
2             (1.7) 
 
13     (10.5) 
52     (41.9) 
26     (21.0) 
22     (17.7) 
11       (8.9) 
0         (0.0) 
 
 
 
     P=0.206 
 
8            (7.4) 
57        (52.8) 
29        (26.9) 
11        (10.2) 
3            (2.8) 
0                (0) 
 
8       (3.1) 
54  (46.2) 
28  (23.9) 
14  (12.0) 
11    (9.4)               
2       (1.7)    
 
 
 
     p=0.245 
 
  Values are numbers and percentage and between group difference significance
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Table 5.13 Change in alcohol consumption and smoking at follow up 
Reduction in alcohol 
intake days/week 
Intervention     
(n=111) 
n       (%) 
Control       
(n=116) 
n       (%) 
Between group 
difference  
p value 
No 
Yes 
No change 
14              (12.6) 
22              (19.8) 
75              (67.6) 
7               (6.0) 
30           (25.9)          
79           (68.1) 
 
 
P=0.169 
Reduction in alcohol 
drinks/day 
(n=105) 
n      (%) 
(n=113) 
n      (%) 
 
No 
Yes 
No change 
37              (35.2) 
29              (27.6) 
39              (37.2) 
38           (33.6) 
37           (32.7) 
38           (33.6) 
 
     
P=0.703 
Smoking status (n=118) 
n      (%) 
(n=128)  
n      (%) 
 
Smoking at baseline          
Yes 
*No  
 
9                   (7.6) 
109            (92.4) 
 
9              (7.0) 
 119        (93.0) 
 
 
 
P= 1.000 Stopped Smoking          
Yes 
N/A 
 
 1                  (0.8) 
 108           (92.4) 
 
1               (0.8) 
119         (93.0) 
Values are numbers and percentage with between group differences  
* combined never and ex-smokers 
 
 
 
5.6 Results (6) from Physical Activity Questionnaires 
5.6.1 Views on Initiating Physical Activity Change 
Questionnaires were completed to assess participant’s views with regard to readiness 
and confidence in increasing levels of physical activity, results are shown in table 5.14. 
When asked “are you currently thinking about increasing physical activity that you 
do?” the majority of participants at baseline and follow-up reported ‘yes’, 79.3% in the 
intervention group and 74.2% in the control group at baseline and 70.2% in the 
intervention group and 72.3 % in the control group at follow up. Chi square tests 
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showed there was no significant difference between groups at baseline or follow up 
(p=0.324 and p=0.131 respectively).  
 When asked “How confident are you that you will stick to this plan?” at baseline  
63.8% in the intervention group and 54% in the control group reported to feel 
“somewhat” or “mildly confident” at follow up confidence had fallen in both groups to 
50% in the intervention group and 52.9% in the control group with no significant 
between group difference p= 0.746. 
At follow up a total of 38 (15.4%) participants felt very confident in increasing their 
physical activity 22 (19.3%) in the intervention group and 16 (13.4%) in the control 
group showing a significant between group difference p=0.008. Overall the majority of 
participants in both groups reported readiness to increase physical activity at baseline 
and follow up, with more people in the intervention group demonstrating an 
increasing confidence in doing so.  
When asked at follow up “Are you still doing more physical activity? of all participants 
completing the programme  significantly more people in the intervention group said 
“yes” 70.2%  versus 45.4% in the control group p=<0.001.  
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Table 5.14 Views on changing levels of PA 
 Baseline 
N (%) 
Follow up 
N (%) 
 Intervention Control Intervention Control 
Currently thinking of increasing amount of 
PA 
    
Yes 92       (79.3) 92      (74.2) 80       (70.2) 86        (72.3) 
No 24       (20.7) 32      (25.8) 34       (29.8) 33        (27.7) 
Total 116 124 114 119 
If yes when do you plan to begin doing 
more PA 
    
Within next month 77       (65.3) 72      (58.0) 70       (61.4) 68        (57.1) 
Within next 6 months 6           (5.1) 7          (5.6) 4           (3.5) 7             (5.9) 
Yet to decide 9           (6.8) 13      (10.5) 6           (5.3) 11           (9.2) 
Answered no to the question  24       (19.5) 32      (25.8) 34       (29.8) 33        (27.7) 
Total 116 124 114 119 
How confident that you will stick to this 
plan 
    
Very confident 
Somewhat confident 
Mildly confident 
Not at all confident 
Answered no to the question 
10         (8.6) 
45       (38.8) 
29       (25.0) 
8           (6.9) 
24       (20.7) 
18      (14.5) 
32      (25.8) 
35      (28.2) 
7          (5.6) 
32      (25.8) 
22       (19.3) 
46       (40.4) 
11         (9.6) 
1           (0.9) 
34       (29.8) 
16        (13.4) 
36       (30.3) 
27        (22.7) 
7             (5.9) 
33        (27.7) 
Total 116 124 114 119 
Have you ever made deliberate effort to 
increase PA 
    
Yes 
No  
93       (80.2) 
23       (19.8) 
100   (80.6) 
24      (19.4) 
99       (86.8) 
15       (13.2) 
98        (82.4) 
21        (17.6) 
Total 116 124 114 119 
If yes are you still doing more PA     
Yes 
No 
Answered no to the question 
48       (41.4) 
45       (38.9) 
23       (19.8) 
41      (33.1) 
59      (47.6) 
24      (19.4) 
80       (70.2) 
19       (16.7) 
15       (13.2) 
54        (45.4) 
44        (37.0) 
21        (17.6) 
Total 116 124 114 119 
If yes have you been able to maintain this 
increased amount of PA for 6 months or 
more 
    
Yes 
No 
31       (26.7) 
17       (14.7) 
26      (21.0) 
9          (7.3) 
46       (40.4) 
33       (29.0) 
33        (27.7) 
18        (15.1) 
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Answered no to the question  
Did not answer the question 
23       (19.8) 
 21      (18.1) 
24      (19.4) 
65      (52.4)   
15       (13.2) 
20       (17.5) 
21        (17.6) 
47        (39.5) 
Total 116 124 114 119 
Questionnaire not completed at baseline Group 1 n=1 / Group 2 n=5  
Questionnaire not completed at follow up Group 1 n=3/ Group 2 n=1  
 
5.6.2  Number of days per week of vigorous physical activity 
Both groups were similar in reporting number of days per week physical activity.  At 
baseline 47 participants in the intervention group (40.2%) and 44 in the control group 
(34.1%) reported not taking any vigorous activity at baseline. At follow up the number 
of participants in the intervention group reporting no vigorous activity dropped by 6% 
to 40 (34.2%) but increased by 1.6 % in the control group to 46 (35.7%). Pearson chi 
square tests confirmed there were no significant differences between randomised 
groups in number of days per week of vigorous activity at baseline or follow up.   
There was no difference between groups at baseline p=0.966 or follow up p=0.884 in 
the number of minutes per week vigorous activity taken, and no change per group 
between baseline and follow up (intervention group: p=0.676 and control group: 
p=0.720).  
5.6.3 Participants achieving recommended level of moderate physical activity 
per week 
 
At baseline 36 participants in the intervention group (31%) and 43 in the control group 
(33.3%) reported no moderate physical activity, at follow up the number of 
participants reporting no moderate activity in the intervention group had reduced by 
7.9% to 27 (23.1%). This increase in activity in the intervention group, however, was 
not significant. 
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The number of participants reported achieving 150 minutes of moderate physical 
activity at baseline was 35 in the intervention group (30.2%) and 22 in the control 
group (17.4%) At follow up 36 (31.6%) in the intervention group and 27 (22.7%) in the 
control group reported achieving 150 minutes per week. The percentage of 
participants achieving the recommended moderate level of physical activity is shown 
in Figure 5.6.  
Overall between baseline and follow-up the percentage of participants achieving the 
recommended 150 minutes of moderate intensity activity per week increased for both 
intervention group (30.2% to 31.6%) p=0.493 and control group (from 17.4% to 22.7%) 
p=0.866 with the control group achieving the greater increase, this was however not a 
significant between group difference. Both groups increased the number of minutes 
per week of moderate activity but not significantly. There was no significant between 
group change shown at follow up p=0.572. 
  
Figure 5.6 Percentage achieving recommended levels of moderate activity per week by group, baseline 
to follow up and levels of significance. Error bars show mean and standard error. 
 
30.2 
31.6 
17.4 
22.7 
0
5
10
15
20
25
30
35
40
Baseline p=0.493 Follow up p=0.866
% Intervention
Control
131 
 
 
5.6.4  Walking 
A small percentage of participants (6.1%), recalled having no walking activity at 
baseline in the past 7 days: (Intervention group (1.6%) and Control group (4.5%)), 
defined as “at work and at home, walking to travel from place to place, and any other 
walking that you might do solely for recreation, sport, exercise, or leisure”. 
At follow up all of the participants reported some walking activity. At baseline 14% 
(intervention group (16.3%) and control group (12.6%)) did report to some walking. 
This increased to a total of 31.4% at follow up: intervention group (15.4%) and control 
group (16%), although this was not an overall significant increase p=0.305.  
5.6.5  Sedentary behaviour 
Participants were asked to report time spent sitting during the previous 7 days in 
relation to time spent at home, work, leisure time, and including activities such as 
reading, visiting friends and watching television. There was no significant difference 
between groups on reported hours per day spent sitting at baseline; 7.1hrs (SD 3.5) in 
the intervention group versus 6.8hrs (SD 2.7) in the control group (p=0.060), and no 
significant difference at follow up p=0.283. Both groups did reduce the amount of time 
sitting with the intervention group achieving largest reduction from 7.1hours (SD4.6) 
to 5.7 hours (SD2.7) a significant mean difference from baseline to follow up of -1.4 
hours (SD4.3) p=0.012.  
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5.7 Results (7) Cardiovascular risk perceptions  
5.7.1 CVD Risk Perception 
To assess participant cardiovascular risk perceptions, a questionnaire was given to all 
subjects’ before and after the TASCFORCE screening and discussion (usual care) (see 
appendix H). Pearson Chi square tests were applied to the data, the results concluded 
there was no difference between the groups in terms of the extent to which they 
changed their risk perceptions pre and post screening see table 25 (p= 0.213). There 
was, however, a small but significant difference in the change in risk perception 
outcome between gender (p= 0.001), with males more likely to report an increase in 
perceived risk  of developing CVD following the post screening “usual care” discussion 
(table 5.16).   
Table 5.17 also shows following screening (TF brief intervention) a significant 
difference in median group scores for perceived CVD risk in the intervention group 
p=<0.001 but not the control group p=0.207 and no between group difference 
p=0.097. Both male and female showed a change in risk perception from average to 
lower than average risk but this was only significant for females p=<0.001 (males 
p=0.760), between gender difference was also significant for changes in perceived risk, 
with females perceiving less risk (p=0.010) (Table 5.16). 
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Table 5.15 Per protocol pre-post CVD risk perception  
Pre risk perception Total 
Intervention 
 (n=118) 
 
Total 
Control 
 (n=127) 
Between group 
difference 
n= % n= % 
Much lower than 
average 
10 (8.5) 7 (5.5)  
 
P=0.309 
Lower  than average 32 (27.1) 28 (22.0) 
Average 48 (40.1) 69 (54.3) 
Higher than average 25 (21.2) 20 (15.7) 
Much higher than 
average 
3 (2.5) 3 (2.4) 
*Pre v post risk 
perception 
questionnaire 
(n=108) (n=121) Between group 
difference 
n= % n= % 
Risk perception score 
increased 
19 (17.6) 
 
31 (25.6) 
 
 
 
      P=0.213 
Risk perception score 
decreased 
46 (42.6) 
 
53 (43.8) 
 
No change in risk 
perception 
43 (39.8) 37 (30.6) 
*     Risk score not available at both time points n=17 
Values are numbers and percentages with between group levels of significance
134 
 
 
 
Table 5.16 Change in CVD risk perception scores by gender (pre v post TASCFORCE screening having 
received usual care)  
 Male 
n=93 
 
Female 
n=136 
 
Between group 
difference 
  
Pre v post risk 
questionnaire 
n= % n= % 
Risk score increased 
 
32 
 
34.4 18 
 
13.2  
 
 
P= 0.001 
Risk score decreased 
 
33 
 
35.5 66 
 
48.5 
No change in risk 
 
28 30.1 52 38.2 
 
 
Median  CVD risk 
perception scores 
Male 
*n=99 
**n=93 
 
 
 
Difference 
to 
baseline 
Female 
*n=146 
**n=136 
 
 
 
Difference 
to 
baseline 
 
 
Between group 
difference 
 Median 
(IQR) 
 
Median 
(IQR) 
 
   *Pre screening 
**Post screening 
 
3          (2) 
3          (2) 
 
P=0.760 3          (2) 
2          (2) 
 
P=<0.001 ^P=0.010 
Risk score not available at both time points n=17.  
Values are numbers and percentages, median risk scores and IQR with between group levels of 
significance. ̂ Kruscal Wallis post-hoc test for significance 
 
Table 5.17 Median CVD risk perception scores (pre v post Tascforce screening having received usual 
care) 
Median CVD  
risk perception 
scores 
 
 
 
 
 
Pre-screening    
Post screening  
 
 
 
Intervention 
n=117 
n=129 
 
Median 
(IQR) 
 
 
 
 
 
Difference 
to 
baseline 
 
Control 
n=117 
n=126 
 
Median 
(IQR) 
 
 
 
 
 
Difference  
to baseline 
 
 
 
 
Between 
group 
difference 
3       (1) 
2       (1) 
 
P=<0.001 3         (1) 
3         (2) 
P=0.207 ^P=0.097 
Median scores per group with IQR and between group levels of significance. Scores range from 1=much 
lower risk to 5=much higher risk.  
^Kruscal Wallis post-hoc test for significance.  
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5.8 Results (8) Self-Reported Quality of Life Outcomes 
5.8.1 Summary Results from Quality of Life Questionnaire 
The SF12v2 Quality of Life questionnaire was used to measure participants’ reported 
health status. The questionnaire was administered at baseline and follow up. Two 
hundred and forty six questionnaires were included in the sample at baseline: 117 in 
the intervention group and 129 in the control group (37% male, 63% female), and 
242 at follow up: 118 in the intervention group and 124 in the control group (40% 
male, 60% female). Responses from the 12 questions are combined in two summary 
scores; The Physical Component Summary (PCS) and The Mental Component 
Summary (MCS). 
Table 5.18 shows HF2 group mean scores for each of the domains in the SF12v2 
questionnaire which can be compared to the *“norm population” scores where each 
domain has a mean score of 50 and a standard deviation of 10. Independent t- tests 
showed there was no significant difference in mean scores between the intervention 
and control groups through each of the domains at baseline or follow up, however, 
there were significant differences seen at individual domain levels  (section 5.8.2). 
Independent paired tests also showed significant differences in groups from baseline 
to follow-up (Table 5.18). 
 
5.8.2 Changes in Reported General Health  
Increases in state of general health perception were reported in table 5.18. The 
intervention group demonstrated a significant increase in score for vitality from 
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baseline to follow up of 2.1 (SD10.2). The control group reported increases of 
general health perception in 3 of the 8 domains and a significant decrease of 1.7 
(SD9.9) in the domain of physical functioning. However, these were the only 
significant domain changes for either group.  Both groups increased their mental 
health component summary scores, however, not significantly. As the study was 
powered to detect change in body weight the number of subjects in this sample may 
not have sufficient statistical power to detect changes throughout all the domains. 
As with the mental component summary, the physical component summary showed 
no significant change see table 5.18. The SF12v2 also shows a percentage of the 
norm and HF2 sample at risk of depression. Baseline and follow up values showed 
the norm population to have a 20% risk; the HF2 sample risk was lower at 15% 
baseline and 14% at follow up. 
 
 
Table 5.18 Baseline and follow up scores from SF12V2 
Scales N= Intervention 
Mean (SD) 
N= Control 
Mean (SD) 
Between group 
differences: mean,   
CI and P value   
Physical Functioning 
BL 
FU 
Change from baseline 
 
115 
117 
 
52.8  (8.0) 
52.7  (8.1) 
P=0.82 
 
126 
123 
 
53.4  (6.9) 
51.7  (8.1) 
**P=0.05 
 
0.9, (-1.11 – 3.00) 
P=0.36 
Role Physical 
BL 
FU 
Change from baseline 
 
115 
116 
 
 
53.6  (6.7) 
53.3  (7.5) 
P=0.76 
 
126 
122 
 
53.7  (6.2) 
53.1  (7.5) 
P=0.41 
 
0.2, (-1.60 – 2.19) 
P=0.75 
Bodily Pain 
BL 
FU 
Change from baseline 
 
116 
116 
 
52.4  (8.2) 
53.1  (8.3) 
P=0.29 
 
126 
124 
 
52.0  (8.1) 
51.0  (9.0) 
P=0.21 
 
2.1, (-0.09 – 4.29) 
P=0.06 
General Health 
BL 
FU 
Change from baseline 
 
113 
116 
 
51.8  (7.6) 
53.5  (6.3) 
P=0.36 
 
127 
122 
 
52.4  (7.1) 
52.5  (7.3) 
P=0.45 
 
0.9, (-0.79 – 0.69) 
P=0.28 
Vitality 
BL 
 
116 
 
52.5  (7.9) 
 
124 
 
51.9  (8.5) 
 
1.3, (-0.73 – 3.23) 
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FU 
Change from baseline 
118 54.3  (7.2) 
**P=0.02 
123 53.1  (8.3) 
P=0.41 
P=0.21 
Social Functioning 
BL 
FU 
Change from baseline 
 
116 
117 
 
51.8  (7.2) 
53.1  (7.3) 
P=0.79 
 
125 
123 
 
52.9  (7.3) 
52.8  (7.3) 
P=0.41 
 
0.3, (-1.54 – 2.18) 
P=0.73 
Role Emotional 
BL 
FU 
Change from baseline 
 
115 
117 
 
50.7  (8.9) 
51.7  (8.3) 
P=0.63 
 
126 
122 
 
52.1  (7.4) 
50.7  (9.4) 
P=0.34 
 
0.9, (-1.28 – 3.24) 
P=0.39 
Mental Health 
BL 
FU 
Change from baseline 
 
116 
118 
 
51.2  (8.4) 
52.4  (8.3) 
P=0.41 
 
125 
124 
 
50.7  (8.9) 
51.7  (8.4) 
P=0.24 
 
0.7, (-1.39 – 2.83) 
P=0.50 
Summaries      
Physical Component 
Summary 
BL 
FU 
Change from baseline 
 
 
115 
117 
 
 
53.3  (7.5) 
53.4  (6.7) 
P=0.94 
 
 
124 
122 
 
 
53.5  (6.7) 
52.3  (8.2) 
P=0.14 
 
 
1.1, (-0.80 – 3.01) 
P=0.25 
Mental Component 
Summary 
BL 
FU 
Change from baseline 
 
115 
117 
 
50.4  (9.1) 
52.2  (8.7) 
P=0.35 
 
124 
122 
 
50.8  (8.7) 
51.6  (9.3) 
P=0.30 
 
0.5, (-1.70  - 2.89) 
P=0.60 
Independent T-Test analysis. Values are scores and (SD) **P=<0.05 
*SF-36v2™ Health Survey 1998 U.S. general population norms and to norm-based scoring (NBS) 
 
The generic SF12v2 was chosen in order to analyse participant’s perception pre and 
post intervention and demonstrate if weight reduction had an effect on, among 
other parameters, general health, vitality and mental health. Both groups scored 
higher than the norm population through all domains with the intervention group 
showing a greater increase in all of these domains, vitality being a significant change 
p=0.02. 
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5.9 Results (9) Participant Acceptability 
5.9.1 Participant Satisfaction with the intervention 
A review of the data showed overall participant satisfaction to be high. There were 
80.1% of questionnaires returned and a high percentage of participants rated the 
HEALTHFORCE 2 study as a worthwhile or excellent program.  This was significantly 
higher in the intervention group (94.5%) than the control group (93.9%) which is 
likely to be due to the differences in the “excellent” rating (between group 
difference p=0.046). Both groups reported the study as being useful (94.9%), helping 
them to change their diet (88.3%) and levels of physical activity (72.6%).  
 
Table 5.19 Results from Participant Acceptability Questionnaire. Chi square tests for significance, 
p=<0.05 
Questionnaire Characteristics Intervention 
n= 128 
N                  % 
Control 
n= 65 
N                  %        
Group not 
Specified * 
n= 7            % 
How did you rate the Healthforce 
Study? 
   
Waste of time 
Disappointing 
Fair 
Worthwhile 
Excellent 
0                       0.0 
2                       1.6 
5                       3.9  
69                   53.9 
52                   40.6 
0                       0.0 
0                       0.0 
4                       6.2 
46                   70.8 
15                   23.1 
0                    0.0 
0                    0.0 
0                    0.0 
7               100.0 
0                    0.0 
Received sufficient study information    
Not enough information 
Sufficient information  
More information than necessary 
0                       0.0 
114                89.1 
14                     0.9 
1                       1.5 
61                     3.8 
3                       4.6 
0                   0.0 
7               100.0 
0                    0.0 
Sufficient opportunity to ask questions    
No opportunity 
Would have liked more opportunity 
Yes, plenty of opportunity 
0                       0.0 
1                       0.8 
127                99.2 
0                       0.0 
5                       7.7 
60                   92.3 
0                    0.0 
2                  28.6 
5                  71.4 
Questions answered satisfactorily    
Not at all 
Not really 
Reasonably 
Satisfactorily 
Yes, completely 
0                       0.0 
0                       0.0 
2                       1.6 
43                   33.6 
83                   64.8 
0                       0.0 
1                       1.5 
2                       3.1 
20                   30.8 
42                   64.6 
0                    0.0 
0                    0.0 
0                    0.0 
2                  28.6 
5                  71.4 
 
How did you find the length of the    
139 
 
questionnaires 
Too short 
Just right 
Too long 
Not sure 
0                       0.0 
107                83.6 
14                   10.9 
7                       5.5 
0                       0.0 
49                   75.4 
12                   18.5 
4                       6.2 
2                  28.6 
5                  71.4 
0                    0.0 
0                    0.0 
How difficult did you find the 
questionnaires to complete 
   
Very Difficult 
Quite difficult 
Had some difficulties 
Not difficult at all 
Did not answer question 
0                       0.0 
0                       0.0 
22                   17.2 
105                82.0 
1                       0.8 
0                       0.0 
0                       0.0 
15                   23.1 
49                   75.4 
1                       1.5 
0                    0.0 
0                    0.0 
3                  42.9 
4                  57.1 
Did you find taking part in the study 
useful 
   
Yes 
No 
Did not answer question 
126                98.4 
1                       0.8 
1                       0.8 
61                   93.8 
3                       4.6 
1                       1.5 
2                  28.6 
0                    0.0 
5                  71.4 
Did taking part in the study help to 
change Diet 
   
Yes 
No 
Did not answer question 
120                93.8 
7                       5.5 
1                       0.8 
54                   83.1 
10                   15.4 
1                       1.5 
3                  42.9 
0                    0.0 
4                  57.1 
Did taking part in the study help to 
change PA 
   
Yes 
No 
Did not answer question 
96                   75.0 
32                   25.0 
0                       0.0 
47                   72.3 
18                   27.7 
0                       0.0 
2                  28.6 
2                  28.6 
3                  42.9 
Did Telephone calls help to change 
Diet/PA 
   
Yes 
No 
N/a 
Did not answer question 
109                55.3 
19                     9.6 
62                   31.5 
 
  
 
 
 
Would you recommend the study to 
family/friends 
   
Yes 
No 
Unsure 
Did not answer question 
117                91.4 
1                       0.8 
3                       2.3 
7                       5.5 
62                   65.4 
0                       0.0 
1                       1.5 
2                       3.1 
 
* Unable to identify which group participants were in. Did not tick box asking “Did telephone calls and 
posted materials help make changes to diet and/or levels of exercise” or indicate “N/A”.  
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6.  DISCUSSION  
6.1 Introduction 
This investigation set out to test the hypothesis that there was no difference 
between a multiple, contact lifestyle change intervention (HF2) versus a single brief 
lifestyle change intervention (usual care) on weight loss and change in cardio-
vascular risk factors in volunteers from the TASCFORCE screening study. The primary 
outcome was body weight change at 16 weeks.  
A review of the literature showed there is evidence that opportunities for initiating 
brief interventions or “teachable moments” in an attempt to modify unhealthy 
lifestyle choices are often missed by healthcare providers  (section 3.5.1.7). The HF2 
investigation was designed to compare the impact of the brief single contact lifestyle 
discussion (usual care) with a multiple contact lifestyle intervention to determine 
what level of intervention input would affect initiation and maintenance of change 
in body weight and cardio-vascular risk factors. This section will propose and discuss 
some of the reasons why the study outcomes may have been realised whilst others 
were not, and will shape further discussion within the context of currently available 
literature, theory and practice. 
6.2 The Sample 
The randomised HF2 intervention and control groups were well matched for age, 
gender, educational qualification, employment and SIMD deciles (section 5.1.2).The 
only significant between group difference was seen in baseline socio-demographic 
characteristics was in marital status, with a significantly lower proportion in the 
intervention group  married or co-habiting and twice as many participants  widowed, 
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separated or divorced, therefore, there were a higher proportion of participants in 
the intervention group living alone, suggesting that social support was given by 
friends and family rather than spouse or partner and contributes to the greater 
weight loss seen in the intervention group. 
The HF2 study sample was shown to be demographically representative of the TF 
population and the Tayside area from which it was drawn. The total TF mean age of  
53 years (58.8% female and 38% male) versus the total HF2 sample mean age of 54 
years (59.8% female and 40.2% male). The HF2 study attracted almost 25% (24.3%) 
volunteer participants from the highest deprivation category, which are often an 
under recruited group, possibly as a result of the diversity in recruitment sites.  
One plausible reason for successful recruitment to HF2 may be that following 
completion of initial CVD risk screening and participants being identified as 
overweight or obese the chance to receive one to one consultation with a health 
professional and make lifestyle modifications may be seen as an opportunity to 
initiate change. Studies have shown the more salient the person finds a condition 
relating to a research study, in this case being overweight, the more they are likely 
to take part (174).  
Current evidence has found recruiting to studies may be slow or more of a challenge 
than anticipated, and can be particularly difficult to recruit from lower income 
populations (175), with engagement in studies favouring the affluent, and better 
educated (174). The Tascforce (TF) project not only recruited to target but similarly 
to HF2, included a substantial proportion of participants (18.7% in SIMD deciles 1-3) 
in the higher deprivation category.  
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Recruitment strategies were designed to capture a proportion of people from areas 
of higher deprivation. This was achieved by targeting General practices from within 
these areas in addition to Tesco and Stagecoach transport (bus drivers) employees. 
These strategies have implications for future study design to create strong 
recruitment strategies when targeting a particular cohort of participants. HF2 
successfully recruiting a substantial number of participants from the lower SIMD 
deciles, where weight status and the health risks in this group are known to be 
greater. 
6.3 Attrition Rates 
Of the eligible participants for the HF2 study, 56.9% agreed to take part v’s 43.1% 
who declined. At 16 weeks the intervention group had 25.5 % (40/157) participants 
withdraw or considered to be loss to follow up (LTFU) versus 17.8% (28/157) for the 
control group. While it is important to strive to have 100 % follow up in the study 
population it is often an unachievable goal. There will always be a proportion of 
research study participants who will withdraw or be lost to follow up. What is 
important is that those who do so are acknowledged and the reasons why explored. 
In both groups retention rates were more than 70% which would be considered 
acceptable best evidence for inclusion as effective behavioural interventions (176).  
The Centers for Disease Control and Prevention's strategic plan 2010, adopted a 
cutoff point to meet the requirements for inclusion as best-evidence for “effective 
behavioral interventions” to be those that include 70% or greater retention rates in 
each study arm at follow up and 60% or greater retention to qualify for  “promising 
interventions”(176). Attrition rates of greater than 30% or 40% in either study arm 
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are considered indicative of “fatal” flaws in the study, in effect negating intervention 
outcome results regardless of other qualification (177). The National Registry of 
Effective Prevention Programs’ study quality assessment scale rates attrition most 
favorably handled in a given study if rates are less than 20% (178), the 20% cut off 
was also adopted in work aiming to synthesize intervention literature (179). 
Loss to follow up is seldom considered to be strictly random, to show transparency  
the flow of participants through the study is shown in Figure 7 with a detailed 
description  in section 5.1.1 describing where participants withdrew or were LTFU.  
While the reasons for 10% of the 68 participants not completing the study (5% in 
group 1 and 5% in group 2) LTFU are unknown, 30% of those 68 gave reasons for 
withdrawing from the study as work or family commitments, and family or personal 
illness. 
Statistical analysis showed there was no significant difference in baseline 
characteristics between those who completed and those who did not. In the HF2 
study attrition rates did not result in a loss of power which could have had an effect 
on the ability to draw robust conclusions from the study population which in turn 
could affect the generalisability of the study.  
In terms of social deprivation there was no statistical significant difference shown in 
SIMD groups and decision to withdraw or loss to follow up, unusually the highest 
proportion of participants (39.7%) who did so were from the lowest deprivation 
category (SIMD 8-10) compared with 26.5% in the higher category (SIMD 1-3). There 
were more in the intervention group (40) than the control group (28) lost to follow 
up or who withdrew but this was not shown to be significant. One plausible 
explanation for this could be the time required for the telephone consultations with 
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the counsellors, as although call times were mutually agreed on the actual day other 
commitments may take priority and rather than call and cancel it may seem easier 
not to respond.   
There were twice as many in the intervention group divorced/widowed/separated 
LTFU than the control group and a higher proportion of married/co-habiting in the 
control group suggesting perhaps partner support may be a factor in completing the 
study, time constraints and motivation may also have been contributing factors. 
Although there is no evidence to demonstrate this, it could be of interest to follow 
up as understanding participants experience and views with regard to partner 
support may influence direction for future research.  
 
6.4 Weight loss at follow up 
This investigation has reported analysis on both intention to treat (ITT) and per 
protocol (PP) data for the primary outcome weight loss. The greatest weight loss 
was seen in the intervention group from analysis of the per protocol (PP) data, 
whilst the greater weight loss in the intention to treat (ITT) data was seen in the 
control group.  Although not significant the ITT data showed a total weight loss of 
2.1kg from baseline to follow for the intervention group and 2.9kg for the control 
group.  
The per protocol data showed a between group difference total weight loss of 1.1kg 
which was significant 95% CI (-2.05 to -0.16), whilst the intention to treat data 
showed a total weight loss difference of 0.9kg which did not reach significance, 95% 
CI (-1.91 to 0.14). When adjusted for baseline weight both the ITT and PP data 
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showed there was a significant between group difference in weight loss, and the 
difference was greater in the PP data (section 5.2.2). Both the intervention and the 
control group (usual care) in the ITT unadjusted data showed a modest but not 
significant reduction in body weight, therefore, the intervention was no more 
effective than usual care on the primary outcome; change in body weight.  
Although not a direct comparison with the HF2 study in terms of support/delivery of 
intervention, other lifestyle change intervention studies of 16 week duration which 
involved combinations of internet, face to face, group versus individuals, and the use 
of behaviour change techniques have shown weight loss of 2.9 to 5.5kg (180), 
however, unlike the control group in the HF2 study which achieved a similar level of 
weight loss, all of these studies involved more than a single contact. The implication 
of this is that delivering a single brief intervention in a screening setting offers an 
opportunity to achieve a similar weight loss to that shown in studies offering a 
multiple contact intervention. 
Recent guidelines have established a 5% weight reduction after one year of 
treatment to be clinically meaningful in terms of evaluating the effectiveness of 
weight loss interventions (181,182) in populations at risk from obesity. The “Look 
AHEAD” study sample of overweight and obese individuals with type 2 diabetes 
incorporated a randomised controlled trial which delivered an intensive lifestyle 
intervention over four years, designed to achieve and maintain weight loss through 
increased physical activity and reduced calorie intake. The comparator group was 
given diabetes support and education consisting of three group sessions per year 
focusing on diet, exercise, and social support during years 1 through 4, the sessions 
were delivered annually thereafter (183). Following an observational period of up to 
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ten years and three months the results showed in both groups a strong relationship 
between glycemic measures and weight loss, with improvement beginning at 2.5% 
to 5% weight loss in patients with Type 2 diabetes. Systolic and diastolic blood 
pressure, HDL cholesterol, and triglycerides, improvement was shown to begin at 
≥5% weight loss (183).  
In terms of percent weight loss the ITT data in the HF2 intervention showed a 2.5% 
weight loss v’s 3.3% in the usual care group, a mean (SD) difference of 0.8% (2.4)% 
(P=<0.005). Based on the results seen in the “Look AHEAD” trial, the HF2 weight loss 
results show there may be some a clinically significant benefits for both groups, 
however, other CVD risk benefits may not be seen until a ≥5% weight reduction 
(183). A systematic review investigating the maintenance of weight loss following 
lifestyle interventions combining diet and exercise showed that during these trials 
the intervention groups lost 9.5% of their baseline weight and 1 year after the 
intervention on average 54% of this weight loss was maintained (184), which is a 
similar percentage maintenance to previous reviews (185,186), which showed 50% 
maintenance at 1 year.  While it remains unknown as to whether the weight loss in 
the HF2 study would have been sustained in a full 1 year period, it is promising to 
see the percentage weight reduction may, if increased over a longer period of time 
have the potential to show a significant future CVD risk reduction.  
Studies selected for inclusion in a recent updated systematic review of interventions 
where the telephone was the principle method of intervention delivery concluded 
that, although there continued to be strong evidence for telephone-delivered 
physical activity and dietary behavior interventions for initiation of behavior change, 
the reporting of intervention implementation was less than optimal, with 
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approximately half of the studies not reporting on the length and number of calls 
completed, the training of staff, and inadequate reporting of methodology for the 
reader to interpret fidelity of the interventions (187). In contrast to these findings 
the HF2 study has reported on the number, the length, and described the individual 
components of the telephone calls in depth, adding to what is already known about 
lifestyle interventions using the telephone as the principle method of intervention 
(Appendix Q/Section 4.11.2). To date there have been no RCT’s involving healthy 
volunteers, 40 years and over recruited to a lifestyle behaviour change intervention 
with the telephone as the principal method of delivery following CVD risk screening  
which could make a true comparison with the HF2 investigation.   
6.5 HF2 Intervention versus brief intervention 
The implication that the brief intervention (usual care) was sufficient to motivate 
both groups to reduce weight and the extra support given to the intervention group 
did not significantly increase weight loss supports the literature (section 3.5.1.8) for 
healthcare professionals to recognise  opportunities for brief interventions as they 
arise and utilise behaviour techniques to encourage behaviour change (72). Perhaps 
the usual care group were more health conscious, and as they were not going to 
receive any further input from baseline to follow up they decided to take it upon 
themselves to be more proactive. As these are speculative reasons and not 
measured it is not possible to draw any conclusions as to the reason why the 
intervention was not successful in promoting a significant difference in weight loss in 
the intervention group compared to weight loss in the usual care group.  
The percentage weight loss in both groups was clinically significant for the 
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unadjusted ITT data based on findings from the “Look Ahead” study, further 
supporting the need for all healthcare professionals to initiate brief interventions as 
the opportunities arise. 
The delivery of the brief intervention (usual care) gave both groups the opportunity 
to discuss how to make realistic lifestyle changes to improve CVD risk with a health 
professional. Although the usual care group were not given additional monthly 
support they were aware they would return for follow up measurements in the 
same timeframe as the intervention group, which may have heightened their 
perception of social norms to include seeking behavioural approval either 
consciously or subconsciously which can in turn increase motivation (188). Evidence 
which supports that weight loss generally plateaus around 6 months (189), 
consequently, the duration of the HF2 intervention may not have been of sufficient 
time to reach a plateau and show a significant weight loss (188). 
There were a sub group of participants from the TASCFORCE project who were 
invited to have an MRI scan post usual care to measure cardio vascular vessel 
atheroma. The number of participants in each group were equal (n=54 intervention 
and n=53 usual care), thus any comparable additional health messages were given to 
both groups. Less than 50% of volunteers in each group had the MRI scan, leaving 
the greater proportion of volunteers not having a scan suggesting it was not the 
necessarily the scan which was the motivator to engage with the intervention. It has 
not been determined whether having an MRI scan would have had any effect on 
weight loss in the investigation, this could be determined in future work.  
In summary both groups showed a modest but not significant reduction in body 
weight, therefore, the HF2 intervention was no more effective than usual care on 
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the primary outcome; change in body weight. In terms of percent weight loss the 
results show there may be some clinically significant benefits for both groups, 
supporting the value of initiating brief interventions. For health professionals to 
initiate a brief intervention not only requires skills and resources to engage the 
individual to make changes but there is a need to provide ongoing and follow up 
support through the course of the behaviour change, which can become a lengthy 
process with implications for cost on manpower and resources in the short term, but 
producing the long term benefits of a healthier population. 
 
6.6 Anthropometric Modifiable Risk Factors  
6.6.1 BMI and Waist Measurement 
BMI has traditionally been an indicator for measuring body size and composition; 
however, alternative measures that reflect abdominal adiposity, such as waist 
circumference and waist–hip ratio have been suggested as being superior to BMI in 
predicting CVD risk. The rational being that increased visceral adipose tissue is 
associated with a range of metabolic abnormalities such as decreased glucose 
tolerance, reduced insulin sensitivity and adverse lipid profiles, which are risk factors 
for type 2 diabetes and CVD (190). 
At baseline a high proportion of male and females had waist measurements above 
the “increased relative risk level for metabolic syndrome” (190) (75.8% and 96.6% 
respectively). Mean BMI in the intervention group was 30.2 (kg/m2) with 58.5% 
overweight and 41.5% obese and 30.4 (kg/m2) in the control group, with 50.1% 
overweight and 49.2% obese. A significant between group difference was seen at 
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follow up for waist circumference (WC) -1.21cm (95% CI -6.021 – 0.90) but not for 
calculated BMI, with a greater reduction in WC seen in the intervention group (-
4.0cm p=0.002) (section 5.3.1). Although still at “increased risk” a reduction was 
seen in the proportion of male and females WC (mean 95cm (57.6%) and mean 
92.2cm (92.5%) respectively). Most behaviour change theories consider self-
monitoring to be an important component of behavioural self-regulation (191). The 
intervention group were provided a tape measure and educational booklets to 
enable self-monitoring of waist measurement reinforcing the significance of 
reducing WC. Further as the intervention group showed the largest waist reduction 
and assuming that study compliance had been adhered to then it could be 
concluded that materials and prompts from counsellors did have an influence on 
reduction of WC further research would be required to test the hypothesis. The 
proportion of male and females with WC at “increased risk” had reduced from 75.8% 
to 57.6% and 96.6% to 92.5% respectively, which is encouraging, however, the 
reduction was not sufficient to bring them out of the “increased risk” category.  
 When predicting CVD risk the evidence is increasing to suggest that measures of 
central obesity that include a measurement of WC as well as BMI, should be 
considered for incorporation into the clinical assessment (192), as BMI does not 
distinguish between fat and free-fat mass therefore when used alone is not a 
sufficient indicator for CVD risk, and can misclassify some people as being normal 
weight or obese (193). Measuring WC alone does not overcome this issue but it can 
provide an independent prediction of risk in people who are normal or overweight, 
however, for individuals with BMI ≥35 (kg/m2) evidence has shown measuring WC 
has little added predictive power of disease risk over BMI (194). A systematic review 
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examining measuring outcomes in weight loss studies concluded that body fat 
measurement is more metabolically informative than total weight and it proposed 
that measurement of visceral body fat should be considered a primary outcome of 
weight loss studies (195). The data presented from the review supported the 
conclusion that percentage body fat measurement or measure of fat mass  before 
and after weight loss interventions which include both diet and physical activity 
components may be a more efficient and informative measure of  change (195).  
This investigation showed that reductions in waist circumference were statistically 
significant indicating that it may be a more sensitive to change than BMI which 
showed no statistically significant change despite weight loss having occurred. It 
may also be true that body composition had changed in the intervention group 
which could account for an increase in fat free mass showing no significant weight 
loss but a statistically significant reduction in waist measurement, particularly as 
increased levels of physical activity were seen at follow up (although not 
significantly). If this is the case then consideration for the intervention and its 
potential for physiological change is worth further investigation perhaps with some 
adjustments made to measurement of body fat. 
Selecting the most appropriate method to measure central obesity is dependent on 
the nature of the research; measurement of BMI and the addition of WC as a 
measure of abdominal visceral fat was the most appropriate method to use in the 
HF2 study given the volume of participants screened, and is still considered a valid 
means of assessing weight change in a study with large numbers of participants  
(196).  
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The addition of body fat measurement methods such as skinfold measure, or 
bioelectrical impedance analysis  (BIA) which are the least costly methods of 
assessment could have added another measurement to enhance the overall picture 
of CVD risk for the HF2 participants. It is a limitation of the investigation that body 
fat was not measured at baseline and follow up as the recent evidence in the 
literature strongly advocates its use (196). It could have been particularly 
advantageous to have utilized these methods of body fat assessment in the 
screening setting where the volume of participants screened in a single day and the 
repetition of the measurement task could lead to user error, particularly in the 
obese where it can be difficult to accurately measure waist circumference, however, 
the HF2 study personnel did adhere to standard operating procedures when carrying 
out these measures in order to eliminate such risk.  
 
6.6.2 Blood Pressure 
A significant reduction was shown in systolic and diastolic blood pressure (BP) in 
both groups from baseline to follow up -4.02 mmHg, (systolic BP) p=<0.001 in the 
intervention group versus -3.57 mmHg, (systolic BP) p=<0.001 in the control group, 
and  a significant between group difference was seen in diastolic BP with the 
intervention group showing a greater reduction section (Table 17). 
Increased weight is a strong indicator for hypertension (197). It seems, therefore, 
reasonable to assume the reduction in weight could be one factor responsible for 
the reduction in systolic and diastolic blood pressure in this investigation. Studies 
have also shown that realistic changes in diet and lifestyle can reduce average blood 
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pressure levels to a limited extent (2-3 mmHg diastolic) (198). As both intervention 
and control groups exceeded these levels of reduction from baseline to follow up, 
and the intervention group significantly reduced diastolic BP indicates the 
improvements seen in diet and physical activity could account for the reduction seen 
in diastolic BP. 
Pulse pressure provides important predictive value for CVD events in middle aged 
adults who are normotensive or have untreated hypertension. It may have been a 
useful measure to have collected and to have included in the CVD risk discussion 
during the brief intervention. From ages 30 to 50 systolic and diastolic BP track 
together almost parallel, however, after the age of 60 systolic BP continues to rise 
whilst diastolic BP decreases, (199). This trend accounts for the underestimation of 
peripheral vascular resistance in older people and the large increase in pulse 
pressure seen in people over the age of 60 (199). Future analysis of pulse pressure 
and the increase in physical activity observed could allude to the possibility that the 
increase in physical activity seen in the intervention group was responsible for the 
significant reduction in diastolic blood pressure.  
Published estimates have suggested that approximately one third of excess CVD and 
all‐cause mortality can be attributed to elevated systolic blood pressure (SBP) at 
levels designated as non-hypertensive (200,201) indicating that benefits achieved 
from decreases in blood pressure are not limited to populations with hypertension 
(202). Meta-analysis from clinical trials looking for evidence of the benefits from 
even small reductions of blood pressure on CVD outcomes showed that a reduction 
of 4mmHg systolic blood pressure and 3mmHg diastolic were shown to reduce CV 
events by 15% and reduce relative risk of stoke by 23% in a cohort of 20,888 patients 
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comparing more intensive versus less intensive blood pressure lowering regimes  
(203). The HF2 intervention group showed a significant reduction in systolic blood 
pressure by 4.02 mmHg and diastolic blood pressure by 3.25 mmHg from baseline to 
follow up indicating a significant clinical outcome for the HF2 intervention. The 
elements of the HF2 intervention such as the behavior techniques used by the 
counsellors to increase motivation, set realistic goals to make small changes in diet 
and physical activity have affected a reduction in body weight and other parameters 
of diet and physical activity. 
The improvements shown in BP can be attributed to dietary changes made in 
relation to the DASH eating plan (204) (Dietary Approaches to Stop Hypertension), a 
diet rich in grains, fruits, vegetables and low-fat dairy products, which the HF2 
intervention counsellors encouraged participants to incorporate into a healthy 
eating plan. The HF2 intervention group saw a statistically significant increase in 
fibre intake (with the inclusion of wholegrains) (see section 5.5.2.2) and an increased 
intake of unsaturated fat (see section 5.5.2.1). Both groups significantly increased 
total number of fruit and vegetable portions in a 24hr period (see section 5.5.2.2) 
and saw a significant reduction in fat intake (see section 5.5.2.1). Increased levels of 
moderate physical activity in both groups, although not statistically significant, may 
also be considered a contributing factor for the improvements seen, as all of these 
factors are known to potentially modulate BP. 
The HF2 intervention group participants were mailed a British Heart Foundation 
booklet containing healthy diet information. A section in the booklet discussed salt 
and gave details regarding recommended daily allowance as well as examples of 
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foods with high salt content; there also contained a section on food labelling and 
how to calculate salt levels on packaging.  
Previous population targeted interventions showed a decrease in morbidity, 
mortality and healthcare costs with 1gram less of salt a day (205). It also showed 
that this type of intervention was feasible as evidenced from a UK salt reduction 
program where in 2006 the UK Food Standards Agency (FSA) introduced voluntary 
sodium reduction targets for more than 80 categories of processed food, which 
decreased mean sodium content in the food supply by 7% (206). Recent studies 
suggest that the UK's strategy has resulted in a significant but modest reduction in 
salt intake (207,208), although intake remained higher in lower SIMD groups, 
younger people, men, and ethnic minorities. It is evident, therefore, that future 
lifestyle interventions consider advice on salt reduction and that robust methods of 
assessing salt intake are adopted particularly in lower SIMD groups, young people 
and ethnic minorities. Dietary assessment of salt intake is time consuming and often 
underestimated, and although 24hour urinary assessment of sodium is likely to be 
more valid than dietary assessment, collection of 24hour urine involves considerable 
burden for subjects (209). 
 
6.6.3 Lipids  
Diet and lifestyle practices can affect concentrations of circulating serum lipids 
including; lack of physical activity, obesity, excessive alcohol intake, smoking and 
unhealthy diets high in saturated fats and salt, and limited or no fruit and 
vegetables, fibre, polyunsaturated and monounsaturated fats (210). The next 
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section will discuss some of the changes seen in serum lipid concentration in the HF2 
study sample.  
There was a significant between group difference seen in levels of total serum 
cholesterol and low density lipoprotein (-0.27 mmol/L, 95% CI -0.45 - 0.09, p=<0.01) 
and (-0.22 mmol/L, 95% CI-0.41 to -0.01, p=<0.05) respectively with the intervention 
group achieving a higher reduction, this is consistent with reported improved dietary 
outcomes in the intervention group including a decrease in total fat and increase in 
unsaturated fat intake. Although both groups reduced total cholesterol and low 
density lipoprotein serum levels significantly, the significant difference between 
groups indicates some success for the intervention; it also shows perhaps that both 
groups had become more health conscious.  
Statistically significant increases were seen in high density lipoprotein from baseline 
to follow up in both groups but there was no between group difference. The 
intervention group increased number of days per week physical activity was taken 
and both groups increased the number of participants achieving the recommended 
150 mins/ week moderate activity, 30.2% to 31.6% (p=0.493) in the intervention 
group and from 17.4% to 22.7% (p=0.866) in the control group which achieved the 
greater increase. However, the increase was not significant between groups 
concluding that despite increased levels of HDL in both groups the intervention was 
not successful in bringing about a sufficient change or indeed a significant increase 
in levels of physical activity between the two groups. Both groups had reduced their 
intake of total fat so it is unlikely that dietary fat intake would have contributed to 
the increase in HDL. Change in alcohol levels may have been a confounder, where 
the intervention group saw the number of drinks per day stay the same, the number 
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of days per week consuming alcohol had reduced, conversely the control group saw 
the number of days per week consuming alcohol remain the same whilst the 
number of drinks per day reduced which may also have contributed to the increase 
in HDL levels in both groups.  
A review examining the effects of aerobic exercise, resistance training and combined 
aerobic and resistance training on cholesterol levels and lipid profile, concluded that 
a dose–response relationship between levels of HDL cholesterol and physical activity 
exists (211), and that regular physical activity consisting of a weekly caloric 
expenditure of 1,000 kcal or more per week is reported to increase HDL cholesterol. 
Recommendations from the review advocated to improve and maintain lipid levels, 
a combination of low-intensity resistance training, prolonged moderate-intensity 
aerobic exercise combined with an increase in physical activity to 5 days of 30 mins 
was required (211). The HF2 counsellor telephone calls provided motivational 
support through setting achievable weekly targets, providing a pedometer to 
measure success and encouraging social support, reinforcing the association and 
importance of regular physical activity and increasing levels of HDL (212). At follow 
up the intervention group had increased the number of days per week of vigorous 
activity by 6% from baseline and by 23.1% for number of days per week of moderate 
activity.  Both groups increased the numbers of participants reporting having 
achieved the recommended levels for moderate activity with the control group 
achieving the greater increase (section 5.6.3).The HF2 study has shown a dose 
response effect with increasing levels of physical activity and increased levels of 
HDL, which could account for the modest changes, however, the intervention did 
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not bring about sufficient change in physical activity levels to see a significant 
between group effect.  
Factors which may have influenced these findings could be related to the limitations 
of self-reporting, over and under estimating levels of physical activity (213). The 
IPAQ questionnaire quantifies activity as carrying light /heavy loads, cycling and 
playing tennis into vigorous and moderate exercise which could be considered to be 
either vigorous or moderate, depending on the individual. Unless an exercise regime 
where levels are easily quantifiable for example 60 minutes of high impact aerobics 
can clearly be viewed as vigorous activity, or the use of objective measures such as 
accelerometers, quantifying the number of minutes per week may prove difficult for 
an individual to report (214). 
 
6.6.4  Blood Glucose  
Mean non fasting blood glucose levels had statistically significantly lowered in the 
intervention group from baseline to follow-up from 5.35 mmol/L  to 5.17 mmol/L a 
reduction of -0.17 mmol/L ( p=0.04). As discussed in section 6.4 with reference to 
the “Look Ahead Study” a strong relationship was seen between glycemic measures 
and weight loss (183) indicating that the 2.5% weight loss seen in the HF2 
intervention group could be directly attributed to the 3.2% reduction in blood 
glucose, which is a notable finding and clinically significant (183), however, there 
was no significant between group difference. Random blood glucose measures were 
used as participants were attending for screening throughout the course of the day, 
therefore, making it unreasonable to fast. Random blood glucose testing is a valid 
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method to include in the assessment of cardio vascular risk in this investigation as it 
is relatively inexpensive, suitable for large numbers in screening studies and requires 
no further blood sampling as a sample had already been acquired for the lipid 
profile. Blood glucose levels tend to remain within a normal range below 6.9 mmol/l, 
however, post prandial blood glucose level can rise up to 7.8 mmol/l or more, 
temporarily,  in non-diabetics highlighting the limitations of acquiring non fasting 
samples.  
The test for levels of glycated haemoglobin (HbA1c), which identifies average plasma 
glucose concentration, is also convenient as no fasting is required. It measures 
average blood glucose control over a period of 2 to 3 months. HbA1c provides a 
longer-term trend, similar to an average of how high blood sugar levels have been 
over a period of time and can be used to reflect average blood glucose levels over 
that duration, providing a useful longer-term gauge of blood glucose control (215).  
The HbA1c test was not used in the HF2 study as it is relatively more expensive than 
random blood glucose testing and although used in health surveys it is more 
commonly used for monitoring glycemic control in diabetic patients. As blood 
glucose testing was not the primary outcome for the study it was considered 
justified to use the validated relatively inexpensive test which met the aims of the 
investigation. 
6.6.5 CVD Risk 
The impact of providing CVD risk assessment on a person can prove complex and is 
likely to be affected by factors such as beliefs about the disease, prior knowledge, 
and peer comparison (216). A recent systematic review has shown that providing 
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patients with CVD risk information and education has shown to change risk 
perception and increases the accuracy of perceived risk (217).The HF2 investigation 
showed both groups 10 year calculated Framingham CVD risk scores to be relatively 
low at baseline; 4.1% for the intervention group and 4.9% in the control group at 
baseline (Table 5.17) than for the average risk estimates derived from the 
Framingham Heart study (159). However, the HF2 sample did not include 
participants with a risk score >20%. 
Both intervention and control groups had statistically significantly reduced their 10 
year CVD risk score at follow up to 3.3% (p=<0.001) and 4.0% (p=<0.001) respectively 
which could be considered clinically significant. There was no statistically significant 
between group differences to suggest the intervention was effective in adding to 
that risk reduction. As the risk score is calculated it would seem logical that the 
improvements observed in both groups for total cholesterol, HDL, and systolic blood 
pressure (those being the only changeable values entered into the calculation) that a 
lowering of mean CVD risk score would be seen. Communicating CVD risk involves 
helping participants to understand the meaning of that risk and offering support in 
particularly to those at high risk, and to make lifestyle changes to reduce that risk. If 
the information is not provided in a way the patient can understand, then the desire 
and ability to initiate change is likely to be limited (217). 
There are three validated means of predicting 10-year risk for cardiovascular disease 
in the UK; Framingham (159), ASSIGN (218), and the QRISK, (219) the latter of which 
is reported to be less likely to overestimate risk in the UK population (220). The 
choice to use the Framingham score in this investigation was historical as the HF2 
study was nested in the TASCFORCE study which was ongoing so it was not an option 
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to consider using a different method. A random 10% sample of participants from 
each group were chosen to recalculate 10 year risk using the QRISK score in order to 
compare with the Framingham scores to determine if they were significantly 
different. The updated QRISK 2-2016 (221) risk calculator was used for the 
calculations. The findings showed there was no statistically significant difference 
between the two scoring methods in both the intervention and control group, which 
justified the use of Framingham in the investigation. However, when calculating the 
Framingham score SIMD was not included in the original Framingham equation and 
was, therefore, not included and in the sub analysis with the QRISK calculation. To 
add SIMD in one calculation and not the other would not have given a comparable 
result. It is a limitation of this investigation that SIMD was not included in the 
Framingham CVD risk calculations as the effects on cardiovascular risk of social 
deprivation are well documented and in excluding this measure the Framingham 
algorithm may have underestimated CVD risk for participants in the most deprived 
groups (222). 
Modest reductions in a number of physiological parameters resulted in modest 
reductions in overall CVD risk. The significant reduction in CVD risk score seen in 
both groups can be attributed to the combination of lowering WC, BP, TC, non-
fasting blood glucose, and the increase in HDL, however, the between group change 
was not shown to be significant and this may be as a result of the sample size which 
was powered to detect the primary outcome, weight loss, only.  A longer study 
duration may also be required to see statistically significant and clinically meaningful 
between group physiological changes.   
Abnormal lipid profiles are risk factors for CVD’s and thus assessment enables early 
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diagnoses of abnormal levels enabling earlier intervention to reduce risk (223). This 
study showed both groups significantly reduce their total cholesterol levels; 
however, the reduction in the intervention group was significantly greater than in 
the control group (-0.27 mmol/L p=0.003). The difference may be attributed to, 
however small, the benefits of the statistically significant increase in dietary fibre, 
specifically soluble fibre, intake in the intervention group, and although not 
statistically significant between groups; the increase in physical activity levels, both 
of which have total cholesterol and Low density lipid lowering benefits (224, 225).  
There were no improvements seen in triglyceride levels, where both groups’ levels 
were similar at baseline and follow up (table17). The participants in this study were 
both fasted and non-fasted. Without data to distinguish fasted from non-fasted it 
would not be possible to say if this would have made a difference to the results. The 
improvements seen in diet and physical activity along with modest weight reduction 
may not have been enough to reduce triglyceride levels but may have been 
sufficient to prevent any increase. The sample was also perhaps too small to detect a 
change, as the study was not powered to detect a difference in levels of triglyceride. 
There can be significant variation in level of triglyceride measures depending on 
whether the person has fasted as levels can be substantially increased in the 
postprandial state (226). There is some evidence to suggest that postprandially 
levels are a more robust indicator of CVD risk, as the greater variability of levels in 
the postprandial state captures important information about an individual's 
metabolism (227). A recent study reported on findings refuting the need for fasting 
and non-fasting triglyceride measurement and questioned the usefulness of fasting 
samples in a screening setting where establishing an initial level would be the 
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primary objective, fasting may then be of more importance when going on to 
establish a diagnosis of genetic dyslipidemias (228). 
NICE guidelines recommend having CVD risk, including cholesterol levels checked 
every 5 years in adults between the ages of 40 and 74 (229).  NHS Health Checks 
were introduced in England in 2009; the purpose of the screening program was to 
tackle avoidable deaths and disability, reducing health inequalities and identifying 
undiagnosed health risks (230). However, the impact of the program is dependent 
on uptake and there is evidence that socio-economic deprivation is associated with 
lower levels of screening participation (231, 232). It is essential that lower socio-
economic groups are targeted as inequitable attendance at screening has the 
potential to widen existing inequality (232).  
In Scotland the Keep Well program, also screened for undiagnosed health risks, 
namely hypertension, abnormal lipids and elevated blood glucose levels targeting 
40-64 year old individuals, initially in the most socio-economically deprived areas 
(233).  In all areas the percentage of individuals attending screening reduced with 
increasing deprivation, although the absolute numbers of targeted individuals was 
greater in the most deprived quintile (233). Both the NHS checks in England and the 
Scottish Keep Well programs indicate a continued need for CVD risk screening in 
lower socio-economic groups, so that risk is not left undetected. The HF2 study was 
successful in attracting almost 25% (24.3%) volunteer participants from the highest 
deprivation category (12.3% less than the medium and 14.7% less than the low 
deprivation categories), possibly as a result of the diversity in recruitment sites 
which were targeted. Therefore, as there were modest but significant changes seen 
in some of the HF2 study’s outcomes such as reduction in weight, waist 
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circumference, lowered blood pressure, improved lipids and overall CVD risk scores, 
this type of intervention appears to be worthwhile, as it was shown to attract a 
substantial number of volunteers from socio-economically deprived areas, however, 
a period of follow up would be required to evaluate change over time.  
6.5.6 Cardio Vascular Risk Perception 
There were no significant changes between groups perceived risk of developing CVD 
in the coming 10 years from pre to post screening. However, differences were seen 
in gender, with males more likely to report a higher perceived risk of developing CVD 
(p=<0.01) at baseline. There was no significant difference between the intervention 
and usual care groups in both thinking risk was average to lower than average, 
however, females significantly considered their risk to be lower than the males 
following screening p=<0.05 (Table5.16) 
Women have been shown to believe incorrectly that they are more likely to die of 
breast cancer and do not perceive CVD as the greatest threat to their health (234) 
despite cardio vascular diseases accounting for 33.2% of global causes of death in 
women, two thirds more than cancers (235). Coronary Heart Disease has a higher 
prevalence in males within each age stratum until after 75 years, which may 
contribute to the misconception that heart disease is a man’s disease  (236). 
Complex explanations about cholesterol and CVD risk alone may not be sufficient for 
motivating behaviour change. CVD risk communication has to be meaningful and 
salient to the individual’s circumstance. Self- Regulatory Theory explains that 
people’s perception of health risk is based on perceptions of a particular illness or 
disability, which creates the development of their own representation of illness risk 
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(129). In the HF2 brief intervention (usual care) the risk perception is realized in 
discussion around the 10yr risk score of developing CVD together with the 
physiological measurements, making it meaningful to the individuals own risk. 
Through utilizing behaviour techniques the investigator can then assist participants 
to identify their risk factors and decide the changes necessary to improve their risk. 
The initial brief intervention discussion also facilitated both groups to consider the 
individual changes required to be made through the course of the 16 week 
investigation.  
Although both intervention and control groups significantly reduced their CVD risk 
scores, these results were not defined by gender, something which could be looked 
at in future analysis. However, given that the HF2 investigation showed CVD risk 
perceptions reflecting women’s risk to be lower than men’s indicates a need to 
emphasis the risks of CVD in women of middle age in future interventions, 
particularly if women continue to hold the view that CVD is a lesser threat to their 
health than to men.  
6.7 Influences on Weight loss 
6.7.1 Marital Status 
It is important to consider which social characteristics may have influenced weight 
loss in order to identify predictors for targeting future interventions. Marital status 
was shown to be a predictor for weight loss in the HF2 investigation. In both groups 
the greatest weight loss was seen in the widowed, separated or divorced category, 
with the greatest weight loss in the intervention group, indicating that perhaps it 
may be easier to modify lifestyle change when not considering a partner, particularly 
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if the partner does not wish to make changes. However, a recent review assessing 
the effectiveness of pragmatic lifestyle interventions in routine practice for the 
prevention of type 2diabetes showed that encouraging engagement of social 
support maximized a reduction in blood glucose in intervention arms compared to 
the control arm (237). As there were a greater proportion of participants not 
married or co-habiting perhaps the social support given by friends and family may 
have been a contributing factor in the greater weight loss seen in the intervention 
group. 
The married or co- habiting group made up the largest proportion of the sample at 
77% whilst the widowed, separated or divorced comprised of 15%. It is difficult to 
draw any conclusions from these results without considering the effect of marital 
transitions which have been recently thought to be more important than marital 
status in predicting body weight change (238). The loss of a partner, the stress of 
dissolution of a marriage and living alone have all been associated with an increase 
or decrease in body weight, therefore, further investigation as to individual reasons 
for weight loss would be needed in order to reach a firm conclusion. 
 6.7.2   Employment 
The largest proportions of participants in the HF2 sample were either employed full 
time (54%) or retired (22%). The smallest weight loss was seen in the largest 
category the employed full time whilst the largest weight loss was in the retired, 
indicating, perhaps the retired had more time to focus on lifestyle improvement 
(239). There is evidence to suggest that many retired people leave the UK to live in 
the sun for a period of time during the winter months where there is the 
opportunity to be more active outdoors (239), however, that would not explain why 
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the intervention group achieved the greater weight loss. The intervention group had 
30 minutes telephone contact time with their counsellor per month which may have 
contributed to increased motivation over the 16 week program and maintained 
focus on reducing weight. The intervention group also lost more weight in the 
months December through to February which may have seen the effect of retired 
people using the daylight hours to get out and be active while the full time people 
may not be as motivated due to travelling and leaving work when it is dark (240).  
Retirement increases leisure time, which may reduce phys ical and mental stress, 
improving both subjective well-being and health (241) and investment in health may 
increase as retired individuals have a lower marginal value of time (241). In addition, 
it is known that people are more receptive to health messages  during life transitions 
(242). These results have shown that the retired group has been receptive to the 
HF2 intervention perhaps as a result of having more time to focus on the 
intervention, and a desire to invest in improving health. The implications for future 
research would suggest that the pre-retiral or retired would be a worthwhile group 
to target for this type of intervention, or that there needs to be more consideration 
to approaches used with people who are in full time employment.  
6.7.3   Seasonal Effects 
The greatest weight loss by seasonal grouping was seen in December through to 
February in the intervention group (2.9kg) and March through to May in the control 
group (1.6kg) with the intervention group seeing the greatest weight loss over all the 
seasonal groupings. It could be argued that the weight loss seen in the intervention 
group during the seasonal grouping December through to February is surprising 
given that it includes the Christmas holiday period, but perhaps counsellor support 
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over this period increased motivation to be more aware of weight gain over this 
period and introduce behaviour techniques to avoid weight increase. The seasonal 
group also included January and February which are often associated with making 
resolutions to reduce weight and improve diet and increase exercise for many 
people (243). A prospective study involving healthy subjects completing one year of 
observation, looked at whether weight gain occurs as a result of small, steady 
increases in weight throughout the year, or because of more discrete periods of 
increased energy intake or decreased energy expenditure that might occur, such as 
holiday periods or during particular seasons (244). It showed that weight increased 
by 0.32kg during a six week winter holiday period, and 0.62 kg over the entire year, 
suggesting that the period contributing most to yearly weight change was during the 
six week holiday (244). It also showed that despite the fact that more than 85 
percent of the study subjects made no efforts to control their weight, large weight 
gains over the winter holiday season were not the norm (244), supporting Jebb’s 
work suggesting the body’s “in built”  mechanism for regulating weight control  
(245). The study also found that those who had a major holiday weight gain, were 
more likely to be overweight or obese and such weight gain may be clinically 
important, particularly for those who are already at-risk for obesity-related 
comorbid conditions (244) which again substantiates Jebb’s theory of the need to 
adopt cognitive restraint in the present day where the environment, high energy 
density rich diets, and sedentary lifestyle have destabilized the body’s natural ability 
to self-regulate weight (245).  
The control group also lost weight in the period December through February (1.4kg), 
although marginally less than their greatest loss of 1.6 kg in March through May. The 
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spring months are often a time where people become active in the garden, and 
there is an increase in daylight hours, which can bring an opportunity to engage in 
physical activity (240). The extra support from the counsellors may well have made 
the difference between the two groups, therefore, the HF2 study results show that 
with support it is possible to reduce weight over a period which is often considered 
difficult to reduce weight (243) 
6.8 Changes in Diet and Lifestyle Behaviours 
6.8.1 Views on Initiating change 
In considering the outcomes regarding weight loss, the success of the intervention 
and the importance of theory of behavior change, it is important to look at 
participant’s views on initiating change together with the Transtheoretical Model of 
Behaviour Change (TTM). There was no significant difference between groups at 
base line or follow up regarding views on initiating change in diet. In both 
Intervention Group and Control Group the majority of participants had “planned to 
start eating a healthy diet”.  A higher proportion in the intervention group (9.8%) 
were hoping to start in the next month, and (7.5%) more in the intervention group 
felt “somewhat” or “mildly confident” in sticking to the plan at baseline. The findings 
indicate that while both groups were at the stage of contemplation within the stages 
of TTM a higher proportion of people in the intervention group were somewhere 
between contemplation and preparation in making the decision to start at a defined 
point. 
At follow up fewer people said they planned to eat a healthy diet, with marginally 
more (1.8%) in the control group than the intervention group, which was perhaps 
because both groups had already started eating a healthy diet or perhaps the IG 
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group had not progressed between contemplation and preparation.  The control 
group felt “very confident” (21.5%) in comparison with the intervention group 
(18.7%) and there were more in the control group who went on to continue eating a 
healthy diet 76% v’s 74.6% (Table 5.9) indicating a continuing progression through 
the stages of change  in this group.  
Improvements in diet were seen in both groups, which may have contributed to the 
higher confidence levels seen at follow up. There was no difference between the 
groups in their views about readiness, timescale and confidence in initiating dietary 
change, however, there were more people in the control group who continued to 
feel “very confident” and “continuing to eat a healthy diet” than the intervention 
group.  
The intervention did not produce a significant change in motivation and perceived 
confidence to initiate and maintain a healthy diet, however, the changes which did 
occur were sufficient to contribute to a weight reduction and show improvements in 
all measured CVD risk factors, with the exception of the intervention group’s 
triglyceride levels which marginally increased, indicating that perhaps the 
intervention group had underestimated their confidence to bring about change. 
It may be the case there were not enough sessions or frequency of calls to maintain 
motivation particularly in people reporting not feeling entirely confident at the start 
of the intervention. More flexibility may have been required in the delivery of the 
different elements of the program. In the intervention group, the sessions were 
delivered by experienced nurse counselors trained in behaviour change theory and 
delivery of behavior change interventions. The sessions incorporated a number of 
behaviour change techniques such as motivational interviewing, goal setting 
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(including individual diet prescriptions), and relapse prevention, other studies have 
incorporated the expertise of clinical psychologists (246).  
Motivation and confidence are key determinants of behaviour change (247). The 
counsellors implementing the HF2 intervention were trained to assess an 
individual’s readiness for change and explore participants beliefs about the benefits 
from improved health and the consequences of not making changes to improve and 
preserve future health (as reviewed in sections 3.6.3 and 3.6.4, Trans theoretical 
Model and TRA Model). Behavioural techniques are then applied such as 
motivational interviewing, goal setting, feedback and relapse prevention strategies 
appropriate for the individuals need. (Appendix Q).  
Both groups began with similar levels of confidence and motivation, however, the 
control group continued to feel more confident and continued to eat a more healthy 
diet at follow up. The difference between groups was not significant, and there was 
no follow up period to estimate if the level of confidence and motivation would 
continue, however, there may be scope for further research to explore which 
aspects of the brief intervention impacted on the control group to enable them to 
feel more confident and continue to eat a healthy diet at follow up.  
 
 
6.8.2 Dietary Changes 
Analysis of various dietary components and the changes in intake of these over the 
course of the intervention can help with interpretation of the changes seen in 
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weight and other CVD risk factors . These changes are discussed in the following 
sections. 
 
6.8.2.1  Fat Intake 
The dietary advice for management of body weight given by the HF2 counsellors 
consisted of total calorie intake control, with recommendations to increase 
consumption of lean meat, fish, whole grain cereals, low-fat dairy, and fruit and 
vegetables, whole grain cereals and fish (248) .  
With regard to dietary fats, it has been suggested that the replacement of 1% of 
energy from saturated fat with polyunsaturated fatty acids will lower low density 
lipoprotein cholesterol, which could reduce incidence of CVD to 2 to 3% (249). The 
counsellors delivering the HF2 intervention encouraged participants to make 
changes in the type of fats consumed (i.e. saturated fat replaced by unsaturated fat), 
or changing the type in combination with an overall reduction of fat in order to 
increase protection against cardiovascular events.  
At baseline both groups’ total fat scores were in the low category with a score less 
than 30 which represents a fat intake of 83g per day or less corresponding to 35% of 
the energy RDA for an average woman (250). The results from the dietary 
questionnaires correlated with the views expressed on initiating change in diet at 
baseline. Both groups significantly reduced their total fat intake, the intervention 
group by 20% and the control group 14.9%, however, the degree of change was not 
significant between groups. Unsaturated fat intake scores increased in the 
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intervention group and decreased in the control group, however, neither groups 
change was significant nor was there significant difference between groups see 
section (5.5.2.1). The results show that the moderate weight reduction seen in the 
intervention group could be attributed to reduced energy intake and the increase in 
unsaturated fat intake and significant decrease in total fat intake contributing to an 
overall improvement in dietary fat intake.  
A recent report into people’s attitudes towards diet and health in Scotland indicated 
that there was an awareness of the main healthy eating messages and in particular 
those messages relating to eating plenty of fruit and vegetables, limiting foods and 
drinks that are high in sugar and salt, and reducing between meals snacking. 
However, there was lack of clarity with specific consideration of the fat, salt and 
sugar content of foods cited by only 4% of the sample as a primary influence on food 
choice, and only a third of respondents mentioning it as a factor at all, suggesting  
that whilst there is claimed awareness of  healthy diet messaging, the majority of 
adults had not accepted  the significance of the specific nutrient based messages or 
incorporated them into their behaviour when making choices regarding dietary 
intake (251).  
Reference to current British Heart Foundation booklets were used as an aid to guide 
discussion regarding fat content in participant’s diet during delivery of the brief 
intervention (usual care). The intervention groups’ increase in unsaturated fat intake 
may have been as a result of continued scrutiny of participants diet by the 
counsellors and continued reinforcing messages over the duration of the 
intervention maintaining motivation to make changes by increasing awareness of 
specific dietary fat content and interpretation of nutritional food labels. 
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To summarise the improvements in specific types of dietary fat intake appeared to 
affect the intervention group’s blood lipids decreasing total cholesterol, low density 
lipids and triglyceride levels as well as increasing high density lipids. Increasing 
unsaturated fat intake also lowered the intervention group blood glucose levels 
preventing insulin resistance, and reduced systolic and diastolic blood pressure and 
overall CVD risk score (224).  
6.8.2.2  Fibre Intake 
The Scientific Advisory Committee on Nutrition reported on the evidence for the 
association of dietary fibre and CVD (252). The report indicated a biologically 
relevant association between higher consumption of insoluble fibre such as high 
fibre breakfast cereals, wholemeal breads, pasta, nuts and seeds, vegetable fibre 
and whole grains but limited evidence of the effect of increased soluble fibre such as 
oats, pulses and root vegetables and fruit fibre and CVD events (252). 
At baseline both groups fibre intake score was low, less than 30 which corresponds 
to a fibre intake of 20g/day or less. Whilst the intervention group increased their 
fibre score significantly out of the low category the control  group reduced their 
intake. The change in intake between the groups was significantly different, see 
section 5.5.2.2. 
There are many important physiological effects associated with the intake of dietary 
fibre including controlling blood sugar levels by slowing digestion and the absorption 
of carbohydrates, thereby, lowering the rise in postprandial blood glucose and the 
insulin response. Isolated viscous fibres such as pectin, rice bran or oat bran lower 
both total serum cholesterol and low density lipoprotein levels (252). The 
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intervention group showed a significant decrease in both total cholesterol and low 
density lipoprotein levels and a decrease in both systolic and diastolic blood 
pressure consistent with an increase in dietary fibre. There was also a significant 
between group difference showing the intervention was successful in bringing about 
a physiological change, which is encouraging. Reasons for this increase may have 
been scrutiny of dietary behaviours by counsellors and providing educational 
materials that reinforce messages about healthy eating, reinforcement of the 
importance of dietary fibre and the health benefits which come from it, including 
improved cholesterol levels (253).  
6.8.2.3  Fruit and Vegetable Intake 
The World Health Organisation advice for adults is to consume at least five varied 
80g portions of fruit and vegetables per day (10). The Scottish Health Survey (SHS) 
reported the average adult intake of fruit and vegetables in the 2014 survey as 3.1 
portions per day with I in 5 adults (20%) and 1 in 10 adults (10%) of adults not taking 
any fruit and vegetables (254).  Both intervention and control groups significantly 
increased the total number of fruit and vegetable portions taken over a 24hr period. 
The results from the HF2 study has shown both groups having a high intake of fruit 
and vegetables, above the recommended levels at baseline and follow up with a 
significant increase from baseline in both groups, however, the difference between 
groups at follow up was not significant. One of the reasons for the above average 
reporting of number of portions may be the difference in reporting methods from 
the SHS and participant’s perception of portion size (255) which was constant at 
both time points for both groups. 
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Whilst fruit and vegetable intake was high at baseline the increased intake at follow 
up which in turn increased dietary fibre intake could be linked to improvements 
seen in the intervention groups CVD risk factors. The control group fruit and 
vegetable intake was also increased but marginally less than the intervention group 
intake, however, the reduction seen in fibre intake showed that although the fruit 
and vegetable intake was high, and the change from baseline to follow up was 
significant the reduction in fibre intake was not enough to show improvements in 
CVD risk factors to the same extent as the intervention group.  
The SHS question to assess fruit and vegetable intake was asked in such a way as to 
aid visualisation of what a portion size is, for instance, tablespoons of vegetables, 
cereal bowls full of salad, handfuls of small fruits (e.g. raspberries) but it was still felt  
there may  have been some variation between participants' interpretation of a 
portion (255). Inaccurate reporting can lead  to inaccurate interpretation and 
dissemination of results, as noted in a study where using a food diary showed a 
significant correlation between saturated fat intake and breast cancer, but using a 
food frequency questionnaire found there was no significant correlation (256). 
Ideally recall and completion of dietary questionnaires would be carried out face to 
face with standardized measuring equipment or photos to eliminate recall bias 
which has cost implications. The resulting high estimation of fruit and vegetable 
intake in this study is possibly due to self-reported over estimation or difficulty in 
distinguishing portion size particularly as both intervention and control groups 
scoring was high and both groups had received the brief intervention prior to 
“baseline”, however, the results show consistent improvements in all CVD risk 
177 
 
factors, indicating that the dietary improvements have affected the physiological 
outcomes and as well as a reduction in body weight. 
6.8.2.4  Sugar Intake 
Higher intakes of sugar, in particular sugar-sweetened beverages (SSB) are 
associated with weight gain and increased levels of triglyceride. There was no 
association between group allocation and change in number of sugary drinks 
consumed, or change in number of teaspoons of sugar consumed per day, however, 
the intervention group did show a significant reduction from baseline to follow up 
from 1.0 to 0.5 of a spoonful p=0.029 (Table 5.11), which is encouraging as sugar 
consumption was discussed in the context of eating a healthy balanced diet. The 
majority of particpants in both groups had not changed the number of drinks 
consumed from baseline to follow up (57.7% IV versus 55.6% CG), there were similar 
proportions in both groups who had decreased the number of drinks and slightly 
more increased drinks in the control group (Table 24). The results are comparable 
with the 2014 SHS findings for this age group showing a slight increase or no change 
in overall sugar consumption (254). The UK March 2016 budget saw the planned 
introduction of a sugar tax on soft drinks, to come into force April 2018, adding 
around eight pence to a can of sugar sweetened beverages (SSBs) in an attempt to 
save a generation from the toll of obesity. One study estimated that a 10% tax on 
SSBs was predicted to reduce the percentage of the overweight or obese adult 
population by 0.7%, equating to 14,380 adults (257).  
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6.8.2.5  Alcohol Intake 
Intake of alcoholic beverages is not only an independent risk factor for CVD by 
reason of the influence of alcohol on blood pressure and increased triglyceride 
levels, it also contributes to a high energy intake and weight gain (258). At follow up 
the intervention group reduced drinking in the 2 to 4 times per month and 2-3 times 
per week category but the control group levels remained the same (Table 5.12). The 
intervention group saw the number of drinks per day consumed stay the same whilst 
the number of days per week consuming alcohol had reduced, conversely the 
control group saw the number of days per week consuming alcohol remain the same 
whilst the number of drinks per day reduced. Possible reasons for the difference 
seen in the groups may be that the intervention group were adhering to advice 
given by the counsellors to have at least 3 days free of alcohol (259), whilst the 
control group also wanted to reduce alcohol but they decided to reduce the number 
of units per day indicating an overall alcohol reduction in both groups which was not 
significant but none the less encouraging and likely to have contributed to the 
reduction in body weight in both groups.  
The intervention group were given an interactive device for measuring the 
alcoholic unit and calorific content in commonly consumed alcohol brands, as the 
intervention group reduced more weight than the usual care group the device 
combined with regular added motivational support, reinforcing health messages on 
benefits to health from counsellors, may have influenced participants awareness of 
units and calorific intake not only to reduce alcohol intake but to reduce body 
weight, however, with no significant change in alcohol consumption between groups 
the intervention may not have been responsible for the changes seen. Reasons for 
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this may be that changing alcohol drinking behaviour requires intensive strategies to 
be implemented (260) and this was not in the scope of this intervention. The 
Institute of Alcohol Studies report in 2012 showed a continuation of the trend in 
consumption frequency that sees older people drinking most often of all age groups. 
Since 2006, 45–64 year-olds have been shown as most likely to consume alcohol in 
the last week, and 65+ year-olds have been most likely to do so on 5 or more days 
over the same time period (261). Older drinkers (45–64 and 65+ year-olds) were 
most likely to consume alcohol most frequently. Self-reported estimates of alcohol 
consumption are generally considered to be subject to various biases and typically 
produce consumption estimates much lower than those based on objective alcohol 
sales data (262)The HF2 intervention was not powered to detect change in alcohol 
intake; however, the reduction in number of days per week drinking is encouraging. 
Future investigations could examine participant’s perception and awareness of 
alcohol consumption and calorific intake and its relationship with CVD disease and 
weight gain to inform future interventions tailored to focus on these factors. 
6.8.2.6  Smoking Habits 
Although the numbers of smokers in both groups were small, smoking is still the 
leading behavioural risk factor for CVD (263). The effects of smoking increase blood 
pressure (264) and the way in which the body processes cholesterol enabling greater 
amounts to remain in the blood circulation decreasing the ratio of high density lipids 
to low density lipids (265,266). There were no differences in smoking status  
between groups at baseline, p=0.858.  Of the nine smokers in each group one 
participant per group had stopped smoking at follow up. The actions taken by the 
Scottish Government to tackle the harm caused by tobacco included legislation to 
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prohibit smoking in public places, which came into effect in March 2006, raising the 
age of sale for tobacco from 16 to 18 in 2007, implementation of a tobacco retail 
register in 2011, a ban on self-service sales from vending machines in 2013, and the 
introduction of a tobacco display ban in shops from 2013.  
The decline between 2013 and 2014, from 23% to 20%, is the sharpest year-on-year 
reduction over the full time series. This follows a period between 2011 and 2013 
when smoking rates were relatively stable at 23% (254). The combination of these 
strategies appeared to have an impact on levels of smoking in Scotland but there 
are/were disparities in social status and smoking with still one in three (34%) adults 
in the 20% most deprived areas in Scotland smoking cigarettes, significantly higher 
than 9% of those in the 20% least deprived areas (254). Discussions around CVD risk 
factors and the effects of smoking were introduced in the HF2 intervention and 
recommendations were given for smoking cessation in line with current NICE 
guidelines (267). As the study sample had a small proportion of smokers, it would 
not be possible to derive a meaningful effect from the intervention.  
 
6.9     Changes in Physical Activity Levels 
6.9.1  Views on Initiating change  
Undertaking regular physical activity is an important component of total daily energy 
expenditure (268). It can affect energy balance by creating an energy deficit through 
increased energy expenditure which in due course can produce weight loss and 
enable weight maintenance (269). Regular physical activity can also help control 
certain CVD risk factors lowering blood pressure and triglycerides, raising HDL and 
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managing blood sugar and insulin levels and lowering the risk of type 2 diabetes 
(270). Questionnaires were completed to assess participant’s views with regard to 
readiness and confidence in increasing physical activity levels. Both groups began 
with similar levels of confidence and motivation (section 5.6.7), however, the 
intervention group continued to feel more confident and reported to continue to 
increase levels of physical activity at follow up, implying that the HF2 intervention 
encouraged motivation and confidence, showing a degree of success with the 
behaviour techniques deployed, such as the agreed physical activity targets, using 
the pedometer to incentivise and continual feedback and re-evaluating progress, 
however, with no follow up period it is not possible to estimate if the level of 
confidence and motivation would continue. Consistent with the greater 
improvements in confidence in improving diet reported in section 5.5.1, the 
intervention group also reported a greater increase in their physical activity levels, 
which may have been as the result of increased confidence and acquired self-
efficacy as a result of the counsellors’ support. 
Both groups were similar in reporting the number of days per week of vigorous 
physical activity at baseline.  At follow up the number of participants in the 
intervention group reporting no vigorous activity dropped by 6% and increased by 
1.6 % in the control group. The intervention group were set physical activity goals 
with the use of a personalised physical activity prescription including set goals for 
number of minutes per week of levels (vigorous, moderate and walking) of activity. 
This may have been enough to motivate more people in the intervention group to 
start vigorous activity compared to the control group who had increased the 
182 
 
percentage reporting no vigorous activity indicating a degree of success for the 
intervention.  
To summarise there was no significant difference between groups in number of days 
per week and more importantly, number of minutes per week in the amount of 
vigorous activity taken, indicating that the HF2 intervention itself was unsuccessful 
in bringing about an increase in levels of vigorous physical activity, however, it was 
successful in increasing a percentage of participants who had not previously 
undertaken vigorous activity to start.  
Overall between baseline and follow-up it is encouraging to note that the 
percentage of participants achieving the recommended 150 minutes of moderate 
intensity activity per week increased for both groups, with the control group 
achieving the greater increase, although this was not a significant between group 
difference (Figure 5.6).  
6.9.2 Walking 
Walking was defined as “at work and at home, walking to travel from place to place, 
and any other walking that you might do solely for recreation, sport, exercise, or 
leisure”. The intervention promoted walking as the main activity as a pedometer and 
a walking plan were provided. There was no significant difference between groups in 
change in walking behaviour, however, walking was included as a separate variable 
as it forms part of ‘moderate intensity’ activity.   
A percentage of participants (6.1%), recalled having no walking activity at baseline in 
the past 7 days indicating a misperception of what precisely was meant by walking 
activity. The question did refer in part to walking at home but it is possible that a 
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proportion of participants when thinking about physical activity immediately 
consider organised or vigorous exercise and not at work and at home, walking to 
travel from place to place, which they may be carrying out but not achieving a 
moderate level of intensity. The limitations of self-reported walking activity and 
unedited data entry is apparent, as it is unlikely that participants have not walked at 
all in a 7 day period given all were physically mobile. The possibility of reviewing the 
form to clarify certain points could be way of possibly counteracting this 
shortcoming, however, it would be time consuming. The addition of an 
accelerometer which can be set to measure the number of accelerations per minute 
would have enabled a more accurate estimation of levels of walking activity. The 
advantage over a pedometers being that although more expensive in terms of cost 
and researcher burden they are less likely to influence physical activities as people 
become accustomed to checking their pedometers and working to increase or 
manipulate their physical activity according (271).  
6.9.3 Sedentary behaviour 
A relationship has been shown to exist between prolonged periods of activity 
involving sitting or reclining, and all-cause mortality and cardiovascular events 
independent of moderate-to-vigorous physical activity (272). Analysis has shown 
that more time spent in sedentary behaviours has been linked to increased risk of 
mortality, CVD (273), impaired lipid and glucose metabolism (274,275) and 
metabolic syndrome (276). 
There was no significant difference between groups on reported hours per day spent 
sitting at follow up. Both groups did reduce the amount of time sitting with the 
intervention group achieving a significant reduction from 7.1 hours (SD3.5) to 5.7 
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hours (SD2.7) which is more in line with the average sedentary time reported in the 
Scottish Health Survey of 5.5 hours on weekdays and 6.1 hrs weekend days for 
males and 5.4 hrs weekdays and 5.9hrs weekend days for women. Sedentary 
behaviour is defined as any waking behaviour characterized by an energy 
expenditure ≤1.5 METs and a sitting or reclining posture (277). There is a desire to 
reduce sedentary behaviour as there has shown to be a strong association reported 
between the physical component of successful ageing and sedentary behaviour, 
which also noted a dose-response relationship, in that, less time spent in sedentary 
activities was associated with higher odds of successful ageing (278). Both groups 
reduced the amount of hours sitting with the intervention group achieving a greater 
significant reduction than the control group, which may have been as a result of 
overall positive health messaging in both groups, and is an encouraging health 
outcome in relation to metabolic disease risk.  
Overall as reported in the last two sections both groups had increased moderate 
physical activity, which may also have included walking. The intervention group 
achieved a significant reduction of hours sitting, which, if sustained may be clinically 
significant, as greater levels of physical inactivity have been reported as being 
associated with an increased likelihood of reporting disease and disability, low 
functional capacities, and being socially disengaged with life (279). Changes seen in 
the intervention group’s reduction in body weight, anthropometric and physiological 
parameters can, therefore, be in part attributed to the significant amount of time 
being less sedentary and physically more active. 
In summary although the intervention group reported high levels of confidence and 
had increased  levels of physical activity the analysis shows it was not enough to 
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show a significant between group difference, and although motivation was high this 
had not translated into significant change in increasing levels of physical activity for 
the intervention group. The effect in both groups of increasing levels of vigorous 
activity, moderate activity and walking along with the reduction in sedentary time 
was associated with an improvement in all physiological CVD risk factors known to 
be attributed to increased physical activity; weight, systolic and diastolic blood 
pressure, waist circumference, total cholesterol, low and high density lipids, blood 
glucose and CVD risk scores, with the exception of a slight increase in triglyceride 
levels in the control group. These findings indicate that the extra input from the 
counsellors did increase confidence and motivation to increase physical activity and 
decrease sedentary time. However, the control group was equally as motivated to 
become more active and were able to improve anthropometric and physiological 
parameters. 
 
6.10   Participants Health Related Quality of Life Perceptions 
The SF12v2 Health Related Quality of Life questionnaire was used to measure 
participants’ reported general health status. Responses from the 12 questions are 
combined in two summary scores; The Physical Component Summary (PCS) and The 
Mental Component Summary (MCS). There was no significant difference in mean 
scores between the intervention and control groups through each of the domains at 
baseline or follow up, however, there were differences seen at individual domain 
levels (Table 28).  
6.10.1 Participants Response and General Health Changes 
The generic SF12v2 was chosen in order to analyse participant’s perception pre and 
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post intervention and demonstrate if weight reduction had an effect on, among 
other parameters, general health, vitality and mental health. There were two 
hundred and forty six questionnaires included in the sample at baseline and two 
hundred and forty two analysed at follow up, as a result of non-completion or 
invalid response, which is not uncommon as studies have shown that unless 
“questionnaires are coercively administered to the target population, a 100 percent 
response rate is rarely achieved” (280).  Reasonable explanations for non-response 
may well have included lack of time; lack of understanding of the question asked or 
genuinely over looked the question. In an attempt to minimise a non-response rate, 
questionnaires were sent close to date for follow up appointment and stamped 
addressed envelopes were included.  Reminder telephone calls may have increased 
response however a 98.4 % return rate could be considered a good response.  
Improvements in physical activity levels, dietary intake, weight reduction and 
physiological measurements may all have conceivably contributed to the significant 
increase in vitality seen in the intervention group, as the effects of these 
improvements are known to have a positive effect on Health related quality of life 
(HRQOL) and psychological health (281),  
As both groups had made positive improvements to dietary intake and physical 
activity levels further investigation would be required to determine reasons for the 
decrease in physical functioning in the control group and not the intervention group. 
As the study was powered to detect change in body weight the number of subjects 
in this sample may not have sufficient statistical power to detect changes 
throughout all the domains.  
The SF12v2 questionnaire showed a percentage of the “norm population” and HF2 
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sample at risk of depression (based on the standardised “normative data of a score 
of 50 and standard deviation of 10) (section 4.6.1). Baseline and follow up values 
showed the norm population to have a 20% risk; the HF2 sample risk was lower at 
15% baseline and 14% at follow up, indicating an increased proportion of participant 
satisfaction with HRQOL in the HF2 sample, which could be attributed to the 
increased vitality and overall improvements seen for both groups in weight, diet and 
physical activity.  
The summary measure in the longer SF36 form do give more reliable estimates of 
individuals levels of health and wellbeing because it defines more levels of health 
and better represents the content of health measures than the SF-12v2 (282), 
however, the questionnaire length being reduced by two thirds and with minimal 
loss of measurement precision makes it a justifiable alternative to the longer and 
more time consuming to administer SF36 form (282). It could be argued as to the 
usefulness of a health related quality of life questionnaire used in an intervention 
such as HF2 without a clear objective as to how the information would be followed 
up, the results show a change from baseline to follow up but without further 
investigation we can only speculate if it was the intervention that effected that 
change. There is a possibility that the information could be used for triaging to other 
services, however, this would require cut off values to determine the level of need 
for physical or mental health intervention (283). In summary the results from the 
HRQOL questionnaire have shown changes which are consistent with the 
improvements seen in diet, physical activity and CVD risk factors for both groups.  
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6.11 Participant Satisfaction with the intervention 
It is important that participants’ satisfaction with the intervention is high as it can 
affect compliance with the intervention if they are not. A review of the data showed 
overall participant satisfaction to be high. There were 80.1% of questionnaires 
returned and a high percentage of participants rated the HEALTHFORCE 2 study as a 
worthwhile or excellent program.  This was significantly higher in the intervention 
group (94.5%) than the control group (93.9%) which is likely to be due to the 
differences in the “excellent” rating (between group difference p=0.046) as if the 
excellent and worthwhile responders had been combined the difference may not 
have been significant. Both groups reported the study as being useful (94.9%), 
helping them to change their diet (88.3%) and levels of physical activity (72.6%). As 
the questionnaires were returned anonymously there was no way to pursue non-
responders for feedback.  
The participant satisfaction questionnaire asked if the telephone calls and posted 
materials help make changes to diet and/or levels of exercise. This question was 
included so as to distinguish between those who had the intervention and those 
who had not. Those who did not receive the intervention had the option to tick a 
“not applicable box”; however, the limitations in self-reporting can be seen, with the 
disparity seen in the numbers shown in each group. It may be as a result of a 
proportion of participants ticking the box to say they were helped by the telephone 
calls and posted materials where in fact they may not have received any calls or 
posted materials (Table 5.19). There were many written notes on the returned 
questionnaires in an effort for the participant to make their feelings and perceptions 
of the intervention and non-intervention across. If this investigation had not been a 
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nested cohort valuable feasibility work could have been carried out with piloted 
questionnaires to improve then data collection quality and assess acceptability of 
the intervention.  
Without further qualitative analysis the results from the participant satisfaction 
questionnaires are limited to descriptive statements, particularly as it is  difficult to 
distinguish from the returned questionnaires which participants had truly had the 
intervention. Further research and analysis could be carried out to explore these 
descriptive statements. 
Medical research requires standardised questionnaires of intraindividual and 
interindividual comparisons to maintain a particular kind of objectivity (284).It 
depends on decontextualising personal experience in order to make the experience 
comparable and transferrable independent of time and place. Questionnaires are 
developed to deduce complex experiences for statistical analysis which is in contrast 
to participants’ sense of personal experience (285). Participants try to describe a 
precise and specific personal experience which aims to be as accurate as poss ible. 
This reduction can make it more difficult to answer the questionnaires and lead to 
frustration in their inability to give an exact depiction of their experience through 
their answers to the questionnaires (285).  
6.11 Strengths and Weakness  
There are a number of strengths and weaknesses arising from the HF2 investigation 
which warrant discussion. To the investigators knowledge an investigation such as 
the HF2 study has not been replicated. The novel components in the investigation 
were; a cohort consisting of a middle aged population having undergone CVD risk 
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screening, a fully powered randomised controlled trial of 16 weeks duration with the 
primary outcome of change in body weight and secondary outcomes to evaluate 
change in CVD risk factors, and using the telephone as the primary mode of delivery. 
One of the major strengths of the study was its ability to recruit participants from a 
range of socioeconomic backgrounds.  
The Healthforce 1 (HF1) (50) study demonstrated that it was feasible to deliver and 
implement a face to face lifestyle intervention with focus on diet and physical 
activity in adults undergoing CVD risk screening, and the findings from the study 
supported the development of this investigation. The HF2 study has shown that it is 
possible for a fully powered randomised controlled trial to show modest changes in 
weight loss and modifiable CVD risk factors in both groups. The weight loss seen in 
the HF1 study was 1.1kg in comparison to 0.8kg in the HF2 investigation which was 
fully powered to detect changes in both intervention and control groups. The reason 
for the larger weight loss seen in the HF1 investigation (50) may have been in part 
due to delivery of one to one consultations rather than telephone consultations, 
although participant acceptability of both programmes was shown to be high. There 
were also comparable changes seen in waist circumference, physical activity and 
diet, with both studies showing increases in levels of moderate physical activity and 
number of daily portions of fruit and vegetables consumed. These findings 
demonstrate support for this type of lifestyle change intervention.  
The interventions’ effectiveness relied on the counsellors identifying predictors of 
the individuals’ behaviour and gaining an understanding of the attitudes and beliefs 
towards that behaviour. The counsellors had to facilitate reaching a decision 
balance, weighing pros and cons of good versus ill health and the consequences of 
remaining over weight. Once established a plan to change the particular behaviour 
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in pursuit of behavioural goals is realised.  The behaviour techniques used to help 
subjects to achieve the behaviour change involved goal setting, self-monitoring, 
feedback and reinforcement improving self-efficacy and enlisting social support.  
Although the HF2 intervention was not successful in achieving statistically significant 
weight loss, there were many positive outcomes. There was a significant percentage 
weight loss in the intervention group at a level which has shown to be clinically 
meaningful (section 6.4) in patients with type2 diabetes (10). There were significant 
improvements in anthropometric modifiable risk factors (section 6.5), shown in the 
intervention group notably a reduction in waist circumference (section 5.3.1), total 
cholesterol and low density lipoproteins, (section 5.3.2.3) all of which contribute to 
increased CVD risk. The study was shown to be acceptable with good participation 
satisfaction feedback for both intervention and control groups, with 94.5% in the 
intervention group rating the program as “worthwhile or excellent”.  
 
The methodology used to determine weight loss in the HF2 investigation was robust 
with the inclusion of waist circumference as a measure of abdominal obesity and is 
strength of the study. Other means of measuring weight loss can include skin fold 
caliper measurement which is considered an accurate, effective, practical and 
repeatable method of measuring body fat, as long as the measures are in the same 
spot each time. It does require to be carried out by trained experienced observers as 
it can be quite susceptible to measurement error.  The gold standard methods to 
measure body fat are hydrostatic weighing and Dual Energy X-ray Absorptiometry 
known as DEXA which are very accurate but expensive but would have not been 
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practical to incorporate into the HF2 study. Both these measures although 
considered more accurate does add to participant burden. 
Reliance on food frequency questionnaires for epidemiological studies has been the 
foundation of assessing dietary intake for several years (286) and although these 
assessment tools are subject to test for reliability and validity, evidence has shown 
that when individuals are asked to recall diet in the very recent past, their memory is 
reasonably accurate; however, after only a few days, memory of diet weakens (286).  
Assessment of food intake is potentially subject to many sources of both random 
and systematic error. Recall ability and psychological characteristics of individuals 
are known to influence dietary reporting, such as reporting behaviour perceived as 
socially desirable rather than accurate (287).  
Future interventions could see incorporating technological devices such as personal 
digital assistants with or without a camera with specifically designed dietary 
software to record data immediately after food consumption, scrolling down a list of  
food groups then selecting a specific food and portions (288) , and relatively cheaper 
recently developed 24hr online dietary software such as INTAKE24 (289) and 
myfood24 (290) . It would not have been possible to incorporate these methods in 
the HF2 investigation due to cost and would have necessitated a feasibility study to 
assess participant compliance and acceptability, when resources and time were 
limited in this investigation. 
According to the principle developed by Hall and colleagues (291) a 1% BMI 
reduction across the UK population, equivalent to a weight loss of 1 kg, would avoid 
up to 179,000  – 202,000 cases of type2 diabetes, 122,000 cardio vascular diseases, 
and 32,000 – 33, 000 incidents of cancer with a gain of about 3 million QALYs over 
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20 years (291), a net 20 kcal per day reduction would be required to be sustained for 
3 years to enable this reduction in the prevalence of NCD’s. In addition to 
compromising the populations' healthy, productive life span, by 2030, these 
increases in obesity-related diseases were projected to add to health-care costs by 
£1.9 –2 billion a year in the UK (291). The HF2 intervention did not achieve a 1kg 
weight loss but did achieve a 0.9kg weight reduction which was a significant amount 
from baseline to follow-up and is encouraging considering the short duration of the 
study.  
6.12 Future Work 
Both groups were successful in achieving weight loss and significantly improving a 
number of CVD risk factors, indicating that the HF2 intervention and the brief (usual 
care) advice were effective at initiating behaviour change. What remains to be seen 
is if the change could be sustained over a period of time. Improvements were seen 
in dietary intake and levels of physical activity, however, reporting of intake and 
physical activity were self-reported which can be subject to bias. Future weight loss 
intervention studies could incorporate  the use of smart phone technology to 
include existing applications which record dietary and physical activity data in real 
time, as currently used in commercial trials, where data can be captured on smart 
phones, transmitted to a central server and analysed by the investigating team. 
Opportunities to incorporate new applications could be explored for inclusion in 
future feasibility studies.  
Methods used to measure alcohol intake in future weight loss interventions could  
include the AUDIT (The Alcohol Use Disorders Identification Test) tool (292)), the 
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addition of this measurement would enable more accurate participant recall , and 
enable a more specific measure of the various types of alcoholic drinks consumed 
and the calorific content.  
Although both intervention and control groups significantly reduced their CVD risk 
scores, these results were not defined by gender, or SIMD something which could be 
explored in future work, particularly as the CVD risk perception questionnaire results 
showed that women perceived their risk to be lower than men’s. These results 
highlight the need to explore CVD risk perception in women to investigate possible 
reasons why they did not recognize the increased level of risk and why they felt their 
risk of CVD is a lesser threat to their health than it is to men. The CVD risk perception 
questionnaire was designed purposely for the HF2 study as the investigator was 
unable to source an appropriate validated questionnaire specific to the question 
asked. A proposal for designing and developing a CVD risk perception measurement 
tool which could initiate discussion on an individual’s level of risk would also be a 
valuable contribution to future interventions investigating CVD risk perception.  
 
6.13  Conclusons 
The UK’s fall in Cardiovascular Disease (CVD) mortality can be attributed to 
increased public understanding of risk factors, government policies to enable 
healthier lifestyles and improved treatment and prevention services. Screening is 
one such preventative measure if followed up. The aim of the (HF2) investigation 
was to assess the outcome of a brief lifestyle intervention versus a multiple contact, 
minimal cost intervention on reducing body weight and modifiable CVD risk factors 
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in healthy volunteers following cardio-vascular risk screening, in order to determine 
what level of intervention input would affect initiation and maintenance of lifestyle 
change, body weight and cardio-vascular risk factors. 
Screening a healthy population for the HF2 investigation, in a research setting, for 
risk of CVD provided a platform and opportunity to discuss individual risk and 
provide lifestyle advice. The target age group for this investigation of those over 
40years old provided an opportunity to target a middle aged group at a time in the 
life course when they may be more likely to weigh up the benefits of future good 
health against the burden of ill health. The HF2 investigation offered an opportunity 
to attempt to bring about behaviour change to a group who were voluntarily 
presenting for risk screening so may by definition already have been thinking about 
their health and more receptive to lifestyle advice. 
There is sufficient scientific evidence to indicate that lifestyle modification 
interventions which include nutritional advice, increased physical activity, moderate 
alcohol intake and smoking cessation can offer a successful approach for the 
prevention of heart disease and stroke.  
The outcome of the HF2 investigation showed there was no difference between the 
multiple contact lifestyle change intervention versus the brief lifestyle change 
intervention (usual care). There were differences seen in the PP analysis, however, 
there was no statistically significant difference seen between the intervention and 
the control group in the ITT analysis in terms of the primary outcome weight loss, 
lending support for instigating brief interventions and the concept of the “teachable 
moment”. The intervention did, however, show that a lifestyle change intervention 
using the HF2 methodology can result in a modest weight reduction and show 
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statistically significant improvements in physiological markers of CVD risk factors 
such as waist measurement, diastolic blood pressure, total cholesterol and low 
density lipoproteins. As there was little difference seen between the multiple 
contact intervention group and the usual care group it is difficult to determine which 
specific elements were successful in the intervention which brought about the 
change. There was little difference in the primary outcome or secondary outcomes. 
Perhaps it was the case that both groups were motivated by the CVD risk screening, 
and that highlighting the future health risks in this age group was enough to 
motivate both groups equally to reduce weight, improve diet and increase activity, 
or that the usual care group were more health conscious, and as they were not 
going to receive any further input from baseline to follow up they decided to take it 
upon themselves to be more proactive. These are speculative reasons and not 
measured and as so means it is not possible to draw any firm conclusions as to the 
reason why the intervention was not successful in promoting a significant weight 
loss in the intervention group compared to the usual care group.  
The results from the investigation will contribute to the existing knowledge base for 
behaviour change intervention studies, by showing that a single brief lifestyle 
intervention delivered in a screening setting was just as effective in affecting 
behaviour change as a multiple contact intervention and enhance the evidence base 
on potentially cost effective strategies to encourage lifestyle change, in order to 
reduce the prevalence of obesity and CVD’s. 
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Appendices 
 
Appendix A.  
 
Search alerts were set in order to ensure notification of new literature as it was 
published. 
 
Alert 
Name 
Search Terms Alert Frequency 
Scopus 
 
Heart Disease prevention physical activity 
Heart Disease prevention weight loss 
Heart Disease prevention and brief interventions 
 
Daily 
BioMed 
Central 
Books, Journals and Information 
Health Services Research 
Public Health  
Nursing 
Physiology 
Psychology 
Medical Research Methodology 
Received  as published 
 
Obesity 
Knowledge 
Update 
  
 
Weekly 
 
International Association for the Study of Obesity (IASO) 
 
Weekly News Brief 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix B   
229 
 
 
Each publication was considered by reviewing the title and abstract and included or 
excluded from the search as determined by a set criterion.  
Criteria for exclusion into Review 
Study Design: Study duration  =>4months   
Population: Babies, Infants   
Studies written in language other than English. 
 
Criteria for inclusion into Review 
 
 
Study Design: Randomised controlled trials, intervention studies, prevalence surveys, case 
studies, systematic reviews and meta-analysis, cross-sectional observational.  
Relevant policy documents, government reports and commentary from Public Health 
Practitioners and other relevant professionals were also included.  
Population: Male/female, middle age, over 40’s, overweight, obese. 
Article Themes: Health behaviour models/theory, beliefs attitudes to health related 
behaviour, behaviour techniques,  the telephone as method to deliver health intervention, 
barriers to behaviour change, strategies for improving diet/physical activity, screening 
setting as opportunity to introduce behavior intervention, perceptions of CVD risk. 
No geographical limitations. 
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Appendix C 
The assessment of methodological quality of the studies included in the review is 
based on a check list for critical appraisal of studies. (19) 
Assessment of Methodological Quality of Studies 
Are the aims and objectives clearly defined? 
Poorly defined aims and objectives may suggest that a research question was not initially 
determined resulting in a poorly defined study. 
What are the sampling methods? 
Was the sampling strategy clearly described and justified?  
Was the sampling strategy theoretically comprehensive enough to ensure 
generalisability of the findings or were they restricted to a highly selective group of 
individuals. This is important for the validity of the findings. 
What is the justification for the sample size? 
Studies should be large enough to represent what is going on and to detect important 
effects. 
Are measurements likely to be reliable and valid? 
Studies of high quality will discuss how reliability and validity were assessed. If they have 
not been described then the reader must consider the possibility that there could be 
measurement errors and decide whether these errors could be important. How was the 
data collected? Could the evidence (physiological, biological, interview transcripts, 
recordings, documentary analysis, etc) be inspected independently by others: if relevant, 
could the process of transcription and calibration of equipment be independently 
inspected? 
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Where there any untoward events during the course of the study? 
Missing data can allow introduction of bias, and if problems occur during the course of 
the study this could lead to changes in the study design which can cause more problems 
and indicates a poor quality study. 
Do the findings fit? 
The size of each effect described in the findings is scrutinized to discover its importance. 
Careful scrutiny for evidence of bias and confounding must also be carried out. Are the 
findings plausible? Do they make biological sense do they fit with what is already known 
about the topic. How do the findings compare with other studies? The findings from a 
single publication must be considered with a balanced overview with findings from all 
other reported studies. 
Assessment of Methodological Quality of Studies 
Are the aims and objectives clearly defined? 
Poorly defined aims and objectives may suggest that a research question was not initially 
determined resulting in a poorly defined study. 
What are the sampling methods? 
Was the sampling strategy clearly described and justified?  
Was the sampling strategy theoretically comprehensive enough to ensure 
generalisability of the findings or were they restricted to a highly selective group of 
individuals. This is important for the validity of the findings. 
What is the justification for the sample size? 
Studies should be large enough to represent what is going on and to detect important 
effects. 
Are measurements likely to be reliable and valid? 
Studies of high quality will discuss how reliability and validity were assessed. If they have 
not been described then the reader must consider the possibility that there could be 
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measurement errors and decide whether these errors could be important. How was the 
data collected? Could the evidence (physiological, biological, interview transcripts, 
recordings, documentary analysis, etc) be inspected independently by others: if relevant, 
could the process of transcription and calibration of equipment be independently 
inspected? 
Where there any untoward events during the course of the study? 
Missing data can allow introduction of bias, and if problems occur during the course of 
the study this could lead to changes in the study design which can cause more problems 
and indicates a poor quality study. 
Do the findings fit? 
The size of each effect described in the findings is scrutinized to discover its importance. 
Careful scrutiny for evidence of bias and confounding must also be carried out. Are the 
findings plausible? Do they make biological sense do they fit with what is already known 
about the topic. How do the findings compare with other studies? The findings from a 
single publication must be considered with a balanced overview with findings from all 
other reported studies. 
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Appendix D 
 
THE TASCFORCE PROJECT 
Tayside Screening for risk of Cardiac Events  
Participant Information Leaflet No 1 (PIL 1 Version 6)  
Cardiovascular Risk assessment by BNP 
You have been sent this information sheet because you have expressed an interest 
in taking part in the TASCFORCE Project. We aim to enroll 5,000 Tayside and Fife 
men and women into this study. Since you are aged 40 years or over and are not 
known to have diabetes, hypertension, stroke, heart or blood vessel disease, you 
may be suitable to take part. Before you decide whether to take part, it is important 
for you to understand why this research is being done and what it will involve. Please 
take time to read the following information and discuss it with others if you wish. Ask 
us if there is anything that is not clear or if you would like more information.  
We have also attached an information leaflet on a sub-study we are carrying out; 
HEALTHFORCE 2. This is our second project looking at the best ways to deliver 
lifestyle advice. If you wish to take part and are eligible, we will be delighted to 
discuss this further with you at your TASCFORCE screening visit.  
PURPOSE OF THE TASCFORCE PROJECT 
Heart attack and stroke are still amongst the most common causes of illness and 
death in Scotland, despite major advances in preventive medicine.  National 
guidelines are in place to assess whether an individual is at risk of heart and blood 
vessel disease, and thus requires treatment.  We believe, however, that some 
people may still be at risk, but that the current methods of assessments fail to detect 
this. The project has been designed to identify these people, to screen for early signs 
of heart disease and to find out how effective new screening techniques are in 
predicting the risk of heart disease so that it can be prevented or treated at an early 
stage. 
 
The project will be carried forward in two stages:  
 
1. Assessment of cardiovascular (heart and blood vessel) risk. 
 
2. Screening for early signs of cardiovascular disease by Magnetic Resonance 
Imaging (MRI, heart and blood vessel scan) in those found to be at risk. 
 
At the first stage of the project, we wish to identify those who may be at, as yet 
undetected, cardiovascular risk by measuring a blood chemical called BNP. The 
level of BNP in the blood shows how well the heart is working and helps us to assess 
risk.  This information sheet tells you about this first stage of the TASCFORCE 
project.  If you are selected to continue to a further stage a separate information 
sheet and explanation will be given at the time before asking for your consent for 
further participation.  
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How will you know that I may be at risk? 
Your blood pressure, weight, height, and levels of blood glucose and cholesterol will 
be measured. These measurements, along with whether you smoke and have a 
family history of heart or stroke disease will be used to calculate your risk of 
developing heart disease. If you are found to be at risk using the standard methods 
of assessment, we will advise you and discuss what next to do to ensure you receive 
treatment. If you do not seem to be at risk using standard methods, then we will take 
a blood sample to measure a substance called BNP which measures risk.   
What will I be required to do? 
You will be asked to attend for one visit to Ninewells Hospital, or to your GP’s  
surgery, or other suitable place. You will have the opportunity to discuss the study 
and to receive answers to any questions you may have before being asked to sign a 
form consenting to take part. This visit is to find out if you are suitable to take part in 
the study and to assess your risk of developing heart disease. 
The study nurse will: 
 Ask you about your present and past illnesses and what medicines you are 
taking.  
 Ask you whether you smoke and whether any members of your family have had 
heart disease. 
 Carry out an ECG (this is a tracing of your heart activity). 
 Measure your blood pressure, weight, height and waist circumference. 
 Take some blood (20 ml - about 4 teaspoons) for various tests. This blood will 
be used to check your blood glucose and cholesterol level, and your level of 
BNP. These tests will be done right away at the bedside.  The rest of the blood 
will be stored for future research into heart and blood vessel disease as part of a 
Bio-bank in the Institute of Cardiovascular Research. 
 Give you advice and leaflets on how to change your lifestyle to reduce your 
risks. 
 Take a separate blood sample 9ml for genetic study (optional) if you agree to it.   
A separate information sheet is attached for the genetic sub-study. 
 
If you need treatment under the current recommendations, we will advise you of this, 
and arrange for you to see your General Practitioner. 
 
If your level of BNP is raised you will be offered a MRI scan of your heart and blood 
vessels.  This will be explained to you at the time and a separate information sheet 
will be given to you before asking for your consent. If your level of BNP is low then 
you will be informed, your participation will be gratefully acknowledged but will not be 
required beyond this first visit. 
 
We will ask your permission to allow us to receive from or pass on any relevant 
information to your GP for the duration of the study and for a period up to twenty 
years beyond the study end. We will ask your permission to register your name with 
the Scottish Office so that we may receive information on any hospital admissions 
you may have and their diagnoses and to be notified in the unlikely event of your 
death for a period of up to 20 years.  We would also ask you to allow us to contact 
you at 2, 5, and 10 years after the study ends to find out if you have had any health 
problems relating to your heart or blood vessels. This will allow us to assess how 
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effective our screening techniques are in predicting and in preventing heart and 
blood vessel disease and help increase our understanding of these diseases. 
Will I be given the results of any tests that you do? 
If you have given a blood sample for DNA, neither you nor your GP will be given the 
result. You will be informed of your blood pressure, cholesterol levels, and whether 
your BNP is high or low. 
 
What are the potential advantages of taking part in the study? 
You will have the opportunity to reduce your cardiovascular risk by receiving lifestyle 
management advice and leaflets on any modifiable risks that you may have. If from 
any of the tests that we do, we feel you should have further investigation, the results 
will be sent to your GP so you can be treated according to current clinical practice. 
There is no guaranteed benefit from taking part in the study but your participation 
contributes to medical science and possible future benefits. 
 
What are the potential disadvantages of taking part in the study? 
Blood sampling: Taking blood can be briefly uncomfortable and can on occasion 
cause some bruising. 
 
How will my information be stored? 
Any information we obtain from you and your health records will remain strictly 
confidential.  Information will be stored securely under conditions in keeping with the 
Data Protection Act 1998. To ensure confidentiality we will allocate a code (not your 
name) to your records and to your blood samples. We will keep your personal details 
(name and address) separate from the information collected but linked by your code.  
Only individuals directly involved with the study will have access to this information. 
Reports or publications of research findings will not contain information through 
which you can be identified. We may be required to allow regulatory authorities, who 
ensure that research is being carried out in the correct manner, to inspect your 
records but they will not have access to your name or address.   
 
What if anything goes wrong? 
Indemnity is provided by the NHS. The University of Dundee covers any non-
negligent harm that occurs due to the design of the clinical trial.  Any harm that may 
occur by the use of medication is covered by the manufacturer under the Consumer 
Protection Act. 
 
What are my rights? 
Participation in this study is voluntary and you are free to withdraw from the study at 
any time without having to give a reason. This will not affect your medical care.  If 
you decide to take part you will be given this Information Sheet to keep along with a 
copy of the Consent Form that you would be required to sign. If you should ever 
have any concerns about this study or the way it has been carried out, you should 
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contact: 
Dr Roberta Littleford, Trial Manager    01382 633963 
Professor Jill JF Belch, Principal Investigator 01382 632457 
The Tayside Committee on Medical Research Ethics has examined this proposal 
and has raised no objections from the point of view of medical ethics. 
Thank you for taking time to read this information sheet. 
One of the study nurses will telephone you in the next week to answer any questions 
that you may have and to make an appointment for you if you decide to take part. 
Roberta Littleford  
Trial Manager  
The TASCFORCE Project 
The Institute of Cardiovascular Research 
Vascular & Inflammatory Diseases Unit 
Ninewells Hospital & Medical School, Dundee DD1 9SY 
Telephone 01382 633963 
E- mail: tascforce@dundee.ac.uk 
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Appendix E 
 
Patient Information Leaflet for HEALTHFORCE 2 Study 
Part of the TASCFORCE PROJECT 
 
 
 
This study is being undertaken in part fulfillment of an educational project. My name 
is Janice Rowland and I am a Clinical Research Nurse on the TASCFORCE Project 
at the University of Dundee. I am required to undertake a project as part of my thesis 
and invite you to take part in the following study. However, before you decide to do 
so, I need to be sure that you understand firstly why I am doing it and secondly what 
it would involve if you agreed to take part. I am therefore providing you with the 
following information. Please read it carefully and be sure to ask any questions you 
might have and, if you want, discuss it with others including friends and family. I will 
do my best to explain the project to you and provide you with any further information 
you may ask now or later.  
 
 
What is the purpose of HEALTHFORCE 2?  
 
In 2009, our first HEALTHFORCE project looked at how useful it was to use multiple 
one to one contacts to implement a lifestyle intervention programme, helping people 
to meet their own weight loss, diet and exercise goals. The vast majority1 of the 
participants’ goals were achieved but the costs may prove to be too expensive where 
there are limited funds available.  
The participants in the first HEALTHFORCE project had also participated in the 
TASCFORCE project.   
TASCFORCE has been screening people for the past 3 years. In that time we have 
heard from previous study participants that as a result of the information they were 
given at their screening visit they had decided to make some changes to their 
lifestyle i.e.; stopped smoking, weight loss or taken up more exercise. 
 
Therefore, HEALTHFORCE 2 is designed to compare the methods used in 
TASCFORCE with the new HEALTHFORCE 2 study.  
 
 
Who will be asked to take part in the HEALTHFORCE 2 study? 
 
We know that increased weight can result in a person being at higher risk for 
developing heart disease. Increasing weight can also lead to other health problems 
such as type 2diabetes and high blood pressure. The Body Mass Index (BMI) is a 
number calculated from an individual’s weight and height that is used to determine 
whether a person is within, or outside of, a normal weight range. If your BMI is found 
to be 25kg/m2 or more then you will be invited to take part in the HEALTHFORCE 2 
Study. 
 
What will happen if I take part in the HEALTHFORCE 2 Study? 
 
This new design will mean half the people who take part will be given lifestyle advice 
alone and the other half will be given additional support and information over a 
period of four months. Both groups return for a mini-screening visit after 4 months. 
We hope to recruit 264 people onto this study.   
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If you are eligible and decide to take part in this study your allocation to either group 
will be completely random. Just like throwing a dice. 
 
On your first TASCFORCE Visit you will be asked to give written consent for both the 
TASCFORCE Project and the HEALTHFORCE 2 study. Your BMI will be calculated 
during the screening visit and it will be at that point you will know if you are eligible to 
take part. No additional tests are carried out at this visit if you choose to take part.  
 
If you do take part, two to three weeks after your TASCFORCE screening visit you 
will be sent a questionnaire which is in three sections, which asks you about your 
general health, current eating habits and exercise patterns. When you return your 
questionnaire, you will be randomly allocated to either of the two groups.  
 
From this point in the study I will not know your group allocation, this will allow me to 
analyze the study’s results without prior knowledge of which group you or the other 
participants are in. The researchers involved in the first HEALTHFORCE project will 
be involved in this part of the study. Therefore, the letters you will receive will be 
from Dr Angela Craigie and the telephone calls will be from one of Dr Craigie’s 
trained lifestyle counsellors.  
 
If you are allocated to Group 1, you will receive a letter that will inform you that we 
will contact you again in four months to arrange your final study assessment at the 
Clinical Research Centre at Ninewells Hospital.                                              
 
If you are allocated to Group 2 you will be informed that you will receive a call from 
your lifestyle counsellor within a week. During this call you can establish a 
convenient schedule for your other calls. The letter will also advise you of the 
information packs and the items that will be enclosed that may help you achieve your 
goals. The first pack will include information on physical activity and a pedometer (a 
small gadget that slips onto your waistband that counts the number of steps you take 
each day). Physical activity will be the first topic discussed during your call with your 
lifestyle counsellors.    
 
One week before your next three scheduled calls you will receive a pack, the 
contents of which will be the topic for your conversation with your lifestyle 
counsellors. Over the next three months you will receive information on fruit and 
vegetables, weight loss and ways to avoid weight gain. With these packs you will 
receive an individual vegetable steamer, apple corer/slicer, waist measuring tape 
and an alcohol and calorie counter wheel.  
 
 
After four months both groups will receive a letter to attend your final assessment. 
Included, will be three questionnaires, the same as you have just completed. We will 
ask you to return them prior to your appointment date. This visit should take 
approximately 30 to 40 minutes and will involve you having a blood sample taken 
(4mls, less than a teaspoon) to measure your cholesterol and blood glucose levels, 
and we will also check your blood pressure. We will take your weight, height and 
waist measurements and calculate your body mass index (BMI). This will enable us 
to assess your weight loss and cardiovascular risk compared to the results from your 
first visit. You will be given these results at the visit, and given the opportunity to 
discuss them with a member of the research team. 
 
The visits will take place in the Clinical Research Centre at Ninewells Hospital, we 
will give you directions before your visit.  
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We will also give both groups simple questionnaires to complete which will enable us 
to compare both group’s thoughts and feelings towards their health, diet exercise 
and risk of developing heart disease.  
 
Do I have to take part? 
 
No. It is up to you whether you take part in the HEALTHFORCE 2 study. Whether 
you choose to or not will not affect you taking part in the main TASCFORCE study. 
 
What are the Disadvantages of taking part?  
 
The study does potentially involve you giving up some of your free time to fill in a few 
questionnaires, post them back, read the information packs and take four calls from 
your lifestyle counsellor. At the four month follow visit at Ninewells Hospital up a 
small sample of blood will be taken (less than a teaspoon) to measure your 
cholesterol and blood sugar levels.  
 
What are the Advantages of Taking Part? 
 
You will have the opportunity to reduce your cardiovascular risk by receiving lifestyle 
management advice if you take part in the main TASCFORCE screening project. In 
addition to this if you are asked to take part in the telephone follow-up phase you will 
receive continued support and advice on how to reduce weight and increase you 
physical activity levels. You will also have the benefit of seeing for yourself if you 
have made any changes to your cardiovascular risk in a four month period. There is 
no guarantee that you will benefit from taking part in the study but your participation 
contributes to medical science and possible future benefits.  
 
How will my information be stored? 
 
Any information we obtain from you and your health records will remain strictly 
confidential.  Information will be stored securely under conditions in keeping with the 
Data Protection Act 1998. To ensure confidentiality we will allocate a code (not your 
name) to your records and to your blood samples. We will keep your personal details 
(name and address) separate from the information collected but linked by your code.  
Only individuals directly involved with the study will have access to this information. 
Reports or publications of research findings will not contain information through 
which you can be identified. We may be required to allow regulatory authorities, who 
ensure that research is being carried out in the correct manner, to inspect your 
records but they will not have access to your name or address.   
 
What if anything goes wrong? 
 
Indemnity is provided by the NHS. The University of Dundee covers any non-
negligent harm that occurs due to the design of the clinical trial.  Any harm that may 
occur by the use of medication is covered by the manufacturer under the Consumer 
Protection Act. 
 
What are my rights? 
 
Participation in this study is voluntary and you are free to withdraw from the study at 
any time without having to give a reason. This will not affect your medical care.  If 
you decide to take part you will be given this Information leaflet to keep along with a 
copy of the Consent Form that you would be required to sign. If you should ever 
have any concerns about this study or the way it has been carried out, you should 
contact: 
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Dr Roberta Littleford, Trial Manager     01382 633963 
Professor Jill JF Belch, Principal Investigator  01382 632457 
 
The Tayside Committee on Medical Research Ethics has examined this proposal 
and has raised no objections from the point of view of medical ethics. 
 
Thank you for taking time to read this information leaflet.  
 
 
 
Janice Rowland   
Clinical Research Nurse  
The TASCFORCE Project 
The Institute of Cardiovascular Research 
Vascular & Inflammatory Diseases Unit 
Ninewells Hospital & Medical School, Dundee DD1 9SY 
Telephone 01382 633963 
e-mail: tascforce@dundee.ac.uk 
 
 
 
1.  Craigie A et al. Healthforce: A feasibility study of a lifestyle management programme for 
cardiovascular risk screening participants. Proceedings of the Nutrition Society (in press). 
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Appendix F 
 
Risk perception Questionnaire 
 
 
 
Risk Perception Question (pre-screening) 
 
Please take the time to complete this question you will be asked the 
same question at the end of the Screening Visit. 
 
 
 
Compared with a person of your own age and sex, how would you rate 
your risk of having a heart attack or stroke in the next 10 years? 
 
Please tick one of the boxes below: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking the time to complete this questionnaire. 
 
 
 
 
 
 
 
Much lower than average 
 
Lower than average 
 
Average 
 
Higher than average 
 
Much higher than average 
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Appendix G 
 
 
 
Risk Perception Question (post-screening) 
 
 
We hope you found your screening informative, and are interested to know if there 
has been any change in how you rate your level of risk since before the screening. 
 
 
 
 
Compared with a person of your own age and sex, how would you rate your risk of 
having a heart attack or stroke in the next 10 years? 
 
Please tick one of the boxes below: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking the time to complete this questionnaire. 
 
 
 
 
 
 
Much lower than average 
 
Lower than average 
 
Average 
 
Higher than average 
 
Much higher than average 
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Appendix H 
 
     
 
YOUR GENERAL HEALTH 
 
 
1. In general, would you say your health is? 
 
Excellent        Very good       Good        Fair        Poor    
   
2.   The following questions are about activities you might do during a typical 
day. Does your health now limit you in these activities? If so, how much? 
 
 Yes, limited 
a lot 
Yes, limited 
a little 
No, not 
limited at all 
a. Moderate activities, such as 
moving a table, pushing a 
vacuum cleaner, bowling, or 
playing golf   
   
b. Climbing several flights of stairs    
 
 
3. During the PAST 4 WEEKS, how much of the time have you had any of the     
following problems with your work or other regular daily activities as a 
result of your PHYSICAL HEALTH? 
 
 All of the 
time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
a. Accomplished less 
than you would like
   
     
b. Were limited in the 
kind of work or 
other activities 
     
 
 
4. During the PAST 4 WEEKS, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a 
result of any EMOTIONAL PROBLEMS (such as feeling depressed or 
anxious)? 
 
 All of the 
time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
a. Accomplished less 
than you would like
   
     
b.   Did work or 
activities less 
carefully than usual 
     
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5. During the PAST 4 WEEKS, how much did PAIN interfere with your normal 
work (including both work outside the home and housework)? 
 
 Not at all      A little bit       Moderately   Quite a bit         Extremely   
 
 
6.   These questions are about how you feel and how things have been with 
you DURING THE PAST 4 WEEKS.  For each question, please give the 
one answer that comes closest to the way you have been feeling.  
 
 How much of the time during the PAST 4 WEEKS... 
 
   All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
a. Have you felt calm 
and peaceful? 
     
b. Did you have a lot 
of energy? 
     
c. Have you felt 
downhearted and 
depressed? 
     
 
 
7.   During the PAST 4 WEEKS, how much of the time has your PHYSICAL 
HEALTH OR EMOTIONAL PROBLEMS interfered with your social activities 
(like visiting friends, relatives, etc.)? 
 
All of the 
time 
Most of the 
time 
Some of the 
time 
A little of the 
time 
None of the 
time 
     
 
 
8. Thinking back to when you were 21 years old, how does your current 
weight compare to what you weighed then? 
 
I weigh 
less now 
I weigh about the 
same now 
I weigh more 
now  
Don’t know /  
not sure 
    
 
 
9. Have you made any previous attempts at weight loss? Yes  No  
 
If yes: 
Have you followed any particular weight loss programmes? If so please list: 
_____________________________________________________________ 
_____________________________________________________________ 
 Were you successful with any of these?  Yes   No  
If successful, please specify which weight loss programme you were following? 
_____________________________________________________________ 
_____________________________________________________________ 
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YOUR UNDERSTANDING OF CARDIOVASCULAR/STROKE RISK FACTORS 
 
 
1.  What do YOU PERSONALLY think are the main factors that might increase or 
decrease a person’s chance of developing cardiovascular disease or a stroke?  
(list as many as you believe do increase or reduce risk of the disease) 
 
INCREASE RISK     DECREASE RISK 
 
……………………………………………….  ………………………………………………. 
 
……………………………………………….  ………………………………………………. 
 
……………………………………………….  ………………………………………………. 
 
……………………………………………….  ………………………………………………. 
 
……………………………………………….  ………………………………………………. 
 
……………………………………………….  ………………………………………………. 
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Have you eaten any of the following foods in the last 24 hours? 
 
 
 
PLEASE “X” THE NUMBER OF PORTIONS OF FOODS EATEN FOR EVERY ROW 
FOR EXAMPLE: 
 
 
NUMBER OF PORTIONS 
 0 1 2 3 4+ 
Fruit as a dessert       
 
 
 
 
NUMBER OF PORTIONS 
 0 1 2 3 4+ 
Breakfast cereal      
 Fruit for breakfast, e.g. on cereal      
Crisps      
Fruit as a between meal snack      
A glass of pure, unsweetened fruit juice 
(not squashes or fruit drink) 
     
Fruit as a starter to a meal      
A baked potato      
A bowlful of home-made style vegetable 
soup 
     
Portions of vegetables with main meals 
(include baked beans and pulses as 
vegetables but not potatoes) 
     
Any type of meat      
A vegetable based meal      
Any type of fish      
A bowlful of salad      
Fruit as a dessert      
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Your Eating Habits: 
Please answer the following questions about your diet by ticking the box 
which best describes your food intake. 
 
About how many times a week do you eat a serving of the following foods? 
 Less 
than 1 
a week 
1-2 a 
week 
3-5 a 
week 
6 or 
more a 
week 
Cheese (any except cottage)     
Beefburgers or sausages     
Beef, pork or lamb (if vegetarian include nuts)     
Bacon, meat pies, processed meat (including 
ham) 
    
 
 
About how many times a week do you eat a serving of the following foods? 
 Less than 
1 a week 
1-2 a 
week 
3-5 a 
week 
6 or more 
a week 
Chicken or turkey     
Fish (NOT fried or in batter)     
Any fried food; fried fish, chips, cooked 
breakfast, samosas 
    
Cakes, pies, puddings, pastries     
Biscuits, chocolate, or crisps     
 
 
How much milk, and of what kind, do you yourself typically use in a day e.g. in 
cereal, tea, coffee, etc?   
 Less than 
quarter pint 
About a 
quarter pint 
About a 
half pint 
1 pint 
or more 
Full cream      
Semi skimmed     
1% milk     
Skimmed/None  
 
 
 
 
 
 
 
score 
  
score 
  
score 
  
1 
2 
3 
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What sort of fat do you use? (choose one on each line) 
 Butter, 
dripping, 
lard, solid 
cooking fat 
(White cap, 
Cookeen) 
Hard or soft 
margarine, 
White Flora, 
Dairy blends 
(Clover, Willow, 
Golden Crown), 
half fat butter 
Polyunsaturated/ 
sunflower 
margarine or low 
fat spread (Gold 
Outline, Shape, 
Flora Extra Light, 
Delight) 
Pure 
vegetable 
oil (e.g. 
sunflower, 
soya, corn, 
peanut, 
olive) 
No fat 
used 
On bread and 
vegetables? 
     
For Frying?      
For baking or 
cooking? 
     
About how many times a week do you have a bowl of breakfast cereal or porridge? What kind 
do you have most often? (choose only one if possible) 
 Less than 1 
a week 
1-2 a week 3-5 a week 6 or more 
a week 
Sugar type: Frosties, Coco 
Pops, Ricicles, Sugar Puffs 
    
Porridge or Ready Brek 
Wheat type: 
Shredded Wheat, Weetabix, 
Puffed Wheat, Fruit ‘n Fibre, 
Nutri grain 
Muesli type: Alpen, 
Jordan’s 
    
Bran type: All Bran, Bran 
Flakes, Sultana Bran, 
    
Total score   
About how many pats or rounded teaspoons of margarine, butter or other spread do you 
usually use in a day, for example on bread, sandwiches, toast, potatoes, or vegetables? 
(enter number in box) 
Butter or margarine:  
Low fat spread:  
5 
6 
4 
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On a typical day, about how many pieces of bread or rolls do you eat?  
Are they usually white, brown or wholemeal? (choose only one if possible) 
 Less than 1 a 
day 
1-2 a day 3-4 a day 5 or more a 
day 
White bread     
Brown or granary 
bread 
    
Wholemeal bread or 
2 slices crispbread 
    
About how many times a week do you eat a serving of the following foods? (choose 
only one if possible) 
 Less than 
1 a week 
1-2 a week 3-5 a week 6 or more a week 
Pasta or rice     
Potatoes     
Peas     
Beans (baked, tinned, 
dried) or lentils 
    
Other vegetables not 
already included (any) 
    
Fruit (fresh, frozen or 
canned) 
    
Total 
score  
  
score 
  
7 
8 
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10.  How many rounded teaspoons of sugar do you have on a usual day e.g. in 
tea or coffee or on cereals?                               
 Rounded teaspoons 
 
11. How often do you have a drink containing alcohol? 
 
 
Never        
    
  Monthly or less  
    
  2 to 4 times a month  
 
  2 to 3 times a week  
 
  4 or more times a week  
    
12. How many drinks containing alcohol do you have on a typical day when you 
are drinking? 
 
  1 or 2 
 
 3 or 4 
 
 5 or 6 
 
 7 to 9  
 
 10 or more  
 
 
 13. Which of the following describes your smoking status? 
 
  Current Smoker How many cigarettes would you smoke per day    
 
  Ex Smoker 
 
  Non Smoker 
 
 
Can you tell me how often, on average, you drink sugary drinks?  
(note – this does NOT include diet or low-calorie drinks or fresh fruit juice)   
6 or more  
a day 
4 / 5 
times a 
day 
2 / 3 
times 
a day 
Once 
a day 
5 / 6 
times a 
week 
2 - 4 
times a 
week 
Once 
a 
week 
1 - 3 
times a 
month 
Less 
often / 
never 
         
9. 
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The following questions ask your views about diet: 
 
 
1 Are you currently thinking about eating a healthier diet in the future? 
 
  Yes  No  If no, go to question 3 
 
 
 
2a   If Yes – When do you plan to begin eating a healthier diet?   
  
Within the 
next month 
Within the 
next 6 months 
Yet to decide 
   
 
 
 
2b    How confident are you that you will stick to this plan? 
 
Very confident Somewhat 
confident 
Mildly 
confident 
Not at all 
confident 
    
 
 
 
3 Have you ever made a deliberate effort to improve your diet?   Yes   No   
 
 
 
4a    If Yes – Are you still eating a healthy diet? Yes  No   
 
 
 
4b   If Yes – Have you been able to maintain eating a healthy diet for 6 months or 
more? Yes   No   
 
 
 
 
 
 
END OF THE QUESTIONNAIRE 
 
Thank you for your time and effort 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (IPAQ) 
 
We are interested in finding out about the kinds of physical activities that people do 
as part of their everyday lives.  The questions will ask you about the time you spent 
being physically active in the last 7 days.  
 
Please answer each question even if you do not consider yourself to be an active 
person.  Please think about the activities you do at work, as part of your housework, 
gardening, getting from place to place, and in your spare time for recreation, 
exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  
 
Vigorous physical activities refer to activities that take hard physical effort and 
make you breathe much harder than normal.  Think only about those physical 
activities that you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on 
one of those days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
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Think about all the moderate activities that you did in the last 7 days.  
 
Moderate activities refer to activities that take moderate physical effort and make 
you breathe somewhat harder than normal.  Think only about those physical 
activities that you did for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or  tennis?  Do 
not include walking. 
 
_____ days per week 
 
   No moderate physical activities  Skip to question 5 
 
 
4. How much time did you usually spend doing moderate physical activities on 
one of those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
 
Think about the time you spent walking in the last 7 days.  This includes at work 
and at home, walking to travel from place to place, and any other walking that you 
might do solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 
minutes at a time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
 
_____ minutes per day  
 Don’t know/Not sure 
   
 
254 
 
 
 
The last question is about the time you spent sitting on weekdays during the last 7 
days.  Include time spent at work, at home, while doing course work and during 
leisure time.  This may include time spent sitting at a desk, visiting friends, reading, 
or sitting or lying down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week 
day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
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Please answer the following questions about increasing the amount of 
physical activity that you do:  
 
 
 
 
1  Are you currently thinking about increasing the amount of physical activity that 
you do?  Yes  No  If no, go to question 3 
 
 
 
2a   If Yes – When do you plan to begin doing more physical activity?   
  
Within the 
next month 
Within the 
next 6 months 
Yet to decide 
   
 
 
 
2b    How confident are you that you will stick to this plan? 
 
Very confident Somewhat 
confident 
Mildly 
confident 
Not at all 
confident 
    
 
 
 
3 Have you ever made a deliberate effort to increase the amount of physical 
activity that you do? Yes  No   
 
 
 
4a    If Yes – Are you still doing more physical activity? Yes  No   
 
 
 
4b   If Yes – Have you been able to maintain this increased amount of physical 
activity for 6 months or more? Yes   No   
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Appendix L 
 
Demogaphic Questionnaire 
 
Thank you for taking part in this study.  The following questionnaire asks some 
questions about you.  There are no right and wrong answers and the answers you 
give will be kept completely confidential.  If there are any questions you would 
prefer not to answer, please leave them blank.  Otherwise please complete the 
questionnaire as fully and honestly as you can (mark X in the box indicating your 
response).   
 
 
1. How would you describe your marital status? 
 
Single 
 
Married/cohabiting 
 
Widowed/separated/divorced 
 
 
 
2. Which of the following ethnic groups do you fall into?  
 
White       Chinese  
 
Mixed       Black or Black British 
 
Asian or Asian British     Other ethnic group   
  
Do not wish to complete     
      
        
3. Educational Attainment 
 
What is the highest educational qualification you have obtained? 
 
Primary school 
 
Secondary school        
 
Other professional/ technical qualification or diploma after leaving school   
 
University degree 
 
Post-graduate degree (eg Masters or PhD)     
 
 
4. How would you describe your employment status? (Please tick only one)             
 
Retired       Unemployed    
 
257 
 
Employed full-time    Employed part-time   
Student full-time    Student part-time     
Other (please specify)………………………………………………………………………………………………  
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Appendix M 
 
 
E-mail: a.craigie@dundee.ac.uk 
Tel: 01382 496788 
 
 
 
Date 
 
RE: HEALTHFORCE 2 STUDY 
 
Dear 
Thank you for completing and returning the questionnaires sent to you as part of the HEALTHFORCE 
2 Study. 
You have now been randomly selected to GROUP 2 in the study. 
This means that in four months time you will receive your final assessment appointment letter. 
Included, will be three questionnaires, the same as you have just completed. We will ask you to 
return them prior to your appointment date. This visit should take approximately 30 to 40 minutes 
and will involve you having a blood sample taken to measure your cholesterol and blood glucose 
levels, and check your blood pressure. We will take your weight, height and waist measurements and 
calculate your body mass index (BMI). This will enable us to assess your weight loss and 
cardiovascular risk compared to the results from your first visit. You will be given these results at the 
visit, and given the opportunity to discuss them with a member of the research team. 
If you have any questions about TASCFORCE or HEALTHFORCE 2 please contact Dr Roberta 
Littleford, our trial manager on 01382 633963. 
Thank you for your assistance in this part of the study, your participation is valuable and will help us 
with our research. 
Yours sincerely 
 
 
 
Dr Angela Craigie 
Centre for Public Health Nutrition Research 
Division of Clinical & Population Sciences & Education (CPSE) 
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Appendix N         
 
 
 
E-mail: 
a.craigie@dundee.ac.uk 
Tel: 01382 496788 
Date 
RE: HEALTHFORCE 2 STUDY 
 
Dear 
Thank you for completing and returning the questionnaires sent to you as part of the HEALTHFORCE 
2 Study. 
You have now been randomly selected to GROUP 1 in the study. 
This means that you will receive a call from the research team within the next week. This will be the 
first of your four calls. At this time we will establish a convenient schedule for your other calls.  
Each month for the next three months you will receive lifestyle information packs and a few items 
that may help you achieve your goals. This will include; a pedometer (a small gadget that slips onto 
your waistband that counts the number of steps you take each day), an individual vegetable steamer, 
apple corer/slicer, waist measuring tape and an alcohol and calorie counter wheel. One week before 
your scheduled call you will receive a pack, the contents of which will be the topic for your 
conversation with your lifestyle counsellor at the next call. A diagram below illustrates this process, 
you could use this to note down the dates and time of the scheduled calls.    
Your first information pack is enclosed with a pedometer (with instructions). The topic this month is 
physical activity. If you require any additional help with the information please do not hesitate to 
contact us.  
In four months time you will receive your final assessment appointment letter. Included, will be three 
questionnaires, the same as you have just completed. We will ask you to return them prior to your 
appointment date. This visit should take approximately 30 to 40 minutes and will involve you having a 
blood sample taken to measure your cholesterol and blood glucose levels, and check your blood 
pressure. We will take your weight, height and waist measurements and calculate your body mass 
index (BMI). This will enable us to assess your weight loss and cardiovascular risk compared to the 
results from your first visit. You will be given these results at the visit, and given the opportunity to 
discuss them with a member of the research team. 
This will enable us to assess your weight loss and cardiovascular risk compared to the results from 
your first visit. You will be given these results at the visit, and given the opportunity to discuss them 
with a member of the research team. 
If you have any questions about TASCFORCE or HEALTHFORCE 2 please contact Dr Roberta 
Littleford, our trial manager on 01382 633963. 
Thank you for your assistance in this part of the study, your participation is valuable and will help us 
with our research. 
Yours sincerely 
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Dr Angela Craigie 
Centre for Public Health Nutrition Research 
Division of Clinical & Population Sciences & Education (CPSE) 
 
 
Diagram illustration information and call scheduling for HEALTHFORCE 2.   
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Appendix O 
 
Alere Cholestech LDX® System 
 
Multi Analyser Kit 
 
 
Appendix O 
 
 
 
 
 
 
 
 
 
eSecure - Aneroid Sphygmomanometer Blood Pressure Monitor Meter  
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Seca Leicester Stadiometer 
 
Seca 703 Wireless 360 High Capacity Digital Medical Scale   
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Appendix P 
 
    E-mail: a.craigie@dundee.ac.uk 
Tel: 01382 496788 
 
 
 
 
 
Date 
 
 
 
RE: HEALTHFORCE 2 STUDY 
 
Dear 
 
We hope you found your first HEALTHFORCE 2 consultation useful, and have had 
some success in making some changes to your activity levels.  As your next 
consultation is due shortly I am writing to provide you with your second information 
pack.  We hope this will be useful in helping you to think about any improvements 
you could make to your diet and monitor your progress.  Your lifestyle counsellor will 
refer to these during their telephone consultation so it would be useful if you could 
have these in front of you during the call. 
 
If you have any questions relating your consultations you may contact your lifestyle 
counsellor on 01382 496788.  Alternatively, if you have any questions about 
TASCFORCE or HEALTHFORCE 2 please contact Dr Roberta Littleford, our trial 
manager on 01382 633963. 
 
Yours sincerely 
 
 
 
 
 
 
 
 
 
 
265 
 
 
 
 
        E-mail: a.craigie@dundee.ac.uk 
Tel: 01382 496788 
Date 
 
 
 
RE: HEALTHFORCE 2 STUDY 
 
Dear 
 
We hope you found your second HEALTHFORCE 2 consultation useful, and have 
been successful in making some changes to your diet and activity levels.  As with my 
previous letter, I am writing to provide you with your next information pack.  Your 
next consultation is scheduled to take place shortly and your lifestyle counsellor will 
refer to these during the telephone call.  We hope the materials provided will helping 
you to keep you motivated to continue with the changes you have made so far, and 
to think about any further changes you could make to reduce your weight. 
 
If you have any questions relating your consultations you may contact your lifestyle 
counsellor on 01382 496788.  Alternatively, if you have any questions about 
TASCFORCE or HEALTHFORCE 2 overall please contact Dr Roberta Littleford, our 
trial manager on 01382 633963. 
 
 
Yours sincerely 
 
 
 
 
 
 
Dr Angela Craigie 
Centre for Public Health Nutrition Research 
Division of Clinical & Population Sciences & Education (CPSE) 
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E-mail: a.craigie@dundee.ac.uk 
Tel: 01382 496788 
Date 
 
 
RE: HEALTHFORCE 2 STUDY 
 
Dear 
 
We hope you found your third HEALTHFORCE 2 consultation useful, and have 
managed to successfully lose some more weight by continuing with the changes to 
your diet and activity levels.  We realise this isn’t always easy, but your lifestyle 
counsellor is on hand to support you with this.  Your next consultation is scheduled 
to take place shortly and I enclosed your last information pack.  It would be useful if 
you could have these at hand during the consultation. 
 
We hope the materials provided will help to you to keep you motivated to continue 
with the lifestyle changes you have made so far - not just over the next month, but 
also in the future.  Remember, if you have any questions relating your consultations 
you may contact your lifestyle counsellor on 01382 496788. 
 
Your final follow-up visit to Ninewells Hospital will be due around 4 weeks after this 
consultation.  Before this consultation you will be contacted to confirm your 
appointment.  You will also be posted 3 short questionnaires to complete before this 
appointment.  In the meantime, if you have any questions about TASCFORCE or 
HEALTHFORCE 2 overall please contact Dr Roberta Littleford, our trial manager on 
01382 633963. 
Yours sincerely 
 
 
 
Dr Angela Craigie 
Centre for Public Health Nutrition Research 
Division of Clinical & Population Sciences & Education (CPSE) 
 
267 
 
Appendix Q 
 
  
Telephone 
consultation 1 
Stage 1 
Telephone 
consultation 2 
Stage 2 
Telephone 
consultation 3 
Stage 3 
Telephone  
consultation 4 
Stage 4 
      
  Time plan (Weeks 0-4) (Weeks 4-8) (Weeks 8-12) (Weeks 12-16) 
  
Focus 
Physical Activity 
(PA) 
Fruit and 
Vegetable (F&V) & 
PA 
Weight loss, PA, 
F&V 
Relapse prevention, PA, 
F&V 
S
tu
d
y
 C
h
a
ra
c
te
ri
s
ti
c
s
 
Aim Minimum increase of at least 30 minutes per week (towards achieving current target for 
moderate exercise of 30 mins on most days of the w eek) 
 
Minimum increase of at least 1 portion per day  
(towards achieving current target of 5 portions of fruit and vegetables 
per day) 
  Weight loss of -7% from baseline 
  
   
Avoidance of weight 
regain 
Contact 
        
Face to Face 
One to one 
telephone 
counselling 
One to one 
telephone 
counselling 
One to one telephone 
counselling 
One to one telephone 
counselling 
Plus Multiple 
Contacts 
Optional telephone 
support 
Optional telephone 
support 
Optional telephone 
support 
Optional telephone 
support 
Counselling Session 
Duration 
30 minutes 30 minutes 30 minutes 30 minutes 
Who Delivers 
Trained staff as 
appropriate 
Trained staff as 
appropriate 
Trained staff as 
appropriate 
Trained staff as 
appropriate 
Content         
Motivational 
Approaches  
a) Goal Setting   b) 
Tools / gift 
- Personalised PA 
goal 1  
- Pedometer 
- Personalised F&V 
intake goal and 
PA goal 2  
- Apple corer / 
vegetable 
steamer 
- Personalised body 
shape/w eight 
maintenance goal, PA 
goal 3 and re-emphasis 
of F&V goal  
- Tape measure 
- Personalised body 
shape/w eight loss goal 
w ith limits for w eight 
regain, PA goal 4 and 
re-emphasis of F&V 
goal  
 - Energy content of 
Alcohol w heel 
Behavioural 
Approaches 
- Walking Record - 5 a day food diary - Weight log book - ‘Ten top tips’ progress 
chart 
- Feedback at 
Telephone call 2 
- Feedback at 
Telephone call 3 
- Feedback at Telephone 
call 4 
- Feedback at follow -up 
visit 
Educational 
Approaches 
- Images of impact 
of w eight gain/loss 
on CVD risk 
- F&V literature 
(including 
recipes) 
- Healthy w eight literature 
e.g. portion   control, 
snacking 
- Ten top tips for a 
healthy w eight leaflet 
- PA literature     
 Suggested group 
activities 
(as available from 
existing community 
groups) 
Physical activity 
groups e.g. w alking, 
keep f it, badminton 
Healthy eating 
groups e.g. cooking 
skills 
Weight reduction groups Weight reduction groups 
Psycho-social 
Aspects 
        
Behaviour theory Emphasis on self 
eff icacy  stages of 
change 
Emphasis on self 
eff icacy  stages of 
change 
Emphasis on self eff icacy 
 stages of change 
Emphasis on relapse 
prevention 
Social Support Encourage enlisted 
support of friend / 
partner 
Encourage enlisted 
support of friend / 
partner 
Encourage enlisted 
support of friend / partner 
Encourage enlisted 
support of friend / partner 
Personalisation  - Involve decisional 
balance 
- Involve decisional 
balance 
- Involve decisional 
balance 
- Involve decisional 
balance 
- Encourage small 
changes 
- Encourage small 
changes 
- Encourage small 
changes 
- Encourage small 
changes 
- Discuss “cheap & 
easy” options and  
“investment” 
priorities 
- Discuss “cheap & 
easy” options and  
“investment” 
priorities 
- Discuss “cheap & easy” 
options and  
“investment” priorities 
- Discuss “cheap & easy” 
options and  
“investment” priorities 
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Appendix R 
Sensitivity Analysis 
A sensitivity analysis was carried out on the primary outcome data to assess robustness and 
consider what impact certain influences may have on the primary outcome data such as 
missing data and outliers.  The analysis intended to show the level of consistency between 
the results of the primary analysis and the results from the sensitivity analysis to strengthen 
the conclusions and credibility of the findings. The sensitivity analysis would control for the 
effect of missing data, outliers and the impact of distributional assumptions on the primary 
outcome weight loss. 
Missing data 
As the study was powered to a detect weight loss of 7%, intention to treat analyses were 
carried out on the primary outcome only and secondary outcomes analysis carried out only 
on subjects who completed the study. To preserve sample size and prevent bias from a non-
representative sample a multiple imputation method was used. Selecting a random number 
generator program in SPSS allowed missing values to be replaced giving reasonable 
assurance that the values that were replaced through the process were appropriate and 
matched the data that was missing. This method gave a best estimate of what the actual 
missing values were likely to have been. 
 
Process of Imputing missing values  
The process was carried out in SPSS version 21. Multiple simulations were run relative to the 
available data in order to identify the probability value of the missing data and create a full 
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data set.  Several iterations were run to find the best fit to replace the missing data. A 
pattern of analysis test run first to identify if the missing data was random or systematic 
indicated that the results showed a non monotonisity, i.e. no pattern.  Thus, it was 
concluded that the data was randomly missing. This confirmed there was minimal risk of the 
original data being biased by missing data.  Numbers were then selected from the random 
number generator program Mersenne Twister and five simulations were chosen. Each of the 
5 simulations generated a value for the variables used as predictors for imputing the missing 
values.  The final value selected to replace the missing value was an average of the 5 
simulations. The full data set was then used to compare results from the original primary 
analysis with the imputed missing data. 
Test for normality 
Visual interpretation of the data in the form of histograms, box plots and QQ plots were 
explored to test for normality of data distribution on the primary outcome variable (kg 
weight loss). The result showed a right skewed distribution with kurtosis displaying a 
leptokurtic distribution, (where the distribution of data is more peaked than that of a 
normal or 'bellcurve' distribution) a skewness of 2.38 (SE 0.14) and kurtosis of 22.95 (SE 
0.28).  Both Kolmogorov-Smirnov and Shapiro-Wilk tests also confirmed a p value of <0.05, 
thereby rejecting the null hypothesis and concluding that the sample did not follow a 
normal distribution. There was little difference in the mean weight loss in the original data 
(n = 246), 1.63kg (SD 3.82) compared with the mean of the imputed data (n= 314), 1.49kg 
(SD 3.94) (Figures 5.1 and 5.2) 
 
270 
 
Figure Error! No text of specified style in document..2:  
kg weight loss with imputed data  
 
 
 
Figure Error! No text of specified style in 
document..3:  kg weight loss original Data 
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Minimising the effect of outliers 
As the data followed a positive skew for kg weight loss the next step was to carry out a log 
transformation in an attempt to normalise the data. The result showed a mean weight loss 
of 0.32kg (SE 0.33) for the original data and skewness of -0.48 (SE 0.19) and kurtosis of 0.58 
(SE 0.38), and in the imputed data a mean of 0.33kg (SE 0.30), a skewness of -0.67 (SE 0.17) 
and kurtosis of 0.76 (SE 0.34). The Kolmogorov-Smirnov test confirmed a p value of <0.05 for 
the original data. The Kolmogorov-Smirnov and Shapiro-Wilk tests rejected the null 
hypotheses for normality for imputed data concluding that log transforming the data did not 
produce a normal distribution. Figure 5.3 shows QQ plot with Log10 transformation. 
 
Figure Error! No text of specified style in document..4:  QQ Plot kg weight loss Log10 Transformed Original 
Data 
A second attempt to normalise the data distribution computed Z-scores to identify outliers. 
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Scores greater than 3 and less than -3 were considered outliers and removed, the results 
showed a mean kg weight loss of 1.24kg (SE 0.72 skewness of -0.07 (SE 0.06) and kurtosis of 
0.50 (SE 0.12),  with the skew now changing to a negative skew but with more normal 
kurtoses. Figure 5.4 shows the original kg weight loss data without conversion of outliers 
whilst figure 5.5 shows QQ plot of kg weight loss with converted z scores on original data.  
  
Figure Error! No text of specified style in document..5:  QQ Plot kg weight loss original data 
 
Figure Error! No text of specified style in document..6:  QQ Plot kg weight loss outliers removed with z scores 
(original data)      
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Appendix S 
Two-variable model to predict weight loss 
Predictor Variables P -values All Variables 
significant 
Adjusted R2 
Randomised Group 
Seasonal Group 
<0.001 
 0.005 
Yes 
 
0.065 
 
Randomised Group 
Marital Status 
<0.001 
<0.005 
Yes 
 
0.088 
Randomised Group 
Employment Status 
<0.001 
0.015 
Yes 0.088 
Randomised Group 
BMI kg/m2 
<0.001 
0.871 
No 0.014 
Randomised Group 
Hip/Waist Ratio 
<0.001 
0.416 
No 0.078 
Randomised Group 
Educational Attainment 
<0.001 
0.503 
No 0.083 
Randomised Group 
Baseline Total Cholesterol 
<0.001 
0.789 
No 0.033 
Randomised Group 
SIMD 
<0.001 
0.332 
No 0.069 
Randomised Group 
Gender 
<0.001 
0.116 
No 0.074 
Seasonal Group 
Marital Status 
0.031 
0.003 
Yes 
 
0.088 
Seasonal Group 
Gender 
0.031 
0.309 
No 0.044 
Seasonal Group 
BMI kg/m2 
0.031 
0.837 
No 0.031 
Seasonal Group 
Hip/Waist Ratio  
0.031 
0.490 
No 0.043 
Seasonal Group 
Educational Attainment 
0.004 
0.773 
No 0.040 
Seasonal Group 
Baseline Total Cholesterol 
0.004 
0.619 
No 0.028 
Seasonal Group 
SIMD 
0.003 
0.234 
No 0.047 
Seasonal Group 
Employment  
0.004 
<0.001 
Yes 0.013 
Employment Status <0.001 No 0.017 
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Gender 0.225 
Employment Status 
BMI kg/m2 
<0.001 
0.887 
No 0.055 
Employment Status 
Hip/Waist Ratio  
<0.001 
0.387 
No 0.026 
Employment Status 
Marital Status 
<0.001 
0.009 
Yes 0.013 
Employment Status 
Educational Attainment 
<0.001 
0.973 
No 0.013 
Employment Status 
Baseline Total Cholesterol  
<0.001 
0.834 
No 0.019 
Employment Status 
SIMD 
<0.001 
0.649 
No 0.014 
Marital Status 
Gender 
<0.005 
0.411 
No 0.063 
Marital Status 
BMI kg/m2 
<0.005 
0.761 
No 0.011 
Marital Status 
Educational Attainment 
<0.005 
0.878 
No 0.054 
Marital Status 
Baseline Total Cholesterol  
<0.001 
0.554 
No 0.056 
Marital Status 
SIMD 
<0.001 
0.469 
No 0.062 
Marital Status 
Hip/Waist Ratio  
0.009 
0.492 
No 0.064 
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Three variable model to predict weight loss 
Predictor Variables P -values All Variables 
significant 
Adjusted R2 
Randomised Group 
Seasonal Group 
Marital status 
<0.001 
0.034 
0.009 
Yes 0.085 
Randomised Group 
Seasonal Group 
Employment 
<0.001 
0.007 
<0.001 
Yes 0.085 
Randomised Group 
Seasonal Group 
BMI kg/m2 
0.002 
0.021 
0.840 
No 0.036 
Randomised Group 
Seasonal Group 
Hip/Waist Ratio  
<0.005 
0.096 
0.560 
No 0.077 
Randomised Group 
Seasonal Group 
Educational Attainment 
<0.001 
0.033 
0.593 
No 0.084 
Randomised Group 
Seasonal Group 
Baseline Total Cholesterol 
<0.001 
0.005 
0.702 
No 0.083 
Randomised Group 
Seasonal Group 
SIMD 
<0.001 
0.004 
0.224 
No 0.062 
Randomised Group 
Seasonal Group 
Gender 
<0.001 
0.007 
0.152 
No 0.073 
Seasonal Group 
Employment Status 
Marital Status 
<0.001 
0.012 
0.026 
Yes 0.009 
Seasonal Group 
Employment Status 
Gender 
0.005 
<0.001 
0.329 
No 0.014 
Seasonal Group 
Employment Status 
BMI kg/m2 
0.031 
<0.001 
0.880 
No 0.010 
Seasonal Group 
Employment Status 
Hip/Waist Ratio 
0.022 
<0.001 
0.406 
No 0.023 
Seasonal Group 0.004 No 0.009 
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Employment Status 
Education 
<0.001 
0.977 
Seasonal Group 
Employment Status 
Baseline Total Cholesterol 
0.004 
<0.001 
0.736 
No 0.015 
Seasonal Group 
Employment Status 
SIMD 
0.003 
<0.001 
0.338 
No  
0.010 
Marital Status 
Employment Status 
Gender 
0.010 
<0.001 
0.331 
No 0.013 
Marital Status 
Employment Status 
BMI kg/m2 
0.005 
<0.005 
0.778 
No 0.011 
Marital Status 
Employment Status 
Hip/Waist Ratio 
0.022 
<0.001 
0.375 
No 0.023 
Marital Status 
Employment Status 
Educational Attainment 
0.012 
<0.001 
0.991 
No 0.009 
Marital Status 
Employment Status 
Baseline Total Cholesterol 
0.002 
<0.001 
0.633 
No 0.015 
Marital Status 
Employment Status 
SIMD  
0.009 
<0.001 
0.656 
No 0.010 
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Four variable Modelling 
Predictor Variables P -values All Variables 
significant 
Adjusted R2 
Randomised Group 
Seasonal Group 
Employment Status 
Marital Status 
0.087 
<0.001 
0.015 
<0.001 
No 0.081 
Randomised Group 
Seasonal Group 
Employment Attainment 
Gender 
<0.001 
0.008 
<0.001 
0.157 
No 0.091 
Randomised Group 
Seasonal Group  
Employment Status 
BMI kg/m2 
<0.005 
0.096 
<0.001 
0.864 
 
No 
 
0.086 
Randomised Group 
Seasonal Group 
Employment Status 
Hip/Waist Ratio 
<0.001 
0.055 
<0.001 
0.409 
No 0.094 
Randomised Group 
Seasonal Group 
Employment Status 
Marital Status 
<0.001 
0.015 
<0.001 
0.087 
No 0.081 
Randomised Group 
Seasonal Group 
Employment Status 
Educational Attainment 
<0.001 
0.028 
<0.001 
0.907 
 
No 
0.091 
Randomised Group 
Seasonal Group 
Employment Status 
Baseline Total Cholesterol 
<0.001 
0.005 
<0.001 
0.744 
No 0.088 
Randomised Group 
Seasonal Group 
Employment Status 
SIMD 
<0.001 
0.005 
<0.001 
0.414 
 
No 
0.081 
Marital Status 
Randomised Group 
Seasonal Group 
Gender 
0.012 
<0.001 
0.035 
0.231 
No 0.091 
Marital Status 0.006 No 0.086 
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Randomised Group 
Seasonal Group 
BMI kg/m2 
0.009 
0.047 
0.702 
Marital Status 
Randomised Group 
Seasonal Group 
Waist 
0.052 
0.004 
0.192 
0.613 
No 0.095 
Marital Status 
Randomised Group 
Seasonal Group 
Educational Attainment 
0.022 
<0.001 
0.127 
0.887 
No 0.085 
Marital Status 
Randomised Group 
Seasonal Group 
Baseline Total Cholesterol 
0.008 
0.003 
0.025 
0.609 
No 0.088 
Marital Status 
Randomised Group 
Seasonal Group 
SIMD 
0.012 
<0.001 
0.027 
0.300 
No 0.081 
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